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Abstract
This dissertation is related to the studies of functionalized nanoparticles for
self-assembly and as controlled drug delivery system. The whole topic is composed of
two parts. In the first part, the research was conducted to design and synthesize a new
type of ionic peptide-functionalized copolymer conjugates for self-assembly into
nanoparticle fibers and 3D scaffolds with the ability of multi-drug loading and governing
the release rate of each drug for tissue engineering. The self-assembly study confirmed
that

such

peptide-functionalized

amphiphilic

copolymers

underwent

different

self-assembly behavior. The bigger nanoparticles were more easily assembled into
nanoparticle fibers and 3D scaffolds with larger pore size, while the smaller nanoparticle
underwent faster self-assembly to form more compact 3D scaffolds with smaller porosity
but more stable structure. Controlled release studies confirmed the ability of governing
simultaneous release of different model drugs with independent release rate from a same
scaffold. Cytotoxicity tests showed that all synthesized peptides, copolymers and
peptide-copolymer conjugates were biocompatible with SW-620 cell lines and NIH3T3
cell lines. This new type of self-assembled scaffolds combined the advantages of peptide
nanofibers and versatile controlled release of polymeric nanoparticles to achieve
simultaneous multi-drug loading and controlled release of each drug, uniform distribution
and flexibility of hydrogel scaffolds.
The investigations in second part were first to design and synthesize organic
biocide-loaded nanoparticles for low-leaching wood preservation using a cost-effective
one-pot method to synthesize amphiphilic chitosan-g-PMMA nanoparticles loading with
~25-28 wt.% of the fungicide tebuconazole with particle size of ~100 nm diameter by
FESEM. FESEM analysis confirmed efficient penetration of nanoparticles throughout the
treated wooden stake with dimension of 1919455 mm. Leaching studies showed that
biocide introduced into sapwood via nanoparticles leached only ~9% compared with the
xv

amount leached from tebuconazole solution-treated control, while soil jar tests showed
that the nanoparticle-treated wood blocks were effectively protected from biological
decay tested against G. trabeum, a brown rot fungus.
Copper oxide nanoparticles with and without polymer stabilizers were also
investigated to use as inorganic wood preservatives to clarify the factor affecting copper
leaching from treated wood. Copper oxide nanoparticles with uniform diameters of ~10
nm and ~50 nm were prepared, and the leachates from southern pine sapwood treated
with these nanoparticles were analyzed. It was found by TEM and EDS analysis that
significant numbers of nanoparticles leached from the treated wood. The 50 nm
nanoparticles leached slightly less than a soluble copper salt control, but 10 nm
nanoparticles leached substantially more than the control. The effect of polymer
stabilizers on nanoparticle leaching was also investigated.

Results showed that polymer

stabilizers increased leaching. The trends showed that nanoparticle size was a major
factor in copper leaching.

xvi

Chapter 1 Introduction
1.1 General Introduction
This dissertation is a collection of already-published articles or articles that are being
prepared for submission. It is comprised of two parts, with both parts being related to
design and synthesis of functionalized nanoparticle for self-assembly and for controlled
drug delivery systems. The first part describes the synthesis and fabrication of a new type
of ionic complementary peptide-functionalized amphiphilic copolymer designed to
self-assemble into sophisticated polymeric nanoparticle fibers and 3D scaffolds that have
the ability to simultaneously load multiple drugs and to separately govern the release rate
of each drug for appropriate release levels. The methodology could be applied for various
applications but here the intended application was for tissue engineering. The second part
of this dissertation describes the synthesis and testing of biocide-loaded nanoparticles for
use in low leaching wood preservation. Each dissertation part has its own features and
considerations for design and application, but also has common features with respect to
nanoparticles as controlled drug delivery system. This chapter will introduce the
background information, rationale, and perceived advantages of the materials
investigated in this dissertation.
1.2 Introduction for Part A
The objective of Part A is to fabricate an advanced self-assembled nanoparticle fiber
scaffolding system with the following advantages: (1) versatility so that different drugs
can be introduced into nanoparticle matrices that are appropriate to each drug so release
rates can be appropriately governed; (2) to control assembly of the individual
nanoparticles into a fiber scaffold; (3) to control the sequence and spatial arrangement of
the drug-loaded nanoparticles in the scaffold; (4) study further self-assembly into a 3D
scaffolding system; and (5) demonstrate the ability to combine the advantages of
1

controlled release of multiple drugs with biocompatible tissue scaffolds, and retain these
abilities in an injectable hydrogel scaffold system.
Such

a

polymeric

nanoparticle

fiber

has

substantial

advantages

over

electrospunnanofibers, traditional hydrogels, and nanofiber/hydrogel blends. To the best
of our knowledge, such polymeric nanoparticle fibers and 3D scaffolds are a
fundamentally new approach to self-assembly systems, and are reported here for thefirst
time.
1.2.1 Background on Polymeric Hydrogel Scaffolds and Their Limitation
Artificial scaffolds, such as hydrogels and nanofibers, have been under extensive
investigations for biological mimic of extracellular matrix to increase cell survival and also
guide cell activities to improve tissue regeneration (1-3). Many studies have shown that
effective tissue regeneration is usually dependent on delivery of multiple drugs and other
active ingredients, such as growth factors, to the cells within the damaged tissue region (4).
For example,effective skin regeneration usually requires a complex set of growth factors
and cytokines, such as fibroblast growth factor, keratinocyte growth factor, vascular
endothelial growth factor and interleukin 1α, to be delivered to and release within the
damaged region to promote cell proliferation and migration to achieve wound healing
(5,6). Another example is regeneration of neural tissue of the retina, which is a light
sensitive layer of tissue lying in the inner surface of the eye. The retina itself consists of
multiple cellular layers across a depth of 100-130 µm (7). Studies show that successful
retina tissue regeneration requires a scaffold having the ability to simultaneously localize
multiple growth factors (i.e. amino-terminal sonic hedgehog for rod photoreceptor cells
and ciliaryneurotrophic factor for bipolar cells) to promote the differentiation of the retinal
precursor cells to mature cells (8). Therefore, it is clear that the tissue regeneration
significantly benefits from scaffolding systems with advanced drug delivery abilities for
multiple drugs.
2

Conventional polymeric hydrogels, whether from synthetic or natural polymers, have
been widely studied as scaffold systems, with and without incorporated drugs, for tissue
regeneration. For example, bioactive ingredients have been physically or chemically
incorporated in synthetic hydrogels such as poly(ethylene glycol) (PEG) hydrogels (9,
10),poly(lactide)-b-poly(ethylene

oxide)-b-poly(lactide)

(PLA-b-PEO-b-PLA)

or

poly(lactic-co-glycol acid) (PLGA) (11,12), and natural polymer hydrogels, e.g. alginate,
collagen, chitosan, gelatin (13-19). But most of these traditional scaffolds can
accommodate only a single drug and have limited ability to control the drug release rate.
Multi-drug loading in polymeric hydrogels has been reported, but as drug delivery
systems and not a tissue scaffold (20-22). For example, Salmaso et al. (21)
simultaneously loaded different model drugs in cyclodextrin-PEG hydrogels by swell
embedding. The maximal incorporation by this method for lysozyme, β-estradiol, and
quinine was 2, 0.6 and 2.4 wt.% respectively, but there was little ability to governing the
release of each drug, which had different physical properties. Lysozyme was quickly
released, while β-estradiol and quinine release was inversely proportional to the
cyclodextrin/PEG ratio. The release profiles were significantly affected by interaction of
the drugs with hexamethylated β-cyclodextrins in the hydrogel matrices. Such release
profiles imply the non-effective distribution of the loaded drugs in hydrogels. If such a
material is used as a multi-drug loaded hydrogel for tissue regeneration, the non-uniform
drug distribution and poor drug release profiles will not be able to guide cell activity and
could be detrimental.
Scaffolding with controlled delivery of multiple growth factors (GFs) for tissue
engineering, including hydrogels, microsphere gels, and polymeric micro/nanoparticle
encapsulations, have also been studied and reviewed (23). Typical methods for
incorporation of multiple GFs include: combining multi-layer hydrogels with each layer
loaded with one type of growth factor, or hydrogel loading coupled with microsphere
3

loading, or hydrogel loading with micro/nanoparticle loading (23). These techniques each
have their own advantages with respect to their ability to load different GFs, and also
showed some control over the release rate of the loaded GFs, but these methods do not
allow control over the placement and distribution of each micro/nanoparticle.
1.2.2 Self-Assembling Peptide Scaffolds and Their Limitation
Self-assembled peptide nanofiber scaffolds have increased in popularity for tissue
engineering due to non-toxicity, biodegradability, and because the micro-environment it
provides may be similar to the extracellular matrix for cell attachment and in situ
formation of a hydrogel under physiological conditions (24). A typical ionic
complementary β-sheet peptide AEAK16-II (AEAEAKAKAEAEAKAK) was first
discovered in a yeast protein, zuotin (25). This type of ionic complementary peptide
shows a spontaneous self-assembly into stable β-sheets in aqueous conditions, across a
broad range of temperature, and a wide pH range, and the scaffold can maintain integrity
in the presence of high concentrations of the denaturing agents of urea and guanidium
hydrochloride (26,27).
The driving forces for self-assembly of the peptides are the hydrophobic interactions
of alanine (A) domains and the ion-pair interactions between negatively charged glutamic
acid (E) side chains and positively charged lysine (K) side chains. The strong ion-pair
interactions contribute to stable β-sheet formation, which was further supported on
studying another pair of designer peptides, i.e. self-repulsive but mutually attractive
peptide sequences that possessed positive charges (Ac-WKVKVKVKVK-amide) and
negative charges (Ac-EWEVEVEVEV-amide) (28). On mixing this pair of ionic
complementary peptides, a rapid assembly into a viscoelastic hydrogel occurred at a
concentration as low as 0.25 wt.%. This hydrogel retained mechanical strength, even after
repeated shear-induced breakdowns, due to the electrostatic interactions. The strong
electrostatic and selective interactions between the opposite charges proved to be one of
4

the key merits of using ion-complementary β-sheet peptides.
Self-assembling peptide nanofibers using designed (i.e. not naturally occurring)
peptides (e.g. EAK16-II, RADA16-I or II) have been widely used as both controlled drug
delivery systems and 3D scaffolds (29,30). This is typically done by physically
incorporating a desired drug into the peptide scaffold during gel formation (31,32), or by
chemically bonding it onto the C-terminal or N-terminal of the peptide (33). Sometimes a
combination of both methods is used to load multiple active agents (34,35). However,
these methods still have significant limitations with respect to the quantity of drug(s) to
be incorporated, and the properties of drug(s) may have an impact on the subsequent
self-assembly process or the mechanical stability of the formed hydrogel. Therefore, this
approach is very limited in its ability to control the release of drugs with different
properties within a same scaffold (36,37). Moreover, effective distribution of multiple
drugs in scaffolds is not always easy to achieve, so the peptide hydrogel itself must be
designed in conjunction with the specific drug(s) that will be incorporated. Because of
these limitations the self-assembling peptide scaffolds are either unsophisticated to satisfy
the current requirements for tissue engineering applications.
1.2.3 Nanocomposite Hydrogel Scaffolds and Their Limitation
Because of the limitations of the scaffoldsystemsmentionedabove, researchers sought
a more powerful and versatile technique to allow multiple drug incorporation within
scaffolding systems so that the release rate of each drug could be controlled appropriately
(23,38). There are many ways to deliver drugs, such asmicelles, colloids, capsules, and
solid polymeric nanoparticles, including self-assembled core-shell nanoparticles (39,40).
Solid polymeric nanoparticles have been used for oral drug delivery (41), epidermal
injection (42), targeted delivery of anticancer drugs to cancer cells (43), and delivery of
bioactive drugs for central nervous system regeneration (44,45). Core-shell polymeric
nanoparticles are particularly attractive for use in tissue scaffolding because the core can be
5

designed to be suitable for a desired hydrophilic or hydrophobic drug while the shell can be
designed to be suitable for the use environment. Also, core-shell nanoparticles are
relatively easy to prepare with a controlled particle size, and various biocompatible
hydrophilic and hydrophobic monomers are commercially available to make block
copolymers that self-assemble into core-shell nanostructures (46).
Even though polymeric nanoparticles have been used as versatile controlled delivery
system for various drugs, the nanoparticle itself lacks scaffolding property to guide cell
activities for tissue regeneration.
In recent years, nanocomposite hydrogels have been studied. In these hydrogels
drug-containing nanoparticles have been blended into hydrogels to form a new generation
of scaffolds for tissue engineering (47). Nanocomposite hydrogels are generally produced
by chemically or physically cross-linking a polymer network to surface functional groups
of the incorporated nanoparticles. Inorganic nanoparticles, such as silicate nanoparticles,
magnetic nanoparticles and calcium phosphate nanocrystals (48-51), have been widely
used to fabricate this type of hydrogel due to the abundance of surface functional groups
that can interact with a polymeric network by covalent bonding, ionic interaction or
hydrogen-bonding.
Studies of composite nanoparticle hydrogels have included specimens loaded with
individual drugs and multiple drugs (23,52,53). For example, encapsulation of
DNA/cationic polymer nanoparticles in hydrogel formed efficient surface-mediated
delivery of genesinto cells (52). Lynch et al. (53) also fabricated a multiple drug loaded
composite hydrogel by separately incorporating two different model drugs within
hydrophobic microgels and anionic microgels and then embedding these within the host
gel. Both model drugs showed simultaneous and independent release at different rates
from the composite hydrogel. Most recently, Caicco et al. (54) developed a physically
blended composite hydrogel of hyaluronan-methylcellulose (HAMC) for the localized
6

delivery and sustainable release of CyclosporinA (CsA), a promising neuroprotective and
neuroregenerative agent for neural stem/progenitor cells for treatment of stroke. The
author incorporated CsA in HAMC gel by three different methods and compared their
release rate from the gel. These incorporation types include a solubilized type
(CsA/acetonitrile solution mixed with HAMC gel), a particulate type (CsA solid
particulate dispersed in methyl cellulose solution and then embedded in HAMC gel) and
poly(lactic-co-glycolic acid) (PLGA) microsphere-encapsulated CsA type (CsA loaded in
PLGA microspheres and then embedded in HAMC gel).Interestingly, the in-vitro
controlled release tests showed that solubilized CsA type directly released from HAMC
gel only for 2 days, while the particulate type gave a controlled release over 7-10 days,
but PLGA microsphere encapsulated CsA type showed sustainable release over 21 to 28
days. Most importantly, the CsA released from PLGA microspheres retained the same
biological activity as fresh CsAwhen compared in aneurosphere assay (54).
Unfortunately, most of the investigations of polymeric nanoparticle composite
hydrogel are still confined to use as drug delivery system. Due to the lack of effective
surface functional groups or ligands, the polymeric nanoparticles themselves cannot
self-assemble into well-organized arrays, leading to ineffective distribution within host
polymer network via limited bond interaction, such as ionic interaction, or hydrogen
bonding, or even just van der waals force. Although multiple drug loading and releasing
in a hydrogel have been tried (23,52), the nanoparticles tend to randomly aggregate
leading to a non-uniform distribution of the drug and an uncontrolled concentration
gradient of the drug within the scaffold if such techniques are used to fabricate composite
hydrogel scaffolds for tissue regeneration. Thus the self-assembly of polymeric
nanoparticles to form well-organized array with effective interaction with the host
hydrogel scaffold are necessary to fabricate more sophisticated composite scaffold
systems for tissue engineering.
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1.2.4 Self-Assembled Peptide-Nanoparticle Precedents
The key merit of using ion-complementary peptides to fabricate sophisticated
assembly systems is their spontaneous self-assembly into stable β-sheets in aqueous
solution, which occurs because of the strong electrostatic and selective interaction
between opposite charges. Using peptide directed assembly of nanoparticles has received
limited attention, and prior to this work was limited to inorganic nanoparticles (i.e. gold
nanoparticles, nanotubes) arraysusing self-assembled peptide structures as templates or as
assembly ligands (55-58). For example, Nikhil et al.(56) reported a well-organized
one-dimensional gold nanoparticle line formed on a self-assembled polypeptide template,
and the formation of the nanoparticle array was directed by positive charges on peptide
fiber surface. Another recent report showed a simple method to fabricate a
two-dimensional gold nanoparticle line pattern on mica surface from a designed β-sheet
peptide (LELC16)-functionalized gold nanoparticles. Here the formation of gold
nanoparticle alignment was directed by β-sheet self-assembly (57). Peptide amphiphiles
with alkyl tails or polymer-peptide conjugates have also been studied, but still limited to
nanofiber hydrogels for biological applications (59,60). No precedent has been found for
using peptide self-assembly to fabricate polymeric nanoparticle arrays or 3D scaffolds for
biological application.
1.2.5 Rationale and Advantages of Research Performed in Part A
To address the limitations of the current scaffolding systems described above, it can be
seen that a more advanced tissue scaffolding system can be achieved by using
peptide-directed assembly of individual controlled-release devices (here core-shell
nanoparticles) to give a new type of scaffold that combines the advantages of easy delivery
of multiple drugs in matrices that give appropriate control of the release rate of each
desired drug and can simultaneously serve as the scaffold device. We propose to fabricate a
novel self-assembled polymeric nanoparticle fibers and 3D scaffolds using the attributes of
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ionic complementary β-sheet peptides, by functionalizing sets of nanoparticles with
oppositely charged peptides, and then combining them so they self-assemble into fibers
that are comprised of sequences of individual nanoparticles which can, if desired, carry
active agents and control their release. The general mechanism is shown in Figure 1.1.

Figure 1.1. General procedure shows fabrication of polymeric nanoparticle fibers with
multi-drug loading abilities.

As Figure 1.1 shows, the ends of two batches of amphiphilic copolymer are
separately

functionalized

with

the

newly

designed

peptides

(P1:

H2N-TTTT-AEAEAEAE-amide and P2: H2N-TTTT-AKAKAKAK-amide) to form
peptide-copolymer conjugates, one carrying negative charges from P1, and the other
carrying positive charges from P2. These two peptide-copolymer conjugates are then
undergone two-level self-assembly in aqueous solution. The amphiphilic copolymer
self-assembles into core-shell nanoparticles as drug carriers with charged peptide arms.
The two batches of nanoparticles are coupled and further self-assembled into nanoparticle
fibers directed by ionic complementary assembly between P1 and P2, and finally lead to
9

form 3D nanoparticle scaffolds. Such self-assembled nanoparticle scaffolds possess
several new features: (1) Simultaneously loading of different drugs; (2) Uniform
distribution of different drugs in scaffolds; (3) Ability to give appropriate controlled
release of each loaded drug from its own nanoparticle; (4) Flexibility and “injectability”
of the self-assembled scaffolds; and (5) Further assembly with host peptide to form
nanoparticle composite peptide hydrogel. Collectively these features allow both temporal
and spatial control of the drug release and the surface properties of the scaffold, so the
polymer nanoparticle surface can also be used as platform to further be modified or
immobilized with functional groups or signals for specific tissue engineering application.
Here we use reversible addition fragmentation chain transfer (RAFT) polymerization
to

synthesize

amphiphilic

copolymer

with

reactive

carboxylic

end

groups

(HOOC-ABA-COOH) using S,S-bis(,-dimethylacetic acid) trithiocarbonate (BDAT)
as the chain transfer agent (CTA) (61). RAFT is a controlled radical polymerization,
which allows the synthesis of block copolymers with controlled block length and block
sequence, and therefore, control over the size of both core and shell. The carboxylic acid
end groups at both chain ends are required for the subsequent peptide coupling. The
hydrophilic block for the nanoparticle shell is 1-vinyl-2-pyrrolidinone (VP),
2-hydroxyethyl methacrylate (HEMA) or 2-hydroxyethyl acrylate (HEA), while methyl
methacrylate (MMA) is used for the hydrophobic core. These monomers were selected
because VP, HEMA, HEA and MMA they have been widely used to synthesize
biocompatible homopolymers or copolymers for biological applications (62-65), and
because they are efficiently incorporated into polymer chains produced by RAFT
polymerization (66).
Two ionic complementary peptides, P1and P2, are synthesized by semi-automatic
solid phase peptide synthesis strategy, using Fmoc chemistry, on rink amide resin. These
detailed synthesis procedures are reported in Chapter 2and Chapter 3.
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In Chapter 2 we will prove the hypothesis (Figure 1.1) that ionic complementary
peptide-functionalized tri-block copolymer will self-assemble into nanoparticle fibers and
further lead to 3D scaffolds, by functionalizing sets of amphiphilic copolymers
synthesized

by

RAFT

polymerization

to

form

peptide-copolymer

conjugates

(P1-ABA-P1 and P2-ABA-P2, ABA: triblock copolymer) and perform self-assembly
study in aqueous solution. Controlled release of a model drug (insulin) and a
biocompatibility study of the synthesized materials using SW-620 cell lines will also be
shown in this chapter.
In Chapter 3 we will continue to study the self-assembly behavior of the designed
peptide-functionalized

copolymer

conjugates

with

different

particle

size

and

self-assembly with additional peptides (P1 and P2) to adjust the scaffold porosity and
mechanical stability. Multiple drug loading capability and the ability of controlling the
drug release rate from different nanoparticle compositions are also studied in this chapter,
using several small molecules as model drugs: a hydrophobic model drug
(4’,5’-dibromofluorecein), a moderately hydrophobic model drug (nitrofurazone) and
slightly water soluble hydrophilic model drug (amoxicillin). The biocompatibility test
with fibroblast cells (NIH3T3 cell line) is also conducted by incubating the
self-assembled 2D scaffold membrane with in a humidified incubator at 37 °C for 2
weeks, showing non-toxic and non-inhibition to the cell proliferation and migration.
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1.3 Introduction for Part B
The objective in Part B is to design and synthesize organic and inorganic
biocide-loaded nanoparticles as controlled release systems for wood preservation. Using
biocide-loaded nanoparticles as controlled release systems for wood preservation affords
several advantages: (1) Environmentally friendly polymers can be used as biocide
carriers; (2) Nanoparticles can effectively penetrate the wood interior to protect the wood
interior as well as its exterior; (3) Nanoparticles can serve as a protective reservoir for the
biocide and control the release rate of biocide to protect the treated wood from biological
decay; (4) They can be prepared using simple and cost-effective routes. This section will
introduce the background information, the rationale for the investigation, and the value of
the work.
1.3.1 Background of Wood Preservation
Wood is an environmentally friendly and renewable material possessing unique
physical and mechanical properties, including high strength, low thermal conductivity,
the ability of damp sound or other vibrations, and has a pleasant appearance. Wood
products have a long history of use as construction materials, but must be protected from
biological attack by insects, fungi, mildew, etc. (67).
One of the most important wood preservatives, chromated copper arsenate (CCA) has
been widely used in wood treatment for decades, but its use is being phased out due to
environmental concerns over the arsenic. Two key advantages of CCA are that it “fixes” to
wood, reducing its leaching from the wood into the environment, and CCA can be
introduced into wood by pressure-treatment in aqueous solution. Any alternative to CCA
must also be able to be introduced into wood in an aqueous medium so the wood surfaces
are not oily, odor-free, and not toxic to non-target species.
Ideally CCA alternatives should not leach out of the wood, because this is inherently
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an inefficient use of expensive biocide, but also is toxic to species not attacking the wood
that are not targets. The main alternatives to CCA are organic biocides, such as azoles, and
arsenic-free cooper biocides. Organic biocides are not water-soluble and so may be
introduced in aqueous emulsions. Copper-based preservatives are typically introduced as
water-soluble salts, or in recent years as water-insoluble nanoparticulate copper salts
(carbonates or oxides). The organic biocides and the water-soluble copper salts are known
to leach from treated wood, especially in damp conditions such as when it rains or in
sensitive wetland areas (68,69). Prior to this work there were no published studies on
leaching of copper oxide/carbonate nanoparticles from treated wood.
The research described in Part B of this dissertation investigated leaching of the
organic biocide, tebuconazole, a commercial and widely used azole biocide, and copper
oxide nanoparticles as a representative of the solid copper salt wood preservatives now in
commercial use (70,71).
Tebuconazole is a water insoluble organic biocide, is susceptible to leaching, reducing
the service life of the treated wood, and adding cost since more tebuconazole is used to
compensate for that lost to leaching, as well as detrimental environmental effects to
sensitive environments such as wetlands (72). Prior research in Dr. Heiden’s lab showed
wood treated with tebuconazole contained within controlled-release nanoparticles afforded
protection to the treated wood, but did not study differences in leaching, and also the
method used released the biocide more quickly than was desired (73-75). In Part B of this
work the objective was to look at different matrix formulations, to allow a slower release
rate to be obtained from the nanoparticles than was exhibited in the prior research, and to
determine how effective the nanoparticle method was at reducing leaching when compared
to wood treated with tebuconazole via a liquid-in-liquid emulsion.
Solid copper carbonate and oxide nanoparticles are also commercially employed for
wood preservation, but leaching studies have not been published concerning these
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nanoparticles. The objective of the study using solid copper oxide nanoparticles was to
determine if they leach as nanoparticles (a potential environmental concern), how their
leaching compares with the soluble copper salts they compete against, and to determine if
the size of the nanoparticle affects the leaching. Commercial copper salt nanoparticles are
sold as “micronized” particles (76), but they contain a mixture of various sizes, most of
which are sub-micron. Prior to this research no leaching studies on such particles-treated
wood were in the literature.
1.3.2 Rationale for Controlled Release of Organic Wood Preservatives
In our earliest work on nanoparticle-treated wood preservation we used a precipitation
route

to

prepare

nanoparticles

from

pre-made

random

copolymers

of

poly(vinylpyridine-co-styrene) (73-75). The work was novel at that time, and showed
effective penetration of the wood interior and protected the treated wood from decay. The
method also had two major drawbacks: the release rate was controlled but faster than it
needed to be, and the nanoparticle preparation method, while simple, required dilute (≤ 1
wt%) conditions. To address these drawbacks we then studied a preparation method that
allowed us to synthesize core-shell nanoparticles in a one-pot/one-step nanoparticle. The
critical advantages of this method are that the core, serving as a reservoir for the biocide,
could be made as hydrophilic or hydrophobic as needed to give significant control over the
rate to biocide release, while the shell could be made hydrophilic to stabilize the resulting
nanoparticles in water. Furthermore, this method allows the polymer synthesis and the
nanoparticle preparation to be made at ≥ 10 wt% solids in water. In that work gelatin was
used to form the shell, and methyl methacrylate (non-polar) and hydroxyethyl methacrylate
(polar) were grafted from the amine groups of the gelatin to prepare the amphiphilic
copolymers that self-assembled into core-shell nanoparticles. When the polymerization
was done in the presence of tebuconazole, the core-shell nanoparticles contained
tebuconazole (77). However, while the gelatin is inexpensive and biologically safe, it is
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itself prone to fungal decay, and un-grafted gelatin complicated leaching tests. For that
reason, in this work a similar study was done using chitosan, the second most abundant
polysaccharide, which is also non-toxic, biodegradable, and bears numerous amine
functional groups to be grafted with hydrophobic monomers to self-assemble into
core-shell nanoparticle (78,79). So we use chitosan as a starting material and grafted with
methacrylate monomers such as methyl methacrylate (MMA) and hydroxyethyl
methacrylate (HEMA) to form amphiphilic copolymers that self-assembled into solid
tebuconazole-containing core-shell nanoparticles and treated wood with these
nanoparticles to test and compare tebuconazole leaching. The reaction mechanism is
outlined in Figure 1.2.

Figure 1.2. Mechanism of preparing self-assembled chitosan-g-PMMA nanoparticles
loading with tebuconazole by one-pot method.
In

Chapter

4,

the

synthesis

and

characterization

of

biocide-loaded

chitosan-g-PMMA nanoparticles are shown, and the synthesis conditions and formulation
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are studied to determine how they affect nanoparticle size and biocide release rate. The
nanoparticle size can be adjusted to < 150 nm by setting reaction concentration and
chitosan to MMA ratio. The release rate of tebuconazole from nanoparticle can be
manipulated by adjusting the monomer ratio of MMA:HEMA comprising the core during
polymerization. Effective nanoparticle penetration throughout the treated wood, low
leaching of biocide, and wood protection when tested for fungi decay are demonstrated in
this chapter.
The biocide-loaded nanoparticle suspension prepared by such one-pot synthesis route
is cost-effective and can be directly used to pressure treat wood products without post
process. The reduced leaching of biocide will increase wood preservation period and
eliminate toxic impact on neighboring environment, and low cost preparation method
also matches the market requirement using nanotechnology for wood preservation.
1.3.3 Rationale for Study of Copper Oxide Nanoparticle Leaching
Since copper oxide nanoparticle treated wood products are already commercially
available, but no research in the public domain has been conducted to determine if the
nanoparticles are leached or factors affecting leaching behavior of copper from the treated
wood including the size of nanoparticles. To answer these questions copper oxide
nanoparticles were prepared at different diameters, with and without a polymer shell, and
used to treat wood and test leaching. The reaction mechanism is shown in Figure 1.3.
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Figure 1.3. Synthesis of CuO nanoparticles with or without polymer-stabilizer by
aqueous thermal hydrolysis using deionized water as the solvent and heating at reflux.

Chapter 5 describes how the copper oxide diameter was controlled so the leaching of
nanoparticles with a uniform sized of ~10 nm and ~50 nm, with and without a polymer
shell. The questions this study asked and answered are: (1) Does nanoparticle size
influence copper leaching; (2) Is any leached copper leached as nanoparticles; (3) Do
copper oxide nanoparticles leach more or less than copper from to soluble copper salt
(ACQ) used as a commercial wood preservative; (4) Do smaller nanoparticles show higher
bioactivity compared to ACQ; and (5) Does a polymer shell on the copper oxide
nanoparticles affect copper leaching?
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Abstract
A novel self-assembled 3D nanoparticle fiber scaffold was designed and synthesized
with the ability to govern the controlled release of multiple drugs, by preparing ionic
complementary peptide-functionalized amphiphilic block copolymers that self-assemble
into polymeric nanoparticles, and then into fibers, leading to 3D fiber scaffolds. Two
complementary peptide sequences were prepared that can assemble into β-sheets in
aqueous solution (neutral water or PBS solution at pH 7.4). The terminal amines of the
peptides were coupled to amphiphilic triblock copolymers, synthesized by RAFT
polymerization, with carboxylic acid terminals (HOOC-A-B-A-COOH), to give the
desired peptide-copolymer conjugates. The peptides, copolymers, and peptide-copolymer
conjugates were characterized by 1H-NMR, matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry and FTIR. Optical microscopy confirmed the assembly
of the peptide-copolymer conjugate nanoparticles into fibers and scaffolds. The assembly
was not hindered when a protein (insulin) was included within the nanoparticles as an
active ingredient. The release rate of insulin was measured over three weeks. MTS
cytotoxicity tests on SW-620 cell lines showed that the peptides, copolymers and
peptide-functionalized

copolymers

were

biocompatible.

The

methodology

of

self-assembled nanoparticle fibers and 3D scaffolds combines the advantages of a flexible
hydrogel scaffold and the versatility of controlled release systems.

Key words: β-sheet peptide, self-assembly, nanoparticle fiber, scaffold, RAFT
polymerization, drug delivery, amphiphilic copolymer, core-shell
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2.1 Introduction
The self-assembly of β-sheet peptides is a well-established and versatile technique to
fabricate 3-dimensional (3D) scaffolds for biological applications, with or without
encapsulation of some bioactive agent (1). A typical β-sheet peptide motif is (AEAK)16-II
(AEAEAKAKAEAEAKAK). This motif, composed of periodic repeats of ionic
hydrophilic and hydrophobic amino acids, was first discovered in a yeast protein (2). This
type of ionic complementary peptide shows a spontaneous self-assembly into stable
β-sheets in aqueous conditions. The driving forces are the hydrophobic interactions of
alanine (A) side chains and ion-pair interaction between negatively charged glutamic acid
(E) side chains with positively charged lysine (K) side chains. The strong ion-pair
interaction leading to β-sheet formation was further illustrated using a pair of
self-repulsing, but mutually attracting, peptide sequences that possessed positive charges
(Ac-WKVKVKVKVK-amide) and negative charges (Ac-EWEVEVEVEV-amide) (3).
On mixing this pair of oppositely charged peptides, a rapid assembly into a viscoelastic
hydrogel occurred, even though the total peptide concentration was only 0.25 wt.%. This
hydrogel retained mechanical strength, even after repeated shear-induced breakdowns,
due to the electrostatic interactions. The strong electrostatic and selective interaction
between

opposite

charges

demonstrated

one

of

the

key

merits

of

using

ion-complementary β-sheet motifs.
Those attributes are used in this work to provide a novel method to fabricate ordered
nanoparticle arrays or fibers, by functionalizing sets of nanoparticles with oppositely
charged peptides, and then combining them so they self-assemble into fibers that are
themselves comprised of sequences of individual nanoparticles which can, if desired, be
used to carry active agents and control their release. This is the hypothesis we are going
to prove in the present work, in its simplest form, by assembling the fibers and scaffolds
with no more than two nanoparticles and a single active agent.
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The use of a single drug at this early stage of the research is to minimize the number
of variable that might affect the assembly. However, it is also important to prove the
ability to control the release of an active agent, because in many biological applications,
it is desirable for the scaffold to contain and potentially release various “active agents”
(e.g. low molecular weight drugs or various proteins), to direct cell activities or improve
therapeutic efficacy. Here, for the sake of simplicity we will use the term drug to refer to
any active agent.
Peptide hydrogels have been a popular device for use as both a controlled drug
delivery system and 3D scaffold, this is typically done by simply physically entrapping a
drug into the peptide scaffold during mixing before gel formation (4,5), or chemically
bonded onto the C-terminal or N-terminal (6), or some combination of both methods to
load multiple active agents (7,8). However, these methods have significant limitations
with respect to the quantity of drug(s) that can be “loaded”, and the drug(s) may have an
impact on the subsequent self-assembly process or the mechanical stability of the formed
hydrogel, and there is very limited ability to control the release of the drug(s). Therefore,
the hydrogel itself must be designed in conjunction with the specific drug(s) that will be
used. Moreover, effective distribution of drugs in scaffolds is not always easy to achieve.
Controlled release nanoparticles can potentially be distributed within hydrogels, but these
also are sometimes difficult to distribute uniformly or effectively, and also might interfere
with assembly.
Because of these limitations, a more powerful and versatile technique is needed that
can allow multiple drugs to be incorporated within scaffolding and also allows the release
rate of each drug to be controlled appropriately. There are many ways to deliver drugs,
such asmicelles, colloids, capsules, and solid nanoparticles, including self-assembled
core-shell nanoparticles (9). Solid nanoparticles have been used for oral drug delivery (10),
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epidermal injection (11), targeted delivery of anticancer drugs to cancer cells (12), and to
deliver drugs for central nervous system regeneration (13).
Core-shell polymeric nanoparticles are particularly attractive for use in tissue
scaffolding because the core can potentially be designed to be suitable for a desired
hydrophilic or hydrophobic drug while the shell can be designed to be suitable for the use
environment. Also, core-shell nanoparticles are relatively easy to prepare with a controlled
particle size and various bio-compatible hydrophilic and hydrophobic monomers are
commrecially available to make self-assembling block copolymers that give core-shell
nanostructures (14).
Thus, we propose a new and highly versatile type of self-assembly scaffolding
system that combines controlled release technology with core-shell self-assembly
techniques and peptide self-assembling techniques, to form “particle fibers”. The
particles themselves can potentially be of any size or composition, and synthesized by
any technique, but in this work we opted for amphiphilic tri-block copolymers
(HOOC-ABA-COOH) synthesized by RAFT polymerization, using BDAT as the CTA
(15). RAFT is a controlled radical polymerization, which allows the synthesis of block
copolymers with controlled block length and block sequence, and therefore, control over
the size of both core and shell, and we used BDAT as the CTA to give carboxylic acid end
groups at both chain ends, which are required for the subsequent peptide coupling. The
hydrophilic block for the nanoparticle shell was 1-vinyl-2-pyrrolidinone (VP),
2-hydroxyethyl methacrylate (HEMA) or 2-hydroxyethyl acrylate (HEA), while methyl
methacrylate (MMA) was used for the hydrophobic core. These monomers were selected
because VP, HEMA, HEA and MMA they have been widely used to synthesize
biocompatible homopolymers or copolymers for biological applications (16-19), and
because they are efficiently incorporated into polymer chains produced by RAFT
polymerization (20).
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The polymeric micro- or nanoparticles (or combination of both), that may or may not
contain drugs, as desired, are functionalized with oppositely charged β-sheet peptides.
Peptide directed assembly of nanoparticles has received some attention, but so far it has
been limited to inorganic nanoparticle arrays using self-assembled peptide structures as
templates (21-23). For example, Nikhil et al. reported a well-organized one-dimensional
gold nanoparticle line formed on self-assembled polypeptide template, and the formation
of the nanoparticle array was directed by regulatory-presented positive charges on peptide
fiber surface (22). Another recent report showed a simple method to fabricate a
two-dimensional gold nanoparticle line pattern on mica surface from a designed β-sheet
peptide (LELC16)-functionalized gold nanoparticles. Here the formation of gold
nanoparticle alignment was directed by β-sheet self-assembly (23). Peptide amphiphiles
with alkyl tails or polymer-peptide conjugates have also been widely studied, but still
limited to nanofiber hydrogels for biological applications (24,25).
This research appears to be the first to report the self-assembly of polymeric
nanoparticles into fiber and scaffolds. This is accomplished by using β-sheet peptides to
direct the assembly process, by designing and synthesized two mutually attractive peptide
sequences,

peptide1

(P1:

H2N-TTTT-AEAEAEAE-amide)

and

peptide2

(P2:

H2N-TTTT-AKAKAKAK-amide). These complementary peptides carry opposite charges,
and by coupling them to the carboxylic acid terminals of these amphiphilic tri-block
copolymers

(HOOC-ABA-COOH),

to

form

the

peptide-copolymer

conjugates

P1-ABA-P1 and P2-ABA-P2 respectively.
The peptide-copolymer conjugates undergo multiple levels of self-assembly in
aqueous solution. First, the amphiphilic copolymers can self-assemble to give
nanoparticles

with

hydrophobic

cores

and

hydrophilic

shells,

while

the

peptide-functionalities assemble the nanoparticles into fibers, and then further assemble
β-sheets to form 3D nanoparticle scaffolds. To the best of our knowledge, this polymeric
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nanoparticle fibers and 3D scaffolds are a fundamentally novel self-assembly system
because these systems allow multiple active agents to be introduced into the assembled
structure using a composition suitable for each active ingredient, and giving an
unprecedented level of both temporal and spatial control over the structure of the scaffold
and the release of the active agents. In this work we report on the design and synthesis of
the scaffold and demonstrate the capability of controlled drug release (insulin as a model
protein) and suitability as a versatile tissue scaffold.
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2.2 Materials and methods
2.2.1 Materials
Fmoc

amide

rink

resin

(0.65

mmol/g),

Fmoc

amino

acids,

and

2-(7-aza-1-H-benzotriazol-1-yl)-1,1,3,3-tetramethylaminium (HATU, coupling agent),
were purchased from AAPPTec company (Louisville, KY). N,N-Dimethylformamide
(DMF, 99.9%), N,N-diisopropylethylamine (DIPEA,99.5%), piperidine (PIP, 99.5%)
and cleaving agents, including trifluoroacetic acid (TFA, 99%), thioanisole (99%) and
anisole (99%) were purchased from Sigma-Aldrich. All reagents for peptide synthesis
were used as received. 1-Vinyl-2-pyrrolidinone (VP) (99%), 2-hydroxyethyl acrylate
(HEA) (96%), 2-hydroxyethyl methacrylate (HEMA) (97%), methyl methacrylate
(MMA) (99%), 1,4-dioxane (99+%), hexane (98.5%), 2,2-azobisisobutyronitrile (AIBN)
(98%), and phosphate buffered saline (biotech) were purchased from Sigma-Aldrich.
1,2-Ethanedithiol (98.0%) was from Fluka, ethyl alcohol (200 proof, anhydrous) was
from PHARMCO-AAPER, and diethyl ether (anhydrous) was from Mallinckrodt Baker
Inc. (Phillipsburg, USA). The monomers HEA, HEMA and VP were purified before use
by passing through a neutral alumina column. MMA was distilled before use. All other
reagents were used as received. SW-620 cell was purchased from ATCC and CellTiter 96
AQueous Non-Radioactive Cell proliferation Assay (MTS) kit was from Promega Corp.
2.2.2 Synthesis of peptides (P1 and P2) bearing opposite charges
Peptides P1 (H2N-Thr-Thr-Thr-Thr-Ala-Glu-Ala-Glu-Ala-Glu-Ala-Glu-amide) and
P2 (H2N-Thr-Thr-Thr-Thr-Ala-Lys-Ala-Lys-Ala-Lys-Ala-Lys-amide) were synthesized
on rink amide resin

(1.0 g, 0.65 mmol amine/g per batch) by semi-automated solid

phase peptide synthesis (Endeavor 90I, AAPPTec LLC, Louisville, KY, USA), using
Fmoc chemistry. The side chains of threonine, lysine and glutamic acid were protected
with tert-Butyl (tBu), t-Butyloxycarbonyl (Boc) and O-tert-Butyl (OtBu) groups,
respectively.After swelling and washing the resin beads in DMF, the resin was
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deprotected 2 times with a 20% PIP/DMF solution (15 mL each time) at room
temperature (5 min the first time and 15 min the second time) with washing of DMF to
remove the Fmoc protection group from the resin. Then the first amino acid (4x0.65
mmol) was dissolved in DIPEA/DMF (5.2 mL, 0.5 M) in the presence of HATU (4x0.65
mmol), and transferred into a reaction vessel to attach to the resin. After de-protecting the
Fmoc protecting group from the previously attached amino acid, the remaining amino
acids (each 4x0.65 mmol) were similarly dissolved in DIPEA/DMF in the presence of
HATU and attached step-wise to the resin beads according to the designed sequence.
After finishing the coupling reactions of the desired 12 amino acids, the peptide-bound
resin beads were transferred into a reaction flask and treated with a cocktail of cleavage
reagents, TFA/Thioanisole/Ethane dithiol/Anisole (90:5:3:2 v/v), to cleave the peptides
from the resin beads. The cleaved peptide/cocktail solution was isolated from the solid
resin beads by filtering through a glass column filled with glass wool, followed by
precipitation into cold diethyl ether, placed in an ice/ethanol bath, to collect the
synthesized peptide solids. The peptide solids were washed 3 times with cold diethyl
ether and freeze-dried for storage. Scheme 2.1 shows the P1 and P2 design and the solid
phase peptide synthesis.
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(a)

(b)

Scheme 2.1.

The design and synthesis of (a) P1 and (b) P2, by solid phase peptide

synthesis using Fmoc rink amide resin.
After synthesis and isolation, P1 and P2 were analyzed by MALDI-TOF MS
(Microflex LRF, Bruker Daltonics, Billerica, USA). Briefly, P1 and P2 were dissolved in
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a matrix solution (50:50 water/acetonitrile with 0.1% TFA) to form two solutions, each
with a concentration of ~100 pmol/µL. Separately, 20 mg of α-cyano-4-hydroxycinnamic
acid (the matrix compound) was also dissolved in 1 mL of the described matrix solution,
and the peptide and matrix solutions were then combined at a ratio of 1:10 (v/v). Then 2
µL of each combined solution were placed on a ground steel plate, then dried, and the
ground steel plate was set up for MALDI-TOF MS analysis using a suitable analysis
model (LP_pepmix model, close to the theoretical molecular weight of the peptides). By
MALDI-TOF the molecular weights of P1 and P2 were found to be 1246.42 [M(P1) +
Na+] and 1220.01[M(P2)+H+] Da, which are in good agreement with the theoretical
molecular weights of 1223.25 and 1219.45 Da respectively (Figure 2.1S a,b). 1H-NMR
(Varian Unity INOVA 400 MHz, McKinley Scientific, Sparta, NJ, USA) confirmed the
peptide structure, with the peaks were assigned as follows.
P1 (DMSO-d6, ): 1.05-1.09 (9H, -CH3 from Thr), 1.22 (12H, -CH3 from Ala),
1.77-1.89 (8H, -CH2- from Glu), 2.26 (8H, -CH2-C=O from Glu), 3.77 (3H, O-CH-C
from Thr), 3.85 (3H, -OH from Thr), 4.03-4.32 (11H, -CH- from peptide backbone), 4.45
(2H, C-NH2 from end amine), 7.04 (2H, O=C-NH2 from terminal amide), 7.70-8.06
(11H, -NH- from peptide backbone). P2 (DMSO-d6, ): 1.05-1.10 (9H, -CH3 from Thr),
1.16-1.22 (8H, γ –CH2- from Lys), 1.32 (8H,  -CH2- from Lys), 1.51 (12H, -CH3 from
Ala), 1.65 (8H, β -CH2-from Lys), 2.75 (8H, -CH2-N from Lys), 3.78-3.86 (11H, -NH2
from Lys and –OH from Thr), 4.03 (3H, β -CH- from Thr), 4.13-4.33 (11H, -CH- from
peptide backbone), 4.43(2H, -NH2 from terminal amine), 7.03 (2H, O=C-NH2 from
terminal amide), 7.75-8.10 (11H, -NH- from peptide backbone).
2.2.3 Synthesis of S,S-bis(,-dimethylacetic acid) trithiocarbonate (BDAT)
The RAFT chain transfer agent, BDAT, was synthesized and purified according to a
reported method (26). The detailed procedure is provided in supplementary information.
The chemical structure of the purified BDAT was confirmed by 1H-NMR (CD3CL): –CH3
38

(s, 12 H) at 1.67 ppm and –COOH (s, 2H) at 13.0 ppm. The chemical reaction is shown in
Scheme 2.2.

Scheme 2.2. Synthesis of BDAT.

2.2.4 Synthesis of hydrophilic block (Macro-CTA) and amphiphilic tri-block
copolymer using BDAT as RAFT CTA
The

amphiphilic

PHEMA-b-PMMA-b-PHEMA,

tri-block
and

copolymers

PVP-b-PMMA-b-PVP,

PHEA-b-PMMA-b-PHEA,

terminated

with

carboxylic acid groups, were synthesized in two steps. First, the hydrophilic block (PVP,
PHEMA or PHEA) was synthesized by RAFT polymerization using BDAT as CTA,
AIBN as the initiator, and the desired hydrophilic monomer, at ratios of
[M]o:[CTA]o:[I]o=1000:5:1. The typical synthesis was done beginning with monomer (30
mmol),BDAT (0.15mmol) and AIBN (0.030 mmol) in a solution of 1,4-dioxane (16 mL)
in a 50 mL three neck round bottom flask. The reaction solution was first purged by
nitrogen gas for 0.5 h, and then heated to 70 C. The reaction was maintained at that
temperature under nitrogen atmosphere for 24 h. The product was collected by
precipitation in cool diethyl ether, and the solvation/precipitation step was repeated 3
times to obtain the purified polymers. In the second step, the purified hydrophilic
polymer was used as a macro-CTA to synthesize the amphiphilic tri-block copolymer.
The ratio of reactants used was MMA:macro-CTA: AIBN of 4.8:0.4:0.0012 g/g (48000 :
45 : 1, mol:mol). These were dissolved together into 18 mL of a mixed solvent of
1,4-dioxane/DMF (2:1, v/v) in a 50 mL three neck round bottom flask. The reaction
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solution was purged with nitrogen gas for 0.5 h and then reacted at 70 C for 48 h under
nitrogen atmosphere. The polymer was collected by solvating and precipitating in cool
ethanol/acetone (7:1,v/v) 3 times to obtain the purified amphiphilic tri-block copolymer.
The feedstock ratios and yield % of (co)polymers are given in Table2.1.
Scheme 2.3 shows the synthetic route to prepare the hydrophilic block (macro-CTA)
and amphiphilic copolymer with carboxylic acid terminals.

Table 2.1. Summary of feedstock, MN and yield (%) from the RAFT synthesis of the
hydrophilic macro-CTA and tri-block copolymers.
Yield

Macro-CTA

[M]o:[CTA]o:[I]o

XNa

MNa, Da

PVP

1000:5:1

78

8954

84.0

PHEMA

1000:5:1

66

8981

97.4

PHEA

1000:5:1

74

8966

97.7

XN/XM

MNb, Da

%

Mass Ratio
Copolymer

(MMA)o:
(Macro-CTA )o:AIBN

Yield
%

g/g

PVP-b-12PMMA-b-PVP

12:1:0.0012

78/382

47200

53.1

PHEMA-b-12PMMA-b-PHEMA

12:1:0.0012

66/726

81668

53.3

PHEA-b-12PMMA-b-PHEA

12:1:0.0012

74/644

73443

49.5

a. MN by MALDI-TOF; XN units calculated as X N 

M N  M BDAT
.
M Monomer

b. MN calculated from 1H NMR by ratio of integrated peaks.
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Scheme 2.3. Synthesis of (a) hydrophilic block macro-CTA and (b) the amphiphilic
triblock copolymers, by RAFT polymerization using BDAT as CTA.

2.2.5 Characterization of hydrophilic blocks and tri-block copolymers
The molar mass of the hydrophilic block was determined from MALDI-TOF MS
analysis using DMF as solvent and 2,5-dihydroxybenzoic acid (DHB) as the matrix
compound. The polymer solution (~2 mg/mL in DMF) and a DHB solution (20 mg/mL in
DMF) were prepared separately, and then the polymer solution was added into the DHB
solution at a ratio of 1:10 (v/v). Then 2 µL of the combined solution was dripped onto a
ground steel plate and allowed to air dry over 48 h. The sample plate was analyzed by
MALDI-TOF MS (LP_14 KDa). The molecular weight (MN) and repeat units (XN)
(calculated from MN) of hydrophilic block are summarized in Table 2.1.
The amphiphilic copolymer was analyzed by 1H-NMR, and the molecular weight
(MN) was calculated by integrating the peak areas associated with the blocks. For
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example, PVP-b-12PMMA-b-PVP shows the peak area of :3.34 (-CH2-N, from PVP
block) and peak area of :3.53 (-OCH3 from PMMA block, -CH- from PVP block) are
used to calculate the block ratio of XN(PVP):XM(PMMA) = 1:4.9 based on the below
equation.

Area( CH 2  N )
2 Xn
4.49


3 Xm  Xn Area( OCH 3 , CH  ) 35.17
The

block

ratio

(XN:XM)

of

PHEMA-b-12PMMA-b-PHEMA

and

PHEA-b-12PMMA-b-PHEA were calculated in a similar manner from the 1H-NMR
spectra (Figure 2.2S a,b and Figure 2.3S a,b, with calculation equation) and found to
be 1:11 and 1:8.7 respectively. From these data the XN of the hydrophilic blocks and XM
of the hydrophobic PMMA block for all three copolymers were found to be as follows:
(PVP)39-b-(PMMA)382-b-(PVP)39,

(PHEMA)33-b-(PMMA)726-b-(PHEMA)33

and

(PHEA)37-b-(PMMA)644-b-(PHEA)37. The results are also given in Table 2.1.
1

H-NMR peak assignments for hydrophilic blocks and copolymers are given below.

PVP Block (in D2O, ): 1.46-1.61(-CH2- from backbone), 1.90 (-CH2- from
vinylpyrrolidone ring), 2.18-2.32 (-CH2-C=O from vinylpyrrolidone ring), 3.19 (-CH2-Nfrom vinylpyrrolidone ring), 3.52-3.66 (-CH- from backbone). PHEMA Block (in
DMSO-d6, ): 0.79-1.10 (-CH3), 1.80 (-CH2-), 3.59 (-CH2-OH), 3.91 (-CH2-O-C=O),
4.80 (-OH). PHEA Block (in D2O, ): 1.54-1.86 (-CH2- from backbone), 2.32 (-CHfrom backbone), 3.53 (-OH), 3.68 (-CH2-OH), 4.08 (-CH2-O-C=O).
The peak assignments for protons the 1H-NMR spectra of copolymers were made as
shown below. PVP-b-12PMMA-b-PVP (in DMSO-d6, ): 0.73-1.04 (-CH3), 1.40-1.82
(-CH2-), 3.34 (-CH2-N-), 3.53 (-OCH3, from PMMA block, also contains some -CH- from
the PVP block). PHEMA-b-12PMMA-b-PHEMA (in DMSO-d6, ): 0.72-1.13 (-CH3),
1.42-1.77 (-CH2-), 3.53 (-OCH3, from PMMA block, also contains –CH2-OH from the
PHEMA block), 3.87 (-CH2-O-C=O). PHEA-b-12PMMA-b-PHEA (in DMSO-d6, ):
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0.74-0.92 (-CH3), 1.80 (-CH2-), 2.38 (-CH-), 3.44-3.54 (-OCH3, from PMMA block, also
contains–CH2-OH from the PHEA block), 3.98 (-CH2-O-C=O).
2.2.6 Coupling of peptide to triblock copolymer
The synthesized peptide was bonded to the triblock copolymer as shown in Scheme
2.4 using the following procedure. The copolymer (0.25g) was dissolved in DIPEA/DMF
(4.0 mL, 0.9 M DIPEA in DMF) at room temperature in a 25 mL three neck round
bottom flask with magnetic stirring. The solution was degassed 15 min with nitrogen.
HATU (2.2 mg) was then added, to activate the terminal carboxylic acid groups of the
copolymer, and stirred for 8 min. P1 (0.022 g, 1.8 x 10-2 mmol, ~ 4 molar excess over the
terminal carboxylic acid groups) was dissolved separately in DMF (2.0 mL, in a glass
vial), and then transferred via syringe to the reaction solution. The coupling reaction was
carried out for 45 min under nitrogen atmosphere at room temperature. P2 was coupled
separately to another batch of copolymer using the same procedure.
The peptide-functionalized copolymer was collected by precipitation into 40 mL of
cold ethanol and centrifuged to remove un-reacted chemicals. The isolated solids were
washed 3 times with 30 mL aliquots of cold ethanol and dried at 50 C for 12 h under
reduced pressure.
The peptide-functionalized copolymer conjugates are designated as follows:
P1-PVP-b-12PMMA-b-PVP-P1,

P1-PHEMA-b-12PMMA-b-PHEMA-P1,

P1-PHEA-b-12PMMA-b-PHEA-P1,
P2-PHEMA-b-12PMMA-b-PHEMA-P2

P2-PVP-b-12PMMA-b-PVP-P2,
and

P2-PHEA-b-12PMMA-b-PHEA-P2,

respectively. The peptide-copolymer conjugates were characterized using FT-IR
(Spectrum One, Perkin Elmer, Massachusetts, USA) to verify effective coupling
reactions.
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Scheme 2.4. Coupling reaction of P1 and P2 with amphiphilic copolymers.
2.2.7 Self-assembly of peptide-copolymer conjugates in phosphate buffered saline
solution (PBS) or deionized water (D.I. H2O)
Peptide-copolymer conjugate self-assemblies were conducted in both sterile PBS
solution

and

D.I.

H2O.

P1-PVP-b-12PMMA-b-PVP-P1

(11

mg)

and

P2-PVP-b-12PMMA-b-PVP-P2 (11 mg) were dissolved together in DMSO (2 mL) by
sonication and magnetic stirring to form a clear solution. The conjugate/DMSO solution
was then slowly injected into PBS (20 mL, pH=7.4) via an insulin syringe (31 G syringe)
with an injection speed of ~ 0.4 mL/min under magnetic stirring at 600 rpm. After the
injection was completed, the suspension was stirred an additional 40 min to give a
well-dispersed suspension. The nanoparticle suspension was allowed to settle for 10 h, so
that the self-assembled nanoparticles settled to the bottom layer giving a sponge-like
appearance. The supernatant was replaced 4 times with fresh sterile PBS solution (or
sterile D.I. H2O if the self-assembly was performed in D.I. H2O) and then dialyzed 24 h
in D.I. H2O to remove any DMSO residue.
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The self-assembled nanoparticle suspension was gently swirled and then 0.5 mL of
the suspension was withdrawn using a 31 G insulin syringe. The suspension was then
slowly injected from the syringe while moving it across the surface of a freshly cleaned
glass slide (washed by D.I. H2O and then immersed in 70% v/v EtOH/H2O solution for
10 h, and gently dried by kimwipe). As the syringe needle was moved slowly down the
slide, a self-assembled nanoparticle fiber formed on the surface of the glass slide as the
water in the PBS solution evaporated. This resulting nanoparticle fibers could be
observed on the slide surface by optical microscopy (OLYMPUS BX60, Olympus
America Inc., PA, USA), equipped with a camera (OPTIXCAM, Summit Series), power
control (Olympus TH3) and observation software (TSview7). Self-assembly studies of
peptide-functionalized

PHEMA-b-12PMMA-b-PHEMA

conjugates,

and

peptide-functionalized PHEA-b-12PMMA-b-PHEA conjugates were similarly carried
out. The microscopy images of the self-assembled nanoparticle fibers and scaffolds are
shown in Figure 2.4.
2.2.8 Controlled release of Insulin from assembled nanoparticles
Insulin was used as a model drug that was loaded into the different self-assembled
nanoparticle compositions. Controlled release studies were performed for 22 days.
Peptides- (P1- and P2-) functionalized PHEMA-b-12PMMA-b-PHEMA conjugates (1:1
g/g) were dissolved in DMSO (3 mL) to form a precursor solution (14 mg conjugate/mL
DMSO), then insulin (0.063 mg, 0.15 wt. % based on conjugate matrix) was added to the
precursor solution and mixed uniformly. The insulin-containing precursor solution was
then slowly injected into sterile PBS to form self-assembled insulin-loaded conjugate
nanoparticles, and allowed to settle for 10 h.
Two

types

of

controls

were

also

tested.

Peptide-functionalized

PHEMA-b-12PMMA-b-PHEMA conjugate nanoparticles, without insulin, were prepared
and used as controls to determine any ‘background release’ of peptides (P1 and P2) from
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the

assembled

conjugate

nanoparticles.

Also,

a

copolymer

(PHEMA-b-12PMMA-b-PHEMA) without peptide-functionalization was loaded with the
same quantity of insulin to give insulin-loaded copolymer nanoparticles to determine if
the release rates of insulin from the peptide-conjugated nanoparticles differed from the
non-peptide conjugated nanoparticles.
All self-assembled nanoparticle suspension was then dialyzed 24 h using dialysis
tubing (Nominal MWCO 3,500, from Fisher Scientific) in PBS buffer solution, to remove
free peptides and organic solvent. The assembled nanoparticle suspension was then
collected and stored at 4 C.
The concentration of insulin-loaded conjugate nanoparticles, insulin-loaded
copolymer nanoparticles, and conjugate nanoparticles without insulin, were all
determined by gravimetric analysis, and found to be 1.8 mg/mL, 2.6 mg/mL and 2.0
mg/mL respectively. For example, 3.0 mL of insulin-loaded conjugate nanoparticle
suspension was vacuum dried to obtain 5.3 mg solid mass, and thus the nanoparticle
concentration was determined to be 1.8 mg/mL. If using PBS solution, 3.0 mL of PBS
solution was dried to get background mass, and thus net solid nanoparticle mass was
obtained by taking off this background mass.
The desired quantity of insulin-loaded conjugate nanoparticles, insulin-loaded
copolymer nanoparticles, and non-insulin-loaded conjugate nanoparticles, was measured
based on the known concentration of these nanoparticles in PBS suspension, and
transferred to a 15 mL centrifuge tube. After centrifugation to remove supernatant with
free insulin, fresh D.I. H2O was added to set up controlled release tests carried out at 37
C for 22 days. At the desired time intervals the supernatant with released insulin was
separated from solid nanoparticles by centrifugation at 4000 rpm for 15 min. Then a
specific amount of fresh sterile deionized water was added and the solids gently
re-dispersed and left to stand until the subsequent release test. The concentration of the
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insulin in the collected supernatant was determined by micro-BCA protein assay
according to the manual instructions.
The morphology of each of the different types of insulin-loaded conjugate
nanoparticles was also characterized by optical microscopy to confirm nanoparticle fibers
and 3D scaffolds, as shown in Figure 2.8.
2.2.9 MTS cytotoxicity assayusing SW-620 cell lines
The synthesized peptides, amphiphilic copolymers, and peptide-copolymer
conjugates were tested for biocompatibility using SW-620 cell lines by standard MTS
cytotoxicity assay. P1 was dissolved in DMSO/PBS (50 v/v %) solution to form 2.8
mg/mL of stock P1 solution, and P2 was dissolved in PBS solution to form 10.8 mg/mL
of stock P2 solution. All three copolymer/DMSO precursor solutions were prepared and
self-assembled in sterile D.I. H2O, and then dialyzed for 24 h in D.I. H2O to form
copolymer nanoparticle stock solutions with concentration ranging from 2.3 mg/mL to
2.7 mg/mL. All three peptide-copolymer conjugate/DMSO precursor solutions were
prepared and self-assembled into D.I.H2O and dialyzed 24 h in D.I. H2O to form
conjugate nanoparticle stock solutions with concentration ranging from 2.5 mg/mL to 3.7
mg/mL.
SW-620 cells were seeded at a concentration of ~1000 cells per well in a 96-well
culture plate and incubated for 16 h at 37 °C with 5% CO2 in an humidified incubator.
The media was removed and the cells were washed with fresh PBS the next day. Then
fresh media with each sample solution was added to 96-well plate at a concentration of 1,
10 and 100 µg/mL and each concentration was repeated with 6 replicates. Then the plate
was incubated for 72 h at 37 °C with 5% CO2 in the incubator. After 72 h of incubation,
20 µL of MTS solution was added into each well and incubated again at 37 °C in the
humidified incubator for 4 h. Finally, the absorbance at 490 nm was recorded using an
ELISA plate reader (BioTek Instruments Inc.). Three control solutions, PBS plus media,
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PBS/DMSO 50 v/v % plus media, and pure media, were similarly subjected to the
cytotoxicity test. For all samples, the final DMSO concentration was not more than 2% to
avoid DMSO toxicity to cells. The samples are designated as follows: P1 and P2 are the
two designed peptides; Copolymer NP1, NP2 and NP3 are nanoparticles assembled from
copolymers

of

PVP-b-12PMMA-b-PVP,

PHEMA-b-12PMMA-b-PHEMA,

and

PHEA-b-12PMMA-b-PHEA; Conjugate NP1, NP2 and NP3 are assembled conjugate
nanoparticle fibers from peptide-copolymer conjugates of PVP-b-12PMMA-b-PVP,
PHEMA-b-12PMMA-b-PHEMA, and PHEA-b-12PMMA-b-PHEA, respectively.
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2.3 Results and Discussion
2.3.1 Design of peptides (P1 and P 2) for -sheet self-assembly
The rationale for the peptide design and coupling the peptides to amphiphilic triblock
copolymers is to produce a peptide-directed self-assembly that undergoes multiple levels
of assembly. Figure2.1a shows the complementary peptides labeled P1 and P2. When
these are attached to amphiphilic copolymers, one batch conjugated to P1 and the other
conjugated to P2 (labeled as P1-A-P1 and P2-B-P2 in Figure 2.1b), and the batches are
combined, the chains undergo two levels of self-assembly. The amphiphilic block
copolymer self-assembles into nanoparticles A and B, which need not be either the same
size or same composition, while the complementary ionic peptides assemble these newly
formed nanoparticles into continuous fibers of nanoparticles. These fibers can then
further assemble to form a -sheet in aqueous solution within the appropriate pH range
by adding additional complementary peptide (P1 and P2 with proper ratio. The broader
implications of this are that multiple active agents can be introduced with appropriate
compositions for desired release, both temporally and spatially.

(a)
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(b)
Figure 2.1. Illustration of (a) the complementary peptides, negatively charged P1 and
positively charged P2, and (b) cartoon representation of two amphiphilic triblock
copolymers, self assembling into core-shell nanoparticles A and B, and peptide linking of
the nanoparticles into a polymeric “nanoparticle nanofiber” (1D) directed by
self-assembly of P1 and P2. Higher assembly into 2D and 3D scaffolds is not shown.

Ionic complementary peptides showed excellent -sheet assembly but were
self-repulsive in aqueous solution (27). Using this principle, two peptide sequences, one
positively charged and the other negatively charged (Figure 2.1a), were designed with
alternating hydrophobic and ionic hydrophilic amino acids that could mutually
self-assemble into -sheet fibrils in aqueous solution.
The designed peptides were synthesized by semi-automated solid phase peptide
synthesis strategy (section 2.2) and characterized by MALDI-TOF MS (Figure 2.1S a,b)
to confirm the molecular weight of 1246.42 [M + Na+] for P1 and 1220.01 [M+H+] for
P2, showing excellent agreement with the theoretic molecular weight of P1 (MW:
1223.25) and P2 (MW: 1219.45). The chemical structure of P1 and P2 were further
confirmed by 1H-NMR analysis (Figure 2.2 a,b) to show desired chemical structure.
50

(a)

(b)
Figure 2.2.1H-NMR (DMSO-D6+1% TMS) spectra of the synthesized P1 (a) and P2 (b).
Each peptide sequence was designed to include two parts (Scheme 2.1), the
self-assembly part bearing complementary electrostatic charges, and the spacer part,
using hydrophilic amino acid (Threonine), that is designed to separate the self-assembly
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part from the amphiphilic block copolymer by increasing its solubility, and its mobility to
facilitate coupling with the complementary peptide units. P1 is designed for negative
charges from glutamic acid (E), which bears carboxylic acids that ionize when the pH is
above 4.4. P2 has lysine (K), which has an amine side group that carries positive charges
when the pH is below 10.0 (27).

Therefore, glutamic acid and lysine will

electrostatically interact with each other when the pH is between 4.4 ~ 10.0 in aqueous
(i.e. PBS) solution. This interaction contributes the main driving force for self-assembly,
as illustrated in Figure2.1a. The hydrophobic alanine (A) also contributes to the
self-assembly between P1 and P2 by burying its own hydrophobic domain of alanine side
change.
The use of electrostatic interaction to drive the self-assembly is preferred because
they are stronger than either hydrogen-bonding interactions or hydrophobic interactions,
and so will dominate the assembly process (28). This is illustrated by the different
self-assembly behavior of the designed peptides in DMF/PBS solution, shown in Figure
2.3. Figure 2.3a and b show a solution of P1 and P2 while Figure 3c shows a combined
solution of P1 and P2. The solution of P1 alone exhibits H-bonding and can form viscous
gelation when concentration is at 1.1wt.%, while P2 exhibits only a solution with
significant flow at same concentration. The combination of P1 and P2 forms a viscous,
non-flowing gel at a lower concentration (0.55 wt.% + 0.55 wt.%), showing stronger
interaction than either P1 or P2 alone.
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Figure 2.3. Photographs of the gels formed by P1, P2 and a mixture of P1 and P2 in
DMF/PBS co-solvent (1:1 v/v) where (a) P1 (1.1 wt.%) gels in 1 mL of DMF/PBS; (b)
P2 (1.1 wt.%) flows in 1 mL of DMF/PBS, able to flow; and (c) a strong gel is formed
after mixing a 1 mL solution of P1 with a 1 mL of P2 solution (giving 0.55 wt.% of each
peptide in 2 mL DMF/PBS).
2.3.2 Synthesis and characterization of amphiphilic tri-block copolymers
Reversible addition-fragmentation chain transfer (RAFT) polymerization was used to
synthesize the amphiphilic tri-block copolymer with reactive carboxylic acid groups at
both chain ends. This was done using BDAT as the chain-transfer agent (CTA) and AIBN
as the initiator (Scheme 2.3) (29). BDAT was selected because it is an efficient CTA for
many monomers. This gives us the ability to produce a range of ABA triblock copolymers
to assemble core-shell nanoparticles that are suitable for many different active agents.
Furthermore, BDAT is a highly efficient CTA giving reactive carboxylic acid
terminals,which is required so that peptide conjugation is efficient, thereby giving
efficient assembly into fibers.
Before the copolymer synthesis the structure and purity of BDAT was confirmed by
1

H-NMR (in CDCl3). The proton peaks of the –CH3 (s, 12 H) at 1.67 ppm and –COOH (s,

2H) at 13.0 ppm, are in agreement with the reported chemical structure (26).
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The first step of the polymerization for all the copolymers in this work was the
synthesis of the hydrophilic block, so that the shell of the final copolymer nanoparticle
was hydrophilic. Thus, after polymerizing the appropriate monomer, using BDAT and
AIBN, to give the PVP, PHEMA, or PHEA in high yield (Table 2.1), the polymer was
used as a macro-CTA to synthesize the PMMA hydrophobic inner block in the second
step, giving the desired tri-block copolymer.
1

H-NMR analysis confirmed the existence of all the appropriate peaks for the

hydrophilic block and the block copolymer (Figure 2.4). For example, the 1H-NMR
spectrum of PVP (in D2O) (Figure 2.4a), shows peaks for protons d (: 1.46-1.61), f (:
2.18-2.32), g (: 1.90), h (: 3.19) and e (: 3.52-3.66) with the ratio of the integrated
areas of d:f:g:h:e = 23.11:22.29:23.16:21.59:9.85  2:2:2:2:1. The number average
molecular weight (MN) analyzed by MALDI-TOF MS (Table 2.1) was found to be
similar for PVP and PHEA, but slightly lower for PHEMA. Accordingly the XN,
calculated from the MN, was found to be 78, 74, and 66 for PVP, PHEA, and PHEMA
respectively. Considering the symmetrical structure of BDAT, these repeat units are
evenly distributed at both sides of CTA and therefore the structure of the macro-CTA is
represented

as:

(PVP)39-BDAT-(PVP)39,

(PHEA)

37-BDAT-(PHEA)37

and

(PHEMA)33-BDAT-(PHEMA)33 respectively.
The amphiphilic block copolymer was synthesized by combining the macro-CTA
with MMA and fresh AIBN. The ratio of the blocks in the final tri-block copolymer was
determined from

1

H NMR (Figure 2.4). An example calculation is given for

PVP-b-PMMA-b-PVP (Figure 4b) in section 2.4 with equation to calculate the actual
block ratio of XN(PVP):XM(PMMA) to be 1:4.9. The block ratio (XN:XM) of
PHEMA-b-PMMA-b-PHEMA and PHEA-b-PMMA-b-PHEA were calculated in a
similar manner from the 1H-NMR spectra (Figure 2S a,b and Figure 3S a,b, with
corresponding equation) and found to be 1:11 and 1:8.7 respectively. From these data the
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XN of the hydrophilic blocks and XM of the hydrophobic PMMA block for all three
copolymers

were

found

to

be

as

follows:

(PVP)39-b-(PMMA)382-b-(PVP)39,

(PHEMA)33-b-(PMMA)726-b-(PHEMA)33 and (PHEA)37-b-(PMMA)644-b-(PHEA)37.
The high ratio of PMMA used relative to the hydrophilic monomer was chosen to
ensure that sufficiently large core-shell nanoparticles would be obtained to allow the
nanoparticles to be visualized by optical microscopy. In fact, the water-swollen particles
that were produced when dripped into water were found to be spherical and possess a
diameter near 1 µm, as shown in Figure 2.6. Smaller ratios of PMMA produce
accordingly smaller particles that have a diameter between 100 to 500 nm by dynamic
lighter scattering test.

(a)
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(b)
Figure 2.4. 1H-NMR spectra (in DMSO-d6) of (a) the synthesized hydrophilic polymer
PVP and (b) tri-block copolymer PVP-b-12PMMA-b-PVP by RAFT polymerization.
2.3.3 Coupling peptides to copolymers
The carboxylic acid groups at the amphiphilic copolymer chain ends were coupled to
the amine group of the P1 and P2 peptides is illustrated in Scheme 2.4. The
peptide-functionalized copolymer conjugates were purified and vacuum-dried, and the
coupling was confirmed by FT-IR (Figure 2.5).
Figure 2.5 shows the P1 and P2 absorption bands of the carbonyl stretching
vibrations (C=O) at ~1670 cm-1 and the amide nitrogen-hydrogen (O=C-N-H) bending
vibrations at ~1530 cm-1. The FT-IR spectra of the peptide-coupled copolymer conjugates
also show the absorption peaks from peptides between 1526 cm-1 to 1678 cm-1, which
differs from the polymer carbonyl absorption at 1720 cm-1. These same peptide bands
were also seen in the other peptide-coupled conjugate polymers shown in the
Supplemental Information (Figure 2.4S a,b).These data confirm the peptide coupling to
the copolymers.
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Figure 2.5. Comparison of FT-IR spectra of the synthesized copolymer, P1(Peptide1),
P2(Peptide2), and Peptide-PVP-b-12PMMA-b-PVP conjugates.

2.3.4 Self-assembly of peptide-copolymer conjugates in aqueous solution
The purpose of the copolymer design is to prepare self-assembled controlled-release
“nanoparticle fibers” that can subsequently self-assemble to produce 3D scaffolds as
directed by -sheet peptide assembly (Figure 2.1b). By this method, the mixing of two
batches of complementary peptide-conjugated polymeric nanoparticles (A and B) results
in their self-assembly into an ordered arrangement of nanoparticle fibers and 3D
scaffolds. This simple 2-part system has the advantage of allowing each nanoparticle to
be customized for a desired active ingredient(s) and also allowing the nanoparticle fibers
to simultaneously serve as a two-drug delivery system and flexible scaffolds for cell
migration and proliferation. Using controlled ratios and sequential addition multi-drug

57

delivery systems are achievable in the desired sequence within the resulting particle
fibers.
Self-assembled nanoparticle fibers and 3D scaffolds, are shown for a two-drug
delivery system in representative microscopic images in Figure 2.6 and 2.7, in aqueous
media (PBS solution or D.I. H2O). Figure 2.6a-c shows PVP-b-12PMMA-b-PVP, after
the complementary peptide-conjugated nanoparticles were combined. The initially
formed fibers are observed with t ~ 0 – 10 h, with the extent of the assembly increasing
further with t > 10 h after combining the complementary peptide-copolymer conjugate
pair,

and

finally

a

3D

assembly

is

observed.

Figure

2.7

a,b

shows

PHEMA-b-12PMMA-b-PHEMA in deionized water with t ~10 h, and (b)
peptide-coupled PHEA-b-12PMMA-b-PHEA in PBS at t~10 h. The self-assembly
process appeared to progress somewhat more rapidly in PBS solution than in D.I. H2O.
This is thought to be due to the presence of the alkaline ions in PBS solution being
beneficial to the self-complementary assembly of the designed peptides (3). Although
PBS is often better than D.I. H2O for peptide dissolution, for these assembled
nanoparticle fibers PBS buffer media facilitates the formation of long NP fibers on glass
slide surfaces when compared to results using D.I. H2O media. There may be other
differences between the two media, but in this work none were noted.

(a)

(b)
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(c)
Figure 2.6. Conjugate NP fibers from peptide-coupled PVP-b-12PMMA-b-PVP in PBS
with self-assembly times of (a) ~10 h showing fibers, (b) t >10 h, showing further
assembly and (c) t >>10 h, showing 3-D scaffolds.

(a)
(b)
Figure
2.7.
Conjugate
NP
fibers
from
(a)
peptide-coupled
PHEMA-b-12PMMA-b-PHEMA in deionized water with t ~10 h, and (b)
peptide-coupled PHEA-b-12PMMA-b-PHEA in PBS with t ~10 h.
This approach has substantial versatility and is effectively a fundamental technology
with significant control over each level of assembly. For example, any approach can be
used to design the nano/microparticle composition and structure, as either a
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homopolymer or a copolymer, with the advantage of an amphiphilic copolymer being that
it will self-assemble into a core-shell design. This allows the particle interior to be
designed to be suitable for a desired cargo such as an active ingredient, and to release the
active ingredient at a desired rate, while the particle exterior can be designed to be stable
in the delivery medium. The core and shell can then be selected for an appropriate release
rate for the specific active ingredient. The peptide assembly also offers significant level
of control, not only in the design of the assembly motif and its stability, but also in how
the assembly manipulates the nano/microparticle arrangement. The assembly can be
designed to couple so that all the nano/microparticles can carry the same drug, but release
the drug at very different rates over an extended release time, or different particles can be
assembled so that multiple drugs can be released from different nano/micro particles with
each particle being released at a rate appropriate for that drug. This can be done for small
molecules or in principle for proteins.
Another block copolymer design was made using poly(ethylene glycol) methyl ether
acrylate as the hydrophilic monomer to give a hydrophilic shell that readily forms a
hydrogel. Our copolymer design, PPEG-b-12PMMA-b-PPEG, like the others, can serve
as controlled release devices but in this case the outer shell, being ethylene glycol based,
would resist protein adsorption and cell adhesion. The same peptide bonding motifs that
are already described, P1 and P2, were used. The peptide-copolymer conjugates were
placed in a DMF precursor solution (13 mg/mL) to self-assemble into a dense 3D
nanoparticle scaffold by adding 2 mL of deionized water. The freeze-dried scaffold was
characterized by FESEM and images are shown in Figure 2.8a. The same composition
was tested, but with P1 and P2 simply being blended into the mixture rather than bonded
to the amphiphilic PPEG-12-PMMA-PPEG copolymer (Figure 2.8b).The results clearly
show the effect of bonding the peptides to the nanoparticles on the assembly process. The
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overall density of the scaffolding can be manipulated by changing composition and
peptide length.

(a)

(b)

Figure 2.8. FESEM images show comparison of self-assembled scaffold morphologies
(a) self-assembled from peptide-coupled PPEG-b-12PMMA-b-PPEG conjugates and (b)
nanoparticle scaffolds control self-assembled from peptide physically mixed with
PPEG-b-12PMMA-b-PPEG.
2.3.5 Controlled release study of Insulin as model drug
The advantage and rationale for the use of an amphiphilic block copolymer is to
allow nanoparticles (or microparticles) to be prepared with a suitable composition to
control the release rate for a desired drug, with the shell allowing the nano/microparticles
to be stable in a given medium, and to serve as a tissue scaffold, or resist protein
adsorption. In a preliminary test of the ability of assembled nanoparticles to serve as
controlled release devices, insulin was used to test the ability to release a model protein.
Insulin was loaded into the synthesized peptide-copolymer conjugates at a theoretical
content of 0.15 wt.%. After combining aqueous solutions of complementary
peptide-functionalized

copolymer

nanoparticles,
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each

containing

insulin,

long

self-assembled nanoparticle fibers and 3D scaffolds were formed, as the representative
images show in Figure 2.9.

(a)

(c)

(b)

(d)

Figure 2.9. Optical microscopy images of insulin-loaded conjugate nanoparticle fibers
and 3D scaffolds, self-assembled in PBS solution. Insulin-loaded nanoparticle fibers of
(a) peptide-coupled PVP-b-12PMMA-b-PVP conjugates self-assembled in PBS with
assembly time t~10h;

(b) peptide-coupled PHEMA-b-12PMMA-b-PHEMA conjugates

in PBS with t~10h; (c) peptide-coupled PHEA-b-12PMMA-b-PHEA conjugates with
t~10h; and (d) representative insulin-loaded nanoparticle scaffolds at condensed phase
with t>10h. Images of (a), (b), (c) were prepared on a glass slide surface by gently
shaking self-assembled conjugate nanoparticles to form a uniform suspension and then
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transferring to the glass slide surface. Image (d) is of self-assembled nanoparticle
scaffolds from peptide-coupled PVP-b-12PMMA-b-PVP conjugates with self-assembly
time >10h without shaking the suspension, used as the representative morphology of 3D
nanoparticle scaffolds.

The self-assembled insulin-loaded nanoparticle fibers from peptide coupled
PHEMA-12PMMA-PHEMA were used in a controlled release test run for 22 days at 37
C. The released insulin solution was collected by centrifugation and the quantity was
determined by micro-BCA test. The cumulative quantity of insulin released over 22 days
is

shown

in

Figure

2.10.

The

release

is

compared

with

insulin-loaded

PHEMA-12PMMA-PHEMA nanoparticles alone, and for the peptides from peptide
coupled PHEMA-12PMMA-PHEMA without insulin.

Insulin release from NPs of PHEMA-12PMMA-PHEMA
Insulin release from NPs of peptide-coupled PHEMA-12PMMA-PHEMA
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assembled

peptide-coupled

PHEMA-b-12PMMA-b-PHEMA conjugate nanoparticle fibers tested by micro-BCA
protein assay.
The results show a steady release of insulin from the assembled conjugate
nanoparticle fibers over a three-week period. A ‘background’ release is measured (blue
triangles) that is due to residual peptides (P1 and P2) remaining in the formulation after
the synthesis of the peptide-copolymer conjugates. Unfortunately, the assay does not
differentiate the insulin from the residual peptides, but even accounting for this release,
the data show that the conjugated peptide nanoparticle fibers give a controlled insulin
release over a three-week period thatis slightly faster than the release from the copolymer
nanoparticle controls.
2.3.6 Biocompatibility study on SW-620 cell lines by MTS assay
The cytotoxicity of the synthesized peptides, copolymers and peptide-copolymer
conjugates were measured by MTS assay using SW-620 cell lines. The results are shown
in Figure 2.11. The cells incubated with media alone or with PBS and/or DMSO were
used as control and the results showed absorption intensity ranging from 0.64 to 0.88 at
490 nm. When absorptions were compared to that of the controls, MTS test for all
synthesized peptides, copolymers and peptide-copolymer conjugates showed similar or
slightly higher absorption intensity at 490 nm. These results suggest that SW-620 cells
cultured in the presence of synthesized biomaterial solution or nanoparticle suspension
with concentration range at 1 ~ 100 g/mL are not adversely affected by these
synthesized biomaterials.
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Figure 2.11. Cytotoxicity test on SW-620 cell lines by MTS assay.
Conjugates NP1, NP2 and NP3 represent self-assembled nanoparticles from
peptide-coupled copolymers (PVP-b-12PMMA-b-PVP, PHEMA-b-12PMMA-b-PHEMA
and PHEA-b-12PMMA-b-PHEA). Copolymer NP1, NP2 and NP3 are nanoparticles for
the non peptide-coupled copolymers. Peptide-1 and Peptide-2 are the synthesized
peptides (P1 and P2).

2.4 Conclusion
A novel fundamental technology was proved in this work that showed how
peptide-directed self-assembly can be used to direct the assembly of individual polymeric
nanoparticles into fibers and 3D scaffolds. This technology combines the advantages of
versatile controlled release systems and flexible scaffolds for tissue engineering. In this
work a single drug, insulin, was tested, but the broader implications of this technology
are that multiple drugs can be loaded into the scaffolding and the release rate of each drug
can be separately controlled by the selection of the nanoparticles used to form the
scaffold. This is because different polymer compositions and structures (e.g. core-shell
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morphology) can be employed, and the assembly of fundamentally different nano- and
microparticles can be controlled.

Although only three different copolymers were

described in this work, the technology allows other polymers to be used, and as long as
the peptides can be coupled to the terminals to induce the assembly process, polymers
can be prepared using any step growth or chain growth process.
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Main Findings in This Chapter:
In

this

chapter,

we

proved

the

hypothesis

that

ionic

complementary

peptide-functionalized amphiphilic copolymer could self-assemble into polymeric
nanoparticle fibers and 3D scaffolds with or without model drug loading. This was done
by functionalizing several sets of amphiphilic triblock copolymers with two oppositely
charged

peptides

(P1

and

P2),

including

PVP-b-PMMA-b-PVP,

PHEMA-b-PMMA-b-PHEMA and PHEA-b-PMMA-b-PHEA, with reactive carboxylic
acid terminals synthesized by RAFT polymerization using BDAT as CTA. Controlled
release study using insulin as model drug showed sustained release of insulin over 3
weeks from self-assembled nanoparticle scaffolds. Cytotoxicity test on SW-620 cell lines
showed all synthesize peptides, copolymers and peptide-copolymer conjugates were
biocompatible with SW-620 cell lines at concentration below 100 g/mL.
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Abstract
Conventional self-assembled peptide nanofiber scaffolds lack the ability to be
simultaneously loaded with multiple drugs that have different chemical and physical
properties, to allow individual controlover the release of each of the loaded drugs, and to
provide uniform, or controlled but non-uniform (e.g. gradient), distribution of the drugs
within the same scaffold system. In this work, a novel ionic complementary
peptide-functionalized polymeric nanoparticle was designed and self-assembled into 1D,
2D, and 3D polymeric nanoparticle scaffolds. Such self-assembled nanoparticle scaffolds
have the potential to overcome each of the above-described limitations of conventional
scaffolds. This new method allows the assembly of individual nanoparticles into a
continuous fiber scaffold. Because of this design, each nanoparticle composition can be
selected to allow it to be loaded with the desired drug and release that drug at an
appropriate rate. In principle this approach also gives control over the spatial distribution
of the drug-containing nanoparticles to allowblocks of nanoparticles with a given drug, or
nanoparticle gradients to be formed in thescaffolds, while also yielding an injectable
system. This process gives unprecedented flexibility into the design and preparation of
the scaffold. The self-assembled nanoparticle scaffold formation was confirmed by
optical microscopy and FESEM micrographs. Several model drugs, including
hydrophobic and hydrophilic small molecules, were loaded in the scaffold system
showing controllable and sustainable release over 3 weeks. The self-assembled 2D
scaffold membrane was incubated with fibroblast cells (NIH3T3 cell lines) in a culture
dish that demonstrated non-toxicity and non-inhibition to the cell proliferation. This type
of nanoparticle scaffold combines the advantages of the precision associated with peptide
self-assembly and the versatility of polymeric nanoparticle controlled release systems for
a new type of tissue engineering.
Keywords: peptide, self-assembly, nanoparticle scaffold, multi-drug controlled release
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3.1 Introduction
An efficient tissue growth is usually dependent on the delivery of various drugs (i.e.
active biomedicine, growth factors) to cells within tissue regeneration. Thus there are
important scientific relationships between tissue engineering and scaffolding system with
drug delivery (1). For example, skin regeneration usually requires a complex delivery of
growth factors and cytokines, such as fibroblast growth factor, keratinocyte growth
factor, vascular endothelial growth factor and interleukin 1α, to release within the wound
bed to promote cell proliferation and migration to achieve wound healing (2,3).
Therefore, there is a need to fabricate a more sophisticated system with multi-drug
delivery abilities within scaffolding for tissue engineering.
Conventional polymeric hydrogels (both synthetic and natural polymers) have been
widely developed to incorporate a single drug in scaffold system for tissue regeneration,
for example, physically or chemically incorporating bioactive ingredients in
poly(ethylene

glycol)

(PEG)

hydrogels

(4,5),

poly(lactide)-b-poly(ethylene

oxide)-b-poly(lactide) (PLA-b-PEO-b-PLA) or poly(lactic-co-glycol acid) (PLGA)
hydrogels (6,7), or natural biomaterial gels (e.g. alginate, collagen, chitosan, gelatin)
(8-14). Most recently, Caicco et al. (15) developed a physically blended hydrogel
composite system of hyaluronan-methylcellulose (HAMC) as for the localized delivery
and sustainable release of CyclosporinA (CsA), a promising neuroprotective and
neuroregenerative agent for neural stem/progenitor cells, for treatment of stroke. The
authors incorporated CsA in HAMC gel by three different methods and compared the
release rate. The three incorporation types include a solubilized type (CsA/acetonitrile
solution mixed with HAMC gel), a particulate type (CsA solid particulate dispersed in
MC solution and then embedded in HAMC gel), and polyl(actic-co-glycolic acid)(PLGA)
microsphere-encapsulated CsA type (CsA encapsulated in PLGA microspheres and then
embedded in HAMC gel). Interestingly, the in-vitro controlled release test showed that
solubilized CsA type released from HAMC gel only for 2 days, particulate type expanded
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to 7-10 days, but CsA from PLGA microsphere-encapsulated type showed sustainable
release over 21 to 28 days. Most importantly, the CsA released from PLGA microspheres
retained bioactivity that was equivalent to that of fresh CsA when compared by a
neurosphere assay (15). However, similarly with most of the other polymeric hydrogel
scaffolds, this study is also limited to single drug incorporation.
Self-assembled peptide nanofiber scaffolds have been gaining in popularity
compared to traditional scaffolding for tissue engineering because of non-toxicity,
biodegradability, and the porosity of fibril structures is similar to extracellular matrix
(ECM) for cell attachment. Also, these materials assemble in situ into a hydrogel at
physiological environment (16). The first generation self-assembling designer peptide,
EAK16-II (AEAEAKAKAEAEAKAK), was discovered in a yeast protein, zuotin (17).
This type of ionic complementary peptide spontaneously self-assembles into stable
β-sheets in aqueous conditions across a broad range of temperature and pH, and even in
the presence of a high concentration of the denaturing agents urea and guanidium
hydrochloride (18,19). The self-assembling forces are the hydrophobic interactions of
alanine (A) domains and ion-pair interactions between negatively charged glutamic acid
(E) side chains with positively charged lysine (K) side chains. That this strong ion-pair
interaction contributes to stable β-sheet formation was further supported by investigation
of a complementary pair of designer peptides, the self-repulsive but mutually attractive
peptide sequences that possessed positive charges (Ac-WKVKVKVKVK-amide) and
negative

charges

(Ac-EWEVEVEVEV-amide)

(20).

On

mixing

this

pair

of

complementary peptides, a rapid assembly into a viscoelastic hydrogel occurred at a
concentration as low as 0.25 wt.%. This hydrogel retained mechanical strength, even after
repeated shear-induced breakdowns, due to the electrostatic interactions. The strong
electrostatic and selective interaction between the opposite charges demonstrated one of
the key merits of using ion-complementary β-sheet motifs.
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These designer self-assembling peptide hydrogels (e.g. EAK16-II, RADA16-I or II)
have been widely used as both controlled drug delivery systems and 3D scaffolds. The
drug delivery capability is typically done by physically incorporating a drug into the
peptide scaffold during the gel formation (21,22), but it can also be chemically bonded
onto the C-terminal or N-terminal (23), or sometimes combination of both methods to
load multiple active agents (24,25). However, these methods still have significant
limitations with respect to the quantity of drug(s) that can be incorporated, but
furthermore the incorporation of drug(s) may have an impact on the subsequent
self-assembly process or the mechanical stability of the formed hydrogel, and there is
very limited ability to control the release of drugs with different properties. Therefore, the
hydrogel itself must be designed in conjunction with the specific drug(s) that will be
incorporated. Moreover, the effective distribution of multiple drugs in scaffolds is not
easy to achieve.
To address these limitations, we designed and reported a new type of ionic
complementary peptide-directed self-assembly of polymeric nanoparticle fibers and 3D
scaffolds to be a more powerful and versatile technique to allow multiple drug
incorporation within a scaffolding system and to allow the release rate of each drug to be
controlled appropriately (26). This new type of designed scaffold having multiple drug
loading ability was achieved by functionalizing an amphiphilictriblock copolymer with
two oppositely charged peptides (P1-ABA-P1 and P2-ABA-P2, ABA: triblock
copolymer,

P1:

H2N-TTTT-AEAEAEAE-CONH2

and

P2:

H2N-TTTT-AKAKAKAK-CONH2), respectively. While the peptides controlled the
nanoparticle assembly the copolymer composition gave domains that self-assembled into
polymeric micro or nanoparticles for use as drug carriers that also possess the peptide
functionalities (P1-NP-P1 and P2-NP-P2). These nanoparticles then further self-assemble
into ‘nanoparticle fibers’ and eventually lead to 3D scaffolds with a ‘sponge-like’
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appearance in aqueous solution.
In the present work, we continue the study of the self-assembly behavior and test the
versatility of the methodology with a series of designed peptide-functionalized copolymer
(P1-ABA-P1 and P2-ABA-P2) with different particle size, and with additional peptides
(P1 and P2) to adjust the scaffold porosity and mechanical stability. Multiple drug
loading and control of the drug releasing rate from different nanoparticle compositions
are demonstrated in this work using several small molecules as model drugs, including
hydrophobic molecule (4’,5’-dibromofluorecein), moderately hydrophobic molecule
(nitrofurazone) and slightly water soluble hydrophilic molecule (amoxicillin). The
biocompatibility test is conducted by incubating the self-assembled 2D scaffold
membrane with fibroblast cells (NIH3T3 cell lines) in a humidified incubator at 37 °C for
2 weeks, showing non-toxicity and non-inhibition to the cell proliferation and migration.
The self-assembly of peptide-functionalized nanoparticles with additional host peptides
(P1 and P2) and with different concentration is also conducted to form nanoparticle
composite peptide hydrogels, to compare mechanical stability and morphology.
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3.2 Experimental Section
3.2.1 Materials
All reagents for peptide synthesis were purchased from AAPPTec LLC (Louisville,
KY) and used as received. Cleavage reagents, including trifluoroacetic acid (TFA, 99%),
thioanisole (99%) and anisole (99%), were purchased from Sigma-Aldrich, and
1,2-ethanedithiol (98.0%) was from Fluka. 1-Vinyl-2-pyrrolidinone (VP) (99%),
2-hydroxyethyl methacrylate (HEMA) (97%), methyl methacrylate (MMA) (99%),
1,4-dioxane (99+%), 2,2-azobisisobutyronitrile (AIBN) (98%), dimethyl formamide
(DMF, 99.9%) and phosphate buffered saline (Biotech) were purchased from
Sigma-Aldrich. Ethyl alcohol (200 proof, anhydrous) was from PHARMCO-AAPER,
and diethyl ether (anhydrous) and dimethyl sulfoxide (DMSO) were from Mallinckrodt
Baker Inc. (Phillipsburg, USA). Model drugs of 4’,5’-Dibromofluorescein (DBF) and cell
adhesion peptide (RGDS) were from Sigma-Aldrich, nitrofurazone powder and
amoxicillin capsules were from Jungle Laboratories Corporation and Shopko pharmacy
(Made by Sandoz International, Germany, NDC code: 007881-2613-01). DBF and
nitrofurazone were used as received, amoxicillin powder was removed from the capsules
and was purified by dissolving in ethanol and removing undissolved components, and
recrystallized before use. VP and HEMA were purified prior to use by passing through a
neutral alumina column. MMA was distilled before use. All other reagents were used as
received. Fibroblast cells (NIH3T3 cell line) were purchased from ATCC and cell media
(DMEM/High Glucose) was from Hyclone Laboratories, Inc. (Utah, USA). Ultrapure
deionized water (>17.6 M-cm) was obtained from MEG-PURE SYSTEM (MP-190
LC).
3.2.2 Synthesis and self-assembly of ionic complementary peptides (P1 and P2)
Two ionic complementary peptides, P1 (H2N-TTTT-AEAEAEAE-amide) and P2
(H2N-TTTT-AKAKAKAK-amide), were synthesized by a standard semi-automatic solid
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phase peptide synthesis strategy (Endeavor 90I, AAPPTec LLC, Louisville, KY, USA),
using Fmoc chemistry, on a rink amide resin. A detailed synthetic procedure, and
characterization of the products by MALDI-TOF MS (Microflex LRF, BrukerDaltonics,
Billerica, USA) and 1H-NMR (Varian Unity INOVA 400 MHz, McKinley Scientific,
Sparta, NJ, USA)were reported elsewhere (26).
Peptide self-assembly was tested in aqueous solution using different salt (NaCl)
concentrations to study the effect of NaCl concentration on the self-assembly behavior of
the designer peptides. Briefly, P1/deionized water solution (11 mg/mL) and P2/deionized
water solution (11 mg/mL) were prepared by dissolving P1 in deionized water with 0.03
mM of NaOH(pH 9.0) and P2 in deionized water with 0.03 mMHCl (pH 5.4). The
solutions of P1 (0.5 mL) and P2 (0.5 mL) were combined with magnetic stirring and
sonicating for 30 min to give a uniform mixture, and then the NaCl concentration in the
combined P1/P2 solution was adjusted to 0.03 mM, 10 mM and 30 mM by adding the
appropriate amount of the NaCl solution (1 M). The combined P1/P2 solution was
allowed to self-assemble for 24 h at room temperature.
Approximately 10 L of each self-assembled peptide hydrogel was transferred onto
the surface of a newly cleaned silicon wafer (cleaned by 10 wt.% HCl and 10 wt.%
NaOH solutions each for 10 h respectively, and then washed by ethanol and deionized
water several times with sonication) and air dried for 1 h at room temperature. The
assembled peptide membrane was rinsed with 100 L of deionized water to remove
unattached peptides and salt. The rinsing and washing process was repeated three times,
and the specimen was allowed to air dry. Once dry, the peptide-covered wafer was coated
with a platinum layer (10 nm) for FESEM characterization (Hitachi S-4700, Hitachi High
Technologies America, Inc.).
In addition to testing the peptide self-assembly in aqueous solution at different salt
concentrations, the process was studied at different total peptide concentrations of 5.5
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mg/mL and 11 mg/mL (P1:P2=1:1 wt./wt.) at a singleNaCl concentration (10mM). The
self-assembled peptide gel was prepared on the silicon wafer surface in the same way as
before and characterized by FESEM.
3.2.3 Synthesis of amphiphilictriblock copolymers with reactive terminals by RAFT
polymerization
Amphiphilictriblock

copolymers

PHEMA-b-PMMA-b-PHEMA,

were

of
synthesized

PVP-b-PMMA-b-PVP
by

RAFT

and

polymerization

usingS,S-bis(,-dimethylacetic acid) trithiocarbonate (BDAT) as chain transfer agent
(CTA) and AIBN as initiator. This CTA gave reactive carboxylic acid terminals at both
chain ends (HOOC-ABA-COOH). The synthesis of BDAT was described elsewhere (26).
The polymerization was done in two steps to build up the amphiphilic block
copolymer. In the first step the hydrophilic block(PVP or PHEMA) was prepared in
dioxaneat 70C (24 h under nitrogen atmosphere) usingthe following ratio of reagents:
[M]o:[BDAT]o:[AIBN]o=1000:5:1. The product was precipitated in cool diethyl ether to
obtain the PVP or PHEMA block as a solid. The precipitation was repeated 3 times to
remove any unreacted monomer. The polymer containing the hydrophilic block was
vacuum-dried at 50 C for 12 h. In the second step, the hydrophilic polymer was used as
a macro-CTA to copolymerize with MMA in a dioxane/DMF (4:1 v/v) solvent mixture
with additional AIBN added (0.0012 g). The reaction was continued at 70 C (48 h) under
nitrogen atmosphere to obtain the amphiphilic triblock copolymer. The as-made
copolymer solution was purified by precipitating in cool diethyl ether 3 times to remove
unreacted residues and vacuum-dried at 50 C for 12 h.
The length of the hydrophilic block was maintained as a constant (with actual XN=
78 for PVP and 64 for PHEMA, see Table 3.1) but the length of the PMMA block,
synthesized in the second step, was varied to adjust the ratio of the hydrophilic to
hydrophobic block in the nanoparticles. This resulted in different core sizes, as well as
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different nanoparticle sizes. The reactant ratios, and molar mass and yields of the
copolymer products are summarized in Table 3.1.

Table 3.1. Reactant ratios and products (Macro-CTA and Copolymer) by RAFT.
Yield

Macro-CTA

[M]o:[CTA]o:[I]o

XNa

MNa, Da

PVP

1000:5:1

78

8954

84.0

PHEMA

1000:5:1

64

8557

92.8

XN/XM

MNb, Da

Copolymer

Mass Ratio
(Macro-CTA )o:(MMA)o

%

Yield
%

PVP-b-1.5PMMA-b-PVP

1:1.5

78/86

17564

72.8

PVP-b-3PMMA-b-PVP

1:3

78/186

27576

70.2

PVP-b-6PMMA-b-PVP

1:6

78/524

61417

53.7

PHEMA-b-3PMMA-b-PHEMA

1:3

64/102

18769

65.8

a. MN tested by MALDI-TOF; X N 

M N  M BDAT
.
M Monomer

b. MN calculated from 1H NMR by ratio of integrated peaks.
3.2.4 Characterization of hydrophilic block and tri-block copolymers
The number average molecular weight (MN) of the hydrophilic block (PVP and
PHEMA) was determined by MALDI-TOF MS and the number average degree of
polymerization (XN) was calculated from the measured MN. These results are given in
Table 3.1. A detailed analysis of the MALDI-TOF MS spectra is described elsewhere
(26). 1H-NMR spectra (performed in DMSO-d6) and peak assignments are shown in
Figure 3.1 (a, b). The integrated peak area from the PVP and PMMA blocks gives the
block ratio XPVP:XPMMA and thus the number average molecular weight of the triblock
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copolymer is determined. For example, analysis of PVP-b-1.5PMMA-b-PVP shows that
theintegratedarea of the peak at : 3.14 (-CH2-N, from PVP block) and the peak areas at
: 3.56 and 3.35 (-OCH3 from PMMA block, -CH- from PVP backbone) are used to
calculate the block ratio of XPVP: XPMMA= 1:1.10 according to equation (1).

Area( CH2  N )
2 X PVP
11.41


3 X PMMA  X PVP Area( OCH3 , CH  ) 24.49
The

actual

block

ratios

of

other

copolymers

(1)
(PVP-b-3PMMA-b-PVP,

PVP-b-6PMMA-b-PVP and PHEMA-b-3PMMA-b-PHEMA) are similarly calculated to
be 1:2.38, 1:6.72 and 1:1.60. According to the known XN and the actual block ratios
calculated, the XN and MN of tri-block copolymers are thus determined and listed in
Table 3.1.
The peak assignments for the 1H-NMR spectra of copolymers were made as shown
below. PVP-b-PMMA-b-PVP (in DMSO-d6, ): 0.73-1.04 (-CH3), 1.40-1.82 (-CH2-),
3.34 (-CH2-N-), 3.53 (-OCH3, from PMMA block, also contains some -CH- from the PVP
block). PHEMA-b-PMMA-b-PHEMA (in DMSO-d6, ): 0.72-1.13 (-CH3), 1.42-1.77
(-CH2-), 3.53 (-OCH3, from PMMA block, also contains –CH2-OH from the PHEMA
block), 3.87 (-CH2-O-C=O).

3.2.5 Coupling reaction of copolymer with P1 and P2
The synthesized peptides (P1 and P2) were coupled with the desired amphiphilic
copolymer to form peptide-copolymer conjugates. The coupling reaction was performed
betweenthe carboxylic acid terminals of the desiredpolymer and the amine terminalsof
the desired peptide using 2-(7-aza-1-H-benzotriazol-1-yl)-1,1,3,3-tetramethylaminium
(HATU) as the coupling agent, as shown in Scheme 3.1. The process for the
PVP-b-6PMMA-b-PVP system is described in greater detail as an example. The
copolymer (1.0 g, ~1.6 x 10-5mol) was dissolved in DIPEA/DMF (8.0 mL, 0.9 M DIPEA
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in DMF) at room temperature in a 25 mL three neck round bottom flask with magnetic
stirring. The reaction solution was degassed for 15 min with nitrogen and then HATU
(0.012 g, ~3.2 x 10-5mol) was added to activate the carboxylic acid groups. P1 (0.10 g,
8.2 x 10-5mol) was pre-dissolved in DMF (5.0 mL) in a glass vial, and then transferred
into the activated copolymer solution via syringe. The reaction was continued for 45 min
at room temperature with magnetic stirring and nitrogen gas bubbling through solution.
P2 was similarly coupled with a second batch of copolymer. The peptide-copolymer
conjugate was precipitated in cool diethyl ether and centrifuged to remove un-reacted
chemicals. The precipitation was repeated 3 times to obtain purified conjugate solids, and
dried under reduced pressure for 12 h at 50 C before storing in a sealed vessel in the
refrigerator at 4 ˚C.

Scheme 3.1. Synthesis of peptide-copolymer conjugates by coupling reaction of peptide
amine terminal with copolymer carboxylic acid terminals.
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Other copolymers that possessed different block ratios were coupled with P1 and P2
using the same procedure. The peptide-copolymer conjugates were characterized by
FT-IR (Spectrum One, Perkin Elmer, Massachusetts, USA) to verify the coupling
reaction. The sample designationsfor the peptide-functionalized copolymer conjugates are
shown in Table 3.2.
3.2.6 Self-assembly study of peptide-copolymer conjugates in aqueous solution
All peptide-copolymer conjugates were first self-assembled in aqueous solution to
form the peptide-functionalized nanoparticles (P1-NP-P1 and P2-NP-P2). Then the
individual nanoparticles bearing complementary peptides (P1-NP-P1 and P2-NP-P2)
were combined together where they then assembled into 1D nanoparticle fibers and
eventually formed 3D scaffolds as directed by the ionic complementary assembly
between P1 and P2.
The assembly process of the nanoparticles into nanoparticle fibers was accomplished
in three steps as follows. First the P1-copolymer conjugates (20 mg) were dissolved in
DMSO (2 mL) to give a clear precursor solution, and then the precursor solution was
slowly injected (0.4 mL/min) into weakly basic deionized water (10 mL, pH 9.0, adjusted
by 1 M NaOH solution) via a 31 G syringe while being stirred at 600 rpm by a magnetic
stirrer to self-assemble into a P1-NP-P1 suspension. After completing the injection of the
precursor solution, the magnetic stirring was continued for 30 min and then sonicated 2
min to form a stable peptide-nanoparticle suspension. In the second step, the
P2-copolymer conjugates were first solvated in DMSO to form a precursor solution and
then added into weakly acidic deionized water (10 mL, pH 5.4, adjusted by 1 M HCl) to
form a P2-NP-P2 suspension and sonicated for 2 min.
The purpose of forming the nanoparticle suspensions in weakly basic (pH 9.0) and
weakly acidic (pH 5.4) deionized water was to completely ionize the carboxylic acid side
groups from P1 and amine side groups from P2 to bear negative and positive charges
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respectively. This gave two separate suspensions of nanoparticles bearing complementary
peptides that were self-repulsive ensuring no assembly until the two separate suspensions
are combined.
Table 3.2. Hydrodynamic diameter of the peptide-copolymer conjugate nanoparticles by
DLS and self-assembly time for each nanoparticle pair.
Peptide-Copolymer Conjugate

Assembled

NP Size

Assembly

NP name

(nm)

time (h)

178±72

3

227±97

6

580±264

10

283±125

6

P1-PVP-b-1.5PMMA-b-PVP-P1

P1-NP1-P1

P2-PVP-b-1.5PMMA-b-PVP-P2

P2-NP1-P2

P1-PVP-b-3PMMA-b-PVP-P1

P1-NP2-P1

P2-PVP-b-3PMMA-b-PVP-P2

P2-NP2-P2

P1-PVP-b-6PMMA-b-PVP-P1

P1-NP3-P1

P2-PVP-b-6PMMA-b-PVP-P2

P2-NP3-P2

P1-PHEMA-b-3PMMA-b-PHEMA-P1

P1-NP4-P1

P2-PHEMA-b-3PMMA-b-PHEMA-P2

P2-NP4-P2

Table 3.2 shows the hydrodynamic diameter of the individual nanoparticle-peptide
conjugates before scaffold assembly, and the time allowed for scaffold assembly after the
complementary nanoparticle conjugates are combined. When larger nanoparticle
conjugates were used the allowed assembly time was increased. For example, the stable
P1-NP1-P1 suspension was injected into the stable P2-NP1-P2 suspension with gentle
magnetic stirring at 400 rpm for 30 min to give a uniformly mixed suspension. Within 10
minutes after the stirring was discontinued there was visual evidence of assembly with
the appearance of a ‘sponge-like’ phase that was settling at the bottom of the vial. The
allowed assembly time ranged from 3-10 h, with longer times being allowed for the larger
nanoparticles.
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The self-assembled nanoparticle scaffolds from smaller peptide-nanoparticles (from
P1-NP1-P1 and P2-NP1-P2) and larger peptide-nanoparticles (from P1-NP3-P1 and
P2-NP3-P2) were applied to silicon wafers to allow observation by FESEM. Briefly, the
assembled nanoparticles (100 L) were transferred onto a cleaned silicon wafer surface
(cleaned by 10 wt.% HCl solution and 10 wt.% NaOH solution for 10 h respectively, and
then washed by ethanol and deionized water several times with sonication). The
nanoparticle layer on silicon wafer surface was air dried to leave an assembled
nanoparticle membrane (designated as a 2D scaffold) and then vacuum dried at 50 C for
6 h. The nanoparticle membrane was coated with platinum (Pt, ~5nm) prior to FESEM
characterization.
3.2.7 Self-assembly study of peptide-functionalized nanoparticles with additional
peptides
A self-assembly study of the peptide-functionalized nanoparticles was performed in
the presence of excess“free” peptides (P1 and P2) to determine if their presence effected
the porous structure and mechanical stability of the final 3D nanoparticle scaffolds.
P1-NP3-P1 and P2-NP3-P2 suspensions (Table 3.2) were similarly prepared in deionized
water as described before, and the nanoparticle suspensions were dialyzed 24 h to remove
organic solvent in 2 L of fresh weak basic deionized water (pH 9.0 for P1-NP3-P1) and
weak acidic deionized water (pH 5.4 for P2-NP3-P2) with replacing fresh deionized
water every 12 h. The concentration of both purified nanoparticle suspensions was
gravimetrically determined to be 2.6 mg/mL.
Then 0.5 mL of P1-NP3-P1 suspension was well mixed with 0.5 mL of P1 solution
(11 mg/mL in deionized water with pH at 9.0) to form a mixed suspension of
P1-NP3-P1/P1 (1.3 mg/mL of nanoparticle with 5.5 mg/mL of P1). A suspension of
P2-NP3-P2/P2 (same concentration as P1-NP3-P1/P1) was similarly prepared. Then the
P1-NP3-P1/P1 suspension was combined with the P2-NP3-P2/P2 suspension by magnetic
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stirring at 400 rpm for 2 h, and allowed to settle during self-assembly to form
nanoparticle/peptide

co-assembled

composite

hydrogel

after

adjusting

NaCl

concentration to be 10 mM by adding 1M NaCl solution. The concentration of the
nanoparticle/peptide composite hydrogel was 1.3 mg/mL of nanoparticle with 5.5 mg/mL
of total peptides (P1 and P2). Using same procedure, 1.3 mg/mL of nanoparticle with 11
mg/mL and 22 mg/mL of total peptides were prepared to compare their stability and
porous structure of 3D nanoparticle/peptide hydrogel scaffolds.
10 µL of the self-assembled nanoparticle/peptide composite hydrogel was dropped
onto a cleaned silicon wafer surface to air dry, giving2Dnanoparticle/peptide membranes.
The membrane was then rinsed with 100 µL of fresh deionized water 3 times to remove
un-bonded peptides and salts and again allowed to air dry. Another 10µL of the composite
hydrogel (1.3 mg/mL nanoparticle with 22 mg/mL P1 and P2) was placed in a silicon
wafer and dried under reduced pressure at room temperaturewithout washing with
deionized

water

in

order

to

compare

the

3D

morphologies

of

the

co-assemblednanoparticle/peptide scaffold because vacuum drying can quickly remove
solvent to retain a 3D structure, but air drying only gives a compact 2D membrane.
Allsamples were then coated with a layer of platinum (5 nm) for FESEM
characterization.

3.2.8 Controlled release test with hydrophobic fluorescein as model drug
A controlled release study was performed for 23 days in deionized water using
4’,5’-dibromofluorescein (DBF) as model for a small hydrophobic drug. The
peptide-copolymer conjugates together with the DBF were dissolved in DMSO to form
two host solutions, DBF/P1-PVP-b-1.5PMMA-b-PVP-P1 (38 mg + 0.2 wt.%
DBF)/DMSO (4mL) solution and DBF/P2-PVP-b-1.5PMMA-b-PVP-P2 (38 mg + 0.2
wt.% DBF)/DMSO (4mL) solution. The DBF/P1-copolymer host solution was then
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slowly injected into weakly basic deionized water (10 mL, pH 9.0) to give a
self-assembled DBF-loaded P1-NP1-P1 suspension. The DBF/P2-copolymer host
solution was similarly injected into weakly acidic deionized water (10 mL, pH 5.4) to
give a self-assembled DBF-loaded P2-NP1-P2 suspension. The DBF-loaded P1-NP1-P1
suspension was then injected (23G syringe) into the DBF-loaded P2-NP1-P2 suspension
with gentle magnetic stirring at 400 rpm for 1h to give a uniform mixture. The mixed
nanoparticle suspension was allowed to self-assemble into a3Dnanoparticle scaffold at
the bottom of the vial.
The concentration of the DBF-loaded nanoparticle scaffold suspension was
gravimetrically determined. This was done bygently shaking the suspensionto gain a
uniform dispersion, and then 2.0 mL of the suspension was measured and gently heated
to remove solvent to obtain a dimensionally stable dry mass (7.0 mg). The remainder of
the nanoparticle suspension was then centrifuged to isolate the uncaptured DBF in the
supernatant. The nanoparticle scaffoldsolids were also collected and washed with fresh
deionized water (2.0 mL each time) and centrifuged at 4000 rpm for 10 min to isolateany
additionaluncaptured DBFthat had been adsorbed onto the nanoparticle surface. This
washing and centrifuging process was repeated two additional times, and all the
supernantants were combined to aid in collecting all uncaptured DBF. The combined
supernatant was evaporated in a dark environment, and the isolated DBF was then
dissolved in a solution of deionized water/ethanol (1:1, v/v) and transferred into a
volumetric flask to allow the uncaptured DBF to be quantified by fluorescence
spectrometry. Thewashed DBF-loaded nanoparticle solids were then dispersed in 3.0 mL
of fresh deionized water and set up at 37±1 C for a controlled release test. At each time
interval, the released DBFsolution was isolated from the solid nanoparticles by
centrifugation at 4000 rpm for 10 min, and then the DBF-containing supernatant was
collected for testing. Then 3.0 mL of fresh deionized water was added to replace the
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collected fluid and thecontrolled release test on the nanoparticles was continued. An
equivalent volume of ethanol was added to each liquid aliquot collected from the sample
being tested so that the releasedDBFwas in a 1:1 water/ethanol solution foranalysis.
Separately, a series of standard DBF solutionswere prepared using deionized
water/ethanol (1:1, v/v) to givea standard curve to quantify uncaptured DBF and released
DBF from the nanoparticle scaffolds. The uncapturedDBFsolution, the released
DBFsample solution, and standard DBF solution, were analyzed by fluorescence
spectrometer (SPEX FLUOROLOG equipped with SPEX 1681 0.22 m Spectrometer and
SPEX dM 3000 power controller, HORIBA Scientific, USA) with slit setup at 0.50 mm
and emission intensity collected at 532 nm. The concentration of uncapturedDBFand each
released DBFsample were quantitatively determined according to the standard curve and
Beer’s Law (Figure 3.1S, supplementary data). And the actual loading content (wt. %) of
DBF in nanoparticles was calculated based on equation (2).
Actual

wt.% 

Wint ial

drug

 Wuncaptured

Wdrugloaded

drug

 100%

(2)

nanopartic
le

All other peptide-copolymer conjugates were loaded with model drug of DBF using
the same procedure, and the actual loading content (wt. %) was determined. The results
are shown in Table 3.3. The cumulative release of DBF (wt.%) based on initially loaded
DBF amount was calculated and results are shown in Figure 3.10.
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Table 3.3. Loading efficiency of model drug (DBF) in different nanoparticles.
DBF
Scaffold/NPs

S-1

S-2

S-3

S-4

P1-NP1-P1
P2-NP1-P2
P1-NP2-P1
P2-NP2-P2
P1-NP3-P1
P2-NP3-P2
P1-NP4-P1
P2-NP4-P2

Theo. Loading

Act. Loading

Loading

wt. %

wt. %

Efficiency%

0.20

0.19

95

0.20

0.16

80

0.20

0.19

95

0.20

0.18
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3.2.9 Multiple-drug loading and controlled release test using nitrofurazone and
amoxicillin as model drugs
Controlled release studies were also done to test the simultaneous release of multiple
drugs contained within one self-assembled scaffold system. These tests used
nitrofurazone as a moderately hydrophobic model drug and amoxicillin asahydrophilic
model drug. P1-NP-P1 and P2-NP-P2 were separately loaded with 5.0 wt.% of
nitrofurazone and 5.0 wt.% of amoxicillin respectively using the same procedure as for
DBF loading.
The two drug-loaded nanoparticle suspensions (P1-NP-P1 and P2-NP-P2) were then
mixed together to self-assemble into a two-drug loaded nanoparticle scaffold. The
nanoparticle scaffold concentration, uncaptured drug quantities and controlled release
tests were performed using the procedures described for DBF, except the controlled
release test time wasonly 96 h due to the rapid release of the hydrophilic model drug,
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amoxicillin. The amount of uncaptured and released drugs was quantified using an HPLC
equipped with a UV-vis detector (SPD-20AT/SPD-20A, SHIMADZU Corporation,
Kyoto, Japan). An example of calibration curve of nitrofurazone and amoxicillin for
quantitative analysis is shown in Figure 3.2S a,b (supplementary data). The actual
quantity of nitrofurazone and amoxicillin that were loaded into the nanoparticles is given
in Table 3.4. The cumulative release of both drugs (wt.% based on initially loaded
amount) was determined and these results are shown in Figure 3.11.
Table 3.4. Loading efficiency of model drugs (Nitrofurazone and Amoxicillin) in
different nanoparticles.
Nitrofurazone
Theo.

Act.

Load

Load

wt. %

wt.%

Theo.

Act.

Load

Load

wt. %

wt.%

P1-NP1-P1

5.0

2.9

58

--

--

--

P2-NP1-P2

--

--

--

5.0

1.3

26

P1-NP2-P1

5.0

4.5

90

--

--

--

P2-NP2-P2

--

--

--

5.0

1.6

32

P1-NP3-P1

5.0

3.1

62

--

--

--

P2-NP3-P2

--

--

5.0

1.2

24

P1-NP4-P1

5.0

4.7

94

--

--

--

P2-NP4-P2

--

--

--

5.0

1.3

26

Scaffold/NPs

S-1

S-2

S-3

S-4

Amoxicillin
Load
Effi. %

Load
Effi. %

3.2.10 Cytotoxicity test on NIH3T3 cell lines
Nanoparticle scaffolds that were self-assembled from P1-NP(x)-P1 and P2-NP(x)-P2
(Table 3.2, NP(x) represents NP1, NP2, NP 3, or NP4), possessing different particle sizes
and/or compositions, were tested for biocompatibility with NIH3T3 fibroblast cells. This
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testing was done by incubating NIH3T3 fibroblast cellsin a glass culture dish that already
possessed an assembled 2D scaffoldingmembraneon the bottom of the dish. The study
was done to test the effects of the different scaffolds on cell viability and activity.
Each self-assembled nanoparticle scaffold (Table 3.3, S-1 to S-4) was similarly
prepared using the same self-assembly procedure. For example, the P1-NP1-P1
suspension was self-assembled from P1-PVP-b-1.5PMMA-b-PVP-P1/DMSO (40
mg/4mL) precursor solution in weakly basic deionized water (10 mL, pH 9.0), and the
P2-NP1-P2 suspension was prepared from P2-PVP-b-1.5PMMA-b-PVP-P2/DMSO (40
mg/4mL) precursor solution but in weakly acidic deionized water (10 mL, pH 5.4). The
two suspensions were then coupled together with gentle magnetic stirring at 400 rpm for
30 min and settled for 3 h to obtain scaffold sample S-1. Other scaffold samples (S-2 to
S-4) were prepared using the same method, but longer assembly time was allowed for
bigger nanoparticles. All scaffold samples were dialyzed using a dialysis tube (Nominal
MWCO 3,500, from Fisher Scientific) in PBS solution for 48 h to remove organic solvent
and free peptide (P1 and P2). Fresh PBS (1L for each sample) was replaced for dialysis at
every 24 h interval. The purified nanoparticle scaffold was then transferred into a
centrifuge tube (15 mL) and stored at 4 C for application.
The concentration of the purified scaffold was gravimetrically determined. 2.0 mL of
uniformly dispersed scaffold suspension (S-1) was measured and gently heated to remove
solvent, leaving dry mass of 7.2 mg after taking off the background mass of 2.0 mL of
dried PBS. So the scaffold concentration of S-1 was determined to be 3.5 mg/mL. Other
nanoparticle scaffold samples (S-2, S-3 and S-4) were determined to be 2.9, 3.0, and 3.6
mg/mL respectively.
Based on the known concentrations, approximately 500 g of dry scaffold mass were
transferred into each pre-sterilized glass culture dish. The suspension drop was air dried
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at room temperature overnight, leaving an assembled scaffold membrane (a circle layer
with diameter of ~2cm) on the dish bottom.
Fibroblast cells were cultured in cell media and passaged at ~95% confluency so that
the cells were able to be cultured for extended periods of time. Cell concentration was
determined to be 1.5105 cells/mL by cytometry. To each culture dish containing S-1 to
S-4scaffold membrane, fibroblast cell seeds (~1.5105 cells) were transferred onto the
membrane surface and incubated for ~15 min at 37 °Cwith 5% CO2in a humidified
incubator, and then 5 mL cell media was slowly added to avoid directly flushing onto the
membrane. The culture dish was then incubated at 37 °C with 5% CO2 in the incubator
and media was refreshed after 12 h and then replaced every 24 h. The cell growth status
was observed every 24 h using optical microscopy (Nikon Eclipse Ti, Nikon Instruments
Inc., USA) and the incubation was allowed to proceedfor 7 days.
In order to improve cell adhesion ability, cell adhesion peptides (RGDS, 1 wt.%
based on peptide-copolymer conjugates) were physically encapsulated into nanoparticles
using the same procedure that was used to load the model drugs, and similarly purified by
dialysis in fresh PBS.The RGDS-loaded nanoparticle scaffold membrane was similarly
prepared on a glass dish, air dried and then incubated with fibroblast cells using same
procedure. Both cell proliferation and migration were observed every 24 h by optical
microscopy.
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3.3 Results and Discussion
3.3.1 Rationale for peptide design and study of peptide self-assembly
The purpose of this project was to design a new type of self-assembled polymeric
nanoparticle scaffold with far greater versatility than other scaffolding systems, including
multi-drug loading abilities and the ability to vary mechanical strength of the scaffolding,
for tissue engineering. The methodology is outlined in Figure 3.1, which demonstrates
the use of 2 different nanoparticles assembled into an alternating pattern. The ends of two
batches of amphiphilic copolymers are separately functionalized with the our designed
peptides (P1 and P2) to form peptide-copolymer conjugates, one carrying negative
charges from P1, and the other carrying positive charges from P2. These
peptide-copolymer conjugates undergo two-levels of self-assembly in aqueous solution.
The first level is the assembly of the core-shell nanoparticle itself, which would be done
separately. In principle any biologically acceptable composition could be selected for a
desired drug to control its release and a desired nanoparticle size (influenced by the ratio
of hydrophilic to hydrophobic monomers and polymer molecular weight) and a desired
mechanical strength (influenced by the same variables). For best control a single drug is
incorporated into a single nanoparticle, and the numbers of each nanoparticle type would
control the total “dose” of each drug. Once the drugs are the appropriate batches of
peptide-functionalized nanoparticles are combined to self-assemble into nanoparticle
fibers directed by ionic complementary assembly between P1 and P2, and finally,
depending on the conditions and assembly time allowed, form 3D nanoparticle scaffolds
with multi-drug loading.
As already described, the advantages of this nanoparticle self-assembly approach
includes: (1)The ability to incorporate multiple drugs, regardless of that drug’s
hydrophilicity or hydrophobicity, within the scaffolding; (2)The ability to control the
distribution of the different drugs within the scaffold; (3) The ability to separately control
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the release of each drug from a nanoparticle whose composition can be designed for that
specific drug; (4)The ability to adjust the porosity and mechanical strength of the final
hydrogel; and (5) The ability to introduce this system into a patient by injection followed
by controlled self-assembled of the scaffold in situ.

Figure 3.1. General procedure shows fabrication of polymeric nanoparticle scaffold with
multi-drug loading abilities.
The key step to achieve these features is the two designed ionic complementary
peptides (P1 and P2) with opposite charges that can assemble into β-sheets in aqueous
solution with appropriate pH range. The two peptides were synthesized by
semi-automatic

solid

phase

peptide

synthesis

strategy

with

sequence

of

H2N-TTTT-AEAEAEAE-amide (P1) and H2N-TTTT-AKAKAKAK-amide (P2). The
spacer part (TTTT) is designed to decrease the steric hindrance of copolymer domain to
the assembly units (AEAEAEAE for P1 and AKAKAKAK for P2) and thus increase the
mobility of the assembly units, and also to increase the solubility of the peptides in
aqueous solution.
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The synthesized peptides were characterized by MALDI-TOF MS, 1H-NMR to
confirm the synthesized sequence and chemical structure matching well with theoretical
ones. It was also demonstrated that P1 and P2 in PBS/DMF (1:1 v/v) at total peptide
concentration of 11 mg/mL showed self-repulsive but mutually attractive self-assembly
behavior. All of the work was concretely presented in previous report (26).
Considering biological applications of the self-assembled scaffold, here we further
study the self-repulsive but mutually attractive property of the designer peptides (P1 and
P2) in aqueous solution with different salt (NaCl) concentration, because it was reported
that alkaline salt concentration could significantly affect ionic peptide self-assembly
behavior by forming ion-pair bridge between opposite charges, or mask the ion-pair
interaction if excessive cation/anion existed (27).
Here, the self-assembly of P1 and P2 was conducted by dissolving P1 in sterile
deionized water (pH 9.0, adjusted by 1M NaOH solution) and P2 in sterile deionized
water (pH 5.4, adjusted by 1M HCl solution).

Each peptide forms clear aqueous

solution with excellent solubility more than 22 mg/mL, but when the two peptide
solutions are combined together, the self-assembly is triggered to form hydrogel after
settling for 3 h even the concentration is as low as 5.5 mg/mL. The results are shown in
Figure 3.2.

Figure 3.2. Gels formed from self-assembly of P1 and P2 (1:1 wt./wt.) at different total
peptide concentration and salt concentration. (a) Gel of P1+P2 at 5.5 mg/mL with NaCl
concentration of 10 mM. (b) Gel of P1+P2 at 11 mg/mL with NaCl concentration of 0.03
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mM. (c) Gel of P1+P2 at 11 mg/mL with NaCl concentration of 10 mM. (d) Gel of
P1+P2 at 11 mg/mL with NaCl concentration of 30 mM.
The gel formation was compared at different NaCl concentration, which showed that
P1 self-assembles with P2 most quickly at a10 mMNaCl concentration, but the gel is
weakened when the NaCl concentration increases to 30 mM (Fig. 3.2d). A self-assembled
peptide gel, at a total concentrationofpeptide of 11 mg/mL (P1+P2, 1:1 wt./wt.) and with
NaCl concentration of 10 mM, was dropped on a silicon wafer surface and air dried to
form a membrane, that was then coated with Pt/Pd layer (5 nm), was observed by
FESEM. The images are shown in Figure 3.3.
Figure 3.3 shows the snowflake-like morphology on top with some smooth
membrane on bottom of the self-assembled peptide membrane before rinsing with
deionized water. But after rinsing with deionized water to remove the salt, the
self-assembled morphology was converted to amorphous aggregation (Fig. 3.3b). This
change is mainly due to the high water solubility of the designer peptides (P1 and P2).
The high water solubility of peptides usually leads to unstable self-assembled structure
and requires high critical concentration to form nanofiber structure (17,18). This appears
to be the main reason for our designer peptides that only show certain extent of assembly
structure but not very stable nanofiber structure due to its high water solubility and short
assembly units (only 8 repeat units, P1: AEAEAEAE and P2: AKAKAKAK).
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(a)

(b)

Figure 3.3. FESEM micrograph of self-assembled peptide membrane of P1+P2 (no
nanoparticle conjugates are present) at a total concentration of 11 mg/mL with NaCl 10
mM. (a) Membrane without rinsing with deionized water. (b) Membrane rinsing with
deionized water.

3.3.2 Synthesis of amphiphilic copolymer with different ratio of hydrophilic and
hydrophobic blocks
In previous work we synthesized peptide-functionalized amphiphilic copolymer
(PVP-b-12PMMA-b-PVP

or

PHEMA-b-12PMMA-b-PHEMA,

hydrophilic

to

hydrophobic block ratio=1:12:1) to self-assemble into peptide-funcitonalized polymeric
microparticle (P1-NP-P1 and P2-NP-P2) with a hydrodynamic size of ~1m, to study
their self-assembly behavior in aqueous solution to form 1D nanoparticle fibers and 3D
scaffolds directed by ionic complementary interaction between P1 and P2 (26). The
present work continues that study, and expands its goals to better understand the effect of
nanoparticle size on self-assembled scaffold morphology, mechanical stability, and to
prove individual control over the release rate of different drugs within the scaffold.
To do this, amphiphilic copolymers with different block ratio are designed and
synthesized by reversible addition-fragmentation chain transfer (RAFT) polymerization
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using S,S-bis(,-dimethylacetic acid) trithiocarbonate (BDAT) as the effective
chain-transfer agent (CTA) (28). The different block ratio is designed to form
nanoparticles with different particle size. The theoretical block ratio of hydrophilic to
hydrophobic block (PVP:PMMA) was ranged from 1:1.5:1 to 1:6:1 (Table 3.1). The
synthesized copolymers were characterized by 1H-NMR to determine the actual block
ratio, as shown in Figure 3.4. As Figure 3.4a shows, the integrated peak ratio at : 3.14
(–CH2-N, h from PVP block) to : 3.56 and 3.35 (-OCH3, a from PMMA block, and
-CH-,e from PVP backbone ) increases as block ratio of PVP:PMMA increase. Using
equation (1) and the integrated peak area ratio, the actual block ratio of hydrophilic to
hydrophobic block (XPVP:XPMMA) of each block copolymer was determined and thus the
repeat units (XM) of PMMA block and the copolymer molecular weight (MN) were
calculated according to the repeat units number of XN and XM. The actual block ratio
and molecular weight of PHEMA-b-PMMA-b-PHEMA was similarly calculated
according to the 1H-NMR analysis (Fig. 3.4b). The results are shown in Table 3.1. The
self-assembled polymeric nanoparticle sizes with different block ratio are tested by DLS
and shown in Table 3.2.
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(a)

(b)
Figure 3.4.1H-NMR spectra of amphiphilic copolymers with different block ratio. (a)
PVP and PVP-b-PMMA-b-PVP with block ratio of PVP:PMMA from 1:1.5 to 1:6; (b)
PHEMA and PHEMA-b-PMMA-b-PHEMA with block ratio of PHEMA:PMMA=1:3.
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3.3.3 Coupling reaction of copolymer with peptides
Each copolymer is then coupled with peptides (P1 and P2) to form P1-copolymer and
P2-copolymer conjugates via the coupling reaction between peptide amine terminals and
copolymer carboxylic acid terminals, as Scheme 3.1 shows. The peptide-copolymer
conjugates were purified by precipitation in cool diethyl ether followed by centrifugation
and drying under reduced pressure. The coupling reaction was qualitatively verified by
FTIR, as shown in Figure 3.5.

(a)

101

(b)

(c)
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(d)
Figure 3.5. Comparison of FT-IR spectra of peptides (P1 and P2), copolymer and
peptide-copolymer conjugates. (a) PVP-b-1.5PMMA-b-PVP coupled with P1 and P2. (b)
PVP-b-3PMMA-b-PVP coupled with P1 and P2. (c) PVP-b-6PMMA-b-PVP coupled
with P1 and P2. (d) PHEMA-b-3PMMA-b-PHEMA coupled with P1 and P2.

As Figure 3.5 shows, FT-IR spectra of copolymers show two carbonyl absorption
peaks at 1730 cm-1 from the PMMA block and 1664 cm-1 from the PVP block. When the
hydrophilic block ratio (PVP or PHEMA) is adjusted from 1:6 to 1:1.5, the absorption
intensity at 1664cm-1 also increase.After the copolymer is coupled with peptides (P1 and
P2), both P1- and P2-copolymer conjugates show weak absorption peaks at
approximately 1628 cm-1 and 1530 cm-1, and also feature absorption peaks of the peptide
amide bonds from P1 and P2. Also, the original absorption peak at 1664 cm-1 from the
hydrophilic block (PVP or PHEMA) is weakened or covered by peptide absorption.
These results qualitatively confirm the effective coupling reaction between copolymer
with peptides to form peptide-copolymer conjugates.
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3.3.4 Self-assembly study of peptide-functionalized nanoparticles
The purpose of this work is to fabricate self-assembled ‘nanoparticle fibers’ that can
subsequently self-assemble to produce 3D scaffolds as directed by -sheet peptide
assembly with multi-drug loading abilities (Fig. 3.1). In previous work we already
showed that peptide-functionalizedmicroparticles with particle size of ~1 m could
effectively assemble to form 1D nanoparticle fibers and eventually lead to 3D scaffolds
after condensation (Fig. 3.6).

(a)

(b)

(c)

(d)

Figure 3.6. Optical microscopy images of self-assembled 1D nanoparticle fibers and 3D
nanoparticle scaffolds on glass slide surfaces. Microparticle fibers and scaffolds from
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peptide-functionalized PVP-b-12PMMA-b-PVPconjugates are shown in(a) and (b).
Microparticle

fibers

and

scaffolds

from

peptide-functionalized

PHEMA-b-12PMMA-b-PHEMA conjugates are shown in(c) and (d).Both 1D
nanoparticle fibers wereprepared by gently shaking self-assembled nanoparticle
suspension (10 h assembling time) and then transferring via 31G syringe onto glass slide
surface with slowly moving syringe needle down along slide surface. Both 3D scaffolds
were prepared without shaking self-assembled nanoparticle suspension.

The effect of particle size on the self-assembly behavior, the assembled scaffold
morphology and its mechanical stability were also studied. The self-assembled
nanoparticles from various peptide-copolymer conjugates with different block ratios
(Table 3.1) were tested by dynamic light scattering (DLS) with particle size ranging from
178±72 nm to 580 ±264 nm as the length of the hydrophobic block (PMMA block) was
increased (Table 3.2). The self-assembly process between P1-NP-P1 and P2-NP-P2 is
illustrated in Figure 3.7.

Figure 3.7.Self-assembly process between P1-NPA-P1 and P2-NPB-P2 with DBF loading
as indicator.
The peptide-functionalized nanoparticle pair (P1-NPA-P1 and P2-NPB-P2) were
loaded with DBF as an indicator to verifythe self-assembly. As Figure 3.7 shows,
initially stable P1-NPA-P1 and P2-NPB-P2suspensions are coupled together with
magnetic stirring. The self-assembly between these two nanoparticles begins once
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magnetic stirring is stopped. It is directed by the ionic complementary assembly between
P1 and P2, and forms a ‘sponge-like’ bottom layer in the vial. Our study shows that the
self-assembly proceeds more quickly for smaller nanoparticles (3 h for P1-NP1-P1 and
P2-NP1-P2) than for bigger particles (10 h for P1-NP3-P1 and P2-NP3-P2) (Table 3.2).
The self-assembled 2D nanoparticle

scaffold membrane was prepared by

transferring ~100 L of the ‘sponge-like’ layer onto the silicon wafer surface and air
dried, which was then coated with 5 nm Pt/Pd layer. FESEM micrographs of the scaffold
membrane with different particle size are shown in Figure 3.8.

(a)

(b)

(c)

(d)

Figure 3.8. FESEM micrographics of self-assembled nanoparticle membrane on silicon
wafer surface after being air dried. (a) Scaffold membrane assembled from P1-NP1-P1
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and P2-NP1-P2; (b) Scaffold membrane assembled from P1-NP3-P1 and P2-NP3-P2; (c)
Cleaved scaffold interface morphology from P1-NP3-P1 and P2-NP3-P2; (d) Scaffold
loaded with 0.2 wt.% of model drug (DBF) within nanoparticles.
Figure 3.8 shows the morphologies of the assembled 2D scaffold membrane on
silicon wafer surfaceand air dried under room temperature. The smaller nanoparticles
(P1-NP1-P1 and P2-NP1-P2, DLS size: 178±72 nm) self-assembled to form more
compact membrane with smooth surface and smaller pores (Fig. 3.8a), while bigger
nanoparticles (P1-NP3-P1 and P2-NP3-P2, DLS size: 580±264 nm) assembled to
formmembrane with rough surface and bigger pores (Fig. 3.8b). However, the
micrographics from the cleaved interface clearly show 3D fibrous structure inside of the
scaffold membrane with or without loading of model drug (DBF) (Fig. 3.8c, d). The
FESEM micrographics also show that the dried nanoparticle size is about 20-50 nm for
smaller nanoparticles and 50-100 nm for bigger nanoparticles, which is much smaller
than the size tested by DLS, mainly due to hydrodynamic size of wet nanoparticles and
slight aggregation in aqueous solution.
On comparing themorphologies ofscaffold membranesassembledfrom smaller and
larger nanoparticles (Fig. 3.8a and b) it is not difficult to understand that smaller
nanoparticles undergo faster self-assembly than the larger ones (Table 3.2) because
smaller nanoparticlescan move more easily to be directed by electrostatic interactions
between P1 and P2, and the nanoparticles themselves have stronger inter-particle
interaction force. Therefore, the smaller nanoparticles self-assemble to form more
compact scaffolds with smaller pores, but are more mechanically stable than those from
larger nanoparticles. Therefore there is a balance between nanoparticle size and
mechanical stability and pore size for such assembled nanoparticle scaffolds when they
are to be used for tissue engineering.
3.3.5 Self-assembly study of peptide-functionalized nanoparticle with additional
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peptides
In order to further increase the mechanical stability and combine the advantage of
self-assembling peptide scaffolds, peptide-functionalized nanoparticles (P1-NP3-P1 and
P2-NP3-P2, total concentration 1.3 mg/mL) are co-assembled with additional peptides
(P1 and P2) with total peptide concentration (P1:P2= 1:1 wt./wt.) ranged from 5.5 mg/mL
to 22 mg/mL. The co-assembled composite gel status is shown in Figure 3.9. From left to
right, as the peptide concentration increases, the stability of the co-assembled composite
gels are correspondingly increased by forming gels, but self-assembled nanoparticle
suspension control (Fig. 3.9a) shows at flow status with ‘sponge-like appearance’. The
stability of composite gels is compared by sonicating 30 seconds, only nanoparticles
co-assembled with 22 mg/mL of peptides remained stable gel status (Fig. 3.9d), while the
composite gels with low peptide concentration was broken into viscous solution status
(Fig. 3.9b,c).

Figure

3.9.

Peptide-functionalized

nanoparticles

(P1-NP3-P1

and

P2-NP3-P2)

co-assembled with additional peptides (P1+P2, 1:1 wt./wt.) to form composite peptide
gels. (a) Self-assembled nanoparticle control without peptides; (b) With total peptide
concentration at 5.5 mg/mL; (c) With total peptide concentration at 11 mg/mL; (d) With
total peptide concentration at 22 mg/mL.

The self-assembled morphologies of P1-NP3-P1 and P2-NP3-P2 with additional
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peptides are further characterized by FESEM microscopy, as shown in Figure 3.10.
FESEM micrographics of Figure 3.10 a,b,c are prepared by dropping composite gels on
silicon wafer surface and air dried under room temperature with washing away
un-bonded peptides by rinsing with deionized water (3 x 100 L). While Figure 3.10
d,e,f are morphologies of composite gel co-assembled with 22 mg/mL of peptides
without washing and dried at room temperature under reduced pressure in a vacuum
oven.

(a)

(b)

(b)

(d)
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(e)

(f)

Figure 3.10. FESEM micrographs of the co-assembled composite peptide gels prepared
by assembling of peptide-functionalized nanoparticles (P1-NP3-P1 and P2-NP3-P2) with
additional ionic complementary peptides (P1 and P2) at different total peptide
concentration and then transferring onto silicon wafer surface.(a) Co-assembled gel with
peptide concentration at 5.5 mg/mL; (b) Co-assembled gel with peptide concentration at
11 mg/mL; (c) Co-assembled gel with peptide concentration at 22 mg/mL.(a), (b) and (c)
are gel membranes on silicon wafer surface after air drying and washing with deionized
water. (d), (e) and (f) are representative morphologies of co-assembled gel with peptide
concentration at 22 mg/mL without washing and dried at room temperature under reduced
pressure.

Comparing the morphologies of self-assembled membrane on silicon wafer surface
by air drying and washing with deionized water, the self-assembled nanoparticles without
additional peptides formed compact porous 3D nanoparticle scaffolds with fiber structure
(Fig. 3.8 b,c).However, the co-assembled composite gels with additional peptides at
concentration from 5.5 mg/mL to 22 mg/mL appear that assembled nanoparticles are
embedded into peptide layers without apparent 3D network structure after washed with
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deionized water (Fig. 3.10 a,b,c), even though the membrane is stably stick onto silicon
wafer surface. Again, the conversion to amorphous aggregation morphology is caused by
water washing due to high water solubility of the designer peptides (P1 and P2). This is
evidenced by comparing the morphology change of the co-assembled composite gel with
22 mg/mL of peptides before and after washing with deionized water, and air dried or
dried under reduced pressure (Fig. 3.10 c compared with d,e,f). It is shown that the
co-assembled composite gel membrane is amorphous aggregation without any 3D
network structure (Fig. 3.10c) if washed deionized water and air dried, but Figure 3.10
d,e,f clearly show the 3D fibrous structurewith somewhat film structure if without
washing and dried under reduced pressure.
Interestingly, there are several new features from this co-assembled composite gel
scaffoldwith total peptide concentration at 22 mg/mL comparing with other reported ionic
complementary peptide nanofiber scaffold. At first, it shows fiber structure
withmicroscale diameter, much larger than conventionalself-assembling peptide
nanofiber (29), even though our co-assembled fiber diameter is not in uniform size.
Secondly, the single fiber length is ranging from tens to hundreds micrometer, also much
longer than traditional peptide nanofibers with length from hundreds nanometer to
several micrometers (29). Thirdly, the 3D scaffolddominant structure is from
self-assembling peptide scaffolds but with microscale porous structure, no apparent
nanoparticle scaffolds is visible from both FESEM images. This is considered that
peptide-functionalized nanoparticles are effectively co-assembled with host peptides and
uniformly distributed in peptide scaffolding system. These new features probably will
expand the peptide scaffold applications where requires larger porosity with longer
diameter, ease of multiple drug loading capability and controlled release rate of each
drug.
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3.3.6 Controlled release test of multi-drug models
The purpose of this project is to design self-assembled polymeric nanoparticle
scaffolds with the ability to load different types of drugs allowing for controlled release
for each drug. In prior work insulin was used as macromolecular model drug and loaded
into nanoparticle scaffolds (0.15 wt.% loading quantity) without destroying the
self-assembled structure. This system showed sustainable release over 3 weeks (26). To
further study multi-drug loading abilities and the simultaneous sustainable release of each
drug, several compounds with different properties are used as model drugs and loaded in
nanoparticle scaffolds, and the controlled release was tested. The compounds were DBF
as a hydrophobic small molecule model, nitrofurazone as a less hydrophobic small
molecule model and amoxicillin as hydrophilic small molecule model drug.
The theoretic and actual loading levels of the model drugs in each type of
nanoparticles are summarized in Table 3.3 and Table 3.4. The cumulative release of each
model drug from the self-assembled nanoparticle scaffolds is shown in Figure 3.11.

(a)
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(b)

(c)
Figure 3.11. Cumulative release (wt.%) of model drugs from self-assembled nanoparticle
scaffolds with different particle size and composition.(a) Cumulative release of DBF from
various assembled scaffolds; (b) Simultaneous cumulative release of nitrofurazone from
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self-assembled scaffolds; (c) Simultaneous cumulative release of amoxicillin from
self-assembled scaffolds.
DBF is first used as hydrophobic small molecule model drug and loaded in both
P1-NP-P1 and P2-NP-P2 to perform controlled release test over 3 weeks from
self-assembled scaffolds to determine long release period. The theoretical loading
quantity is set up to 0.2 wt.% and high loading efficiency is achieved between 85 to 95%
for these hydrophobic small molecules. The releasing profile in Figure 3.11a shows only
1.5 to 5.5 wt.% of DBF released from scaffold over 3 weeks, and smaller nanoparticles
generally released more quickly than bigger ones, except S-3 showing faster than from
S-2 (Table 3.3, S-3 has bigger particle size than S-2).
Simultaneous loading of multiple drugs and governing release rate of each drug from
same scaffold is one of the main objectives of this project. Here we use nitrofurazone
(less hydrophobic small molecule) and amoxicillin (slight water soluble hydrophilic small
molecule) as model drugs to load in P1-NP-P1 and P2-NP-P2 separately, and then couple
these two peptide-functionalized nanoparticles to self-assemble into scaffold to perform
simultaneous controlled release test of both drugs from same scaffold. For these two
model drugs, the theoretical loading quantity is increased to 5.0 wt.% with actual loading
efficiency ranging from 58 to 94 % for nitrofurazone and from 24 to 32% for amoxicillin.
Again, the high loading efficiency for less hydrophobic small molecules (nitrofurazone)
is still achieved though the loading quantity is increased to 5.0 wt.%. While loading
efficiency for hydrophilic small molecule (amoxicillin) is relatively reduced due to its
water solubility.
Figure 3.11 b,c show the simultaneous releasing profiles from the self-assembled
nanoparticle scaffolds. Two main results can be read from their releasing profiles: (1)
Hydrophilic molecules (amoxicillin) release more quickly than hydrophobic molecules
(nitrofurazone); (2) The general trends are that smaller nanoparticles release drugs more
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quickly than bigger nanoparticles (S-1>S-2>S-3),where hydrophobic core (PMMA) is
increased for these nanoparticle scaffolds, except nitrofurazone released from S-3 showed
inverse trend (Fig. 3.11 b).
While comparing release behavior of nitrofurazone and amoxicillin from S-2 and S-4
(self-assembled

from

peptide-functionalized

PVP-b-3PMMA-b-PVP

and

PHEMA-b-3PMMA-b-PHEMA), the nanoparticle composition of hydrophilic shell is
changed, but the particle size is very close, the releasing behavior shows significant
difference.

It appears that hydrophilic shell of PHEMA enhanced amoxicillin release

rate, but reduced nitrofurazone release. This is most likely due to hydrogen bonding
interaction with drugs from hydroxyl groups of PHEMA shell, while PVP shell does not
possess such groups. This means the shell property is another factor to govern release rate
of drugs with different hydrophilicity, but not only be controlled by hydrophobic core
domain and particle size.
Even though the detailed release rate of drugs from core-shell nanoparticles is
complexly influenced by several factors, such as drug properties, actual loading quantity,
core-shell ratio, porous structure and shell properties, the basic principle is that
hydrophobic molecules (i.e. DBF and nitrofurazone) prefer to be encapsulated into
hydrophobic core (i.e. PMMA) of the self-assembled core-shell polymeric nanoparticles,
while hydrophilic molecules (i.e. amoxicillin) are more likely to be captured in
hydrophilic shell (i.e. PVP or PHEMA). So the general trends are that the bigger
hydrophobic core domain more easily encapsulates with hydrophobic molecules, while
the hydrophilic molecules are more likely to be captured in more hydrophilic shell
domain. The releasing rate of hydrophobic drugs (i.e. DBF or nitrofurazone) is mainly
governed by diffusion through hydrophobic core to hydrophilic shell and then entering
into aqueous media, so that they release more quickly from smaller nanoparticles than
bigger ones. While the hydrophilic drugs (i.e. amoxicillin) are mostly captured in
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hydrophilic shell and thus have shorter diffusion route to aqueous media, showing higher
releasing rate, but release rate can be affected by both diffusion speed and molecular
interaction force with shell functional groups.
3.3.7 Cytotoxicity test with NIH3T3 cell lines
The cytotoxicity test of the self-assembled scaffolds with different particle size and
composition was conducted by incubating Fibroblast cells (NIH3T3 cell lines) with
self-assembled nanoparticle scaffold membrane (~500 g for each scaffold membrane) in
each glass culture dish with cell media in a humidified incubator with 5% CO2 at 37 C.
The cell growth behavior was monitored by optical microscopy observation every 24 h
with total testing period for one week. At 72 h, the optical microscopy images of the cell
proliferation status in each culture dish were recorded and the results are shown in Figure
3.12.

(a)

(b)
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(c)

(d)

Figure 3.12. Cytotoxicity tests of an assembled scaffold membrane with Fibroblast cells
in a glass culture dish. The micrographs were recorded after incubating for 72 h in a
humidified incubator with 5 % CO2 at 37 C. The nanoparticle scaffold samples in each
culture dish are: (a) S-1 from P1-NP1-P1and P2-NP1-P2; (b) S-2 from P1-NP2-P1and
P2-NP2-P2; (c) S-3 from P1-NP3-P1and P2-NP3-P2; (d) S-4 from P1-NP4-P1 and
P2-NP4-P2 (see Table 3.3). Scale bar 100 m.

Figure 3.12 shows that the nanoparticle scaffold membranes, prepared with different
particle sizesand copolymer compositions (S-1 to S-4, Table 3.3) showedno toxicity nor
did they inhibit fibroblast cell growth at concentrations of ~500 g scaffold/5 mL cell
media. All theself-assembled scaffold membrane remained stable in the cell media
throughout the incubation period, except S-3 (assembled from P1-NP3-P1 and
P2-NP3-P2, Fig. 3.12 c), which broke down into small pieces after incubating 72 h in cell
media. However, optical microscopy images also showed that the fibroblast cells did not
effectively adhere to this membrane surface for migration and proliferation.
In order to improve cell adhesion to membrane surface, we tried to physically
incorporate cell adhesion peptides (RGDS) into nanoparticles and then self-assemble into
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2D membrane for cell tests.Here we loaded peptides (RGDS, 1 wt.%) in nanoparticles of
both P1-NP2-P1 and P2-NP2-P2, and P1-NP4-P1 and P2-NP4-P2 (Table 3.3), to
self-assemble into RGDS-loaded S-2 and S-4. The peptide-loaded scaffold membrane
was similarly prepared and incubated with fibroblast cells in a humidified incubator for 1
week with optical microscopy observation every 24 h.

Figure 3.13 shows optical

micrographics taken after incubating 108 h.Again, both scaffold membrane did not show
toxicity or inhibition to cell growth with stable structure. But unfortunately, our study
shows that physical incorporation of cell adhesion peptides in nanoparticle scaffold did
not apparently improve cell adhesion efficiency to membrane surface.

(a)
Figure 3.13.

(b)

Fibroblast cell proliferation and migration on self-assembled nanoparticle

membrane surface after the nanoparticle was physically incorporated with cell adhesion
peptides (RGDS). (a) S-2 self-assembled from P1-NP2-P1 and P2-NP2-P2; (b) S-4
self-assembled from P1-NP4-P1 and P2-NP4-P2.

3.4 Conclusion
A novel type of self-assembled fibrous nanoparticle scaffolding system was
demonstrated that employs peptide-functionalized polymeric nanoparticles that
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self-assemble into continuous ‘nanoparticle-fibers’ in aqueous solution. This type of
nanoparticle scaffold possesses all the advantages of nanoparticles’ abilities to contain
and control the release of active ingredients (demonstrated here with model hydrophobic
and hydrophilic drugs) with the ability of peptides to assemble into controlled 1D, 2D,
and 3D structures. Combining these capabilities into a single “device” allows the
simultaneous incorporation of multiple drugs, each with the desired quantity and release
rate appropriate for that drug, along with the ability to obtain a uniform distribution of
these drugs in a scaffolding system, or if desired a non-uniform distribution, and couples
these abilities with the flexibility of hydrogel scaffold if desired. The porosity of the
nanoparticle scaffolds, and the release rate of incorporated drugs, can be controlled by
adjusting polymeric nanoparticle size and composition. This can be accomplished by any
controlled polymerization route, but was done hereby RAFT polymerization. The
versatility of this fundamental technique can be expanded to other biocompatible
amphiphilic copolymers as long as it contains reactive end groups that are able to couple
with ionic complementary peptides. This system can also co-assemble with host ionic
complementary peptides to form nanoparticle-peptide composite gel scaffolds, which can
further broaden the applications of polymeric controlled drug delivery system and peptide
nanofiber scaffolds for tissue engineering. Our studies show that optimization of the
scaffold surface is required to improve cell adhesion to nanoparticle surface s, which can
be accomplished by immobilizing cell adhesion ligands on polymeric nanoparticle
surfaces. In this work we also noted that the designer peptide self-assembly is easily
converted into an amorphous aggregate after washing with aqueous solution, which was
due to an overly water-soluble peptide structure, so alternative designer peptides can be
designed with less solubility to increase the mechanical stability and lower the critical
concentration to form stable self-assembled peptide nanofibers with enhanced mechanical
strength.
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Main Findings in This Chapter:
Amphiphilic triblock copolymers were synthesized by RAFT polymerization using
BDAT as CTA. These amphiphilic copolymers were shown to self-assemble into
core-shell nanoparticles, tobe functionalized with ionic complementary peptides (P1 and
P2), and then to undergo furtherself-assembly into fibrous nanoparticle scaffolds with
porosity and morphology depending on nanoparticle size. The nanoparticle scaffolds
were prepared with different model drugs that were hydrophobic and hydrophilic, and
that could be loaded into different sets of peptide-functionalized nanoparticles and
self-assembled into nanoparticle scaffolds. Controlled release tests showed simultaneous
release with different releasing rates from the scaffolding system, and that the releasing
rate of these model drugs were effectively governed by particle size and composition. The
peptide-functionalized nanoparticles can also co-assemble with host ionic complementary
peptides (P1 and P2) to form composite peptide hydrogels, showing uniform distribution
of nanoparticles in peptide hydrogel scaffolds with microscale diameter and in a fiber
length that is hundreds ofmicromemters long, which is much larger scale than traditional
peptide nanofiber scaffolds. The designed nanoparticle scaffolds with different particle
size and shell composition demonstratedexcellent biocompatibility with NIH3T3
fibroblast cell lines and also possessed excellent stability in cell media throughout the cell
test period.
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Abstract
A simple, one-step and one-pot method was used to synthesize amphiphilic
self-assembling chitosan-g-PMMA nanoparticles (~100 nm diameter by SEM, but
~150-200 nm in water by DLS), containing ~25-28 wt% (~82–93% capture efficiency) of
the fungicide tebuconazole. The matrix composition was selected to be environmentally
low impact, while the nanoparticle preparation conditions were designed to ensure the
nanoparticles sufficiently small to be able to penetrate the pit-pores of solid wood. These
nanoparticles were delivered into southern pine sapwood blocks at target fungicide
retentions of 0.2, 0.4 and 0.8 kg tebuconazole/m3 wood. SEM analysis of a 1919455
mm nanoparticle-treated wooden stake confirmed penetration throughout the interior of
the treated stake. Leaching studies confirmed that biocide introduced into sapwood via
nanoparticle carriers leached only about 9% as much fungicide as solution-treated
controls, while soil jar tests showed the nanoparticle-treated wood blocks effectively
protected the wood from biological decay when tested against G. trabeum, a brown rot
fungus.

Keywords: controlled release, chitosan-g-PMMA nanoparticle, amphiphilic nanoparticle,
core-shell structure, tebuconazole, biocide leach
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4.1 Introduction
Amphiphilic block and graft copolymers are routinely used to prepare
self-assembling core-shell nanoparticles. Such copolymers are readily prepared from
synthetic polymers, biopolymers, or combinations of both (1-8). Polysaccharides and
proteins are well-suited for preparing grafted amphiphilic copolymer nanoparticles
because of the large number of polymerizable groups they possess along their backbone.
Chitosan is possibly the most commonly selected polysaccharide for grafted
amphiphilic copolymer nanoparticles. Its repeat units bear either a primary amine group
or an amide group if that unit is not hydrolyzed. The large number of amine groups can
be utilized in either grafting-to or grafting-from reactions. A recent review describes the
synthesis, properties, and uses of many different chitosan amphiphiles (8,9). One
“grafting from” reaction uses these amines to react with peroxides under mild conditions
yielding amine radicals that can efficiently react with hydrophobic monomers to form
amphiphilic core-shell nanoparticles (1).
Chitosan’s biocompatibility, biodegradability, and antimicrobial activity are why it is
employed in many biomedical and cosmetic applications. A recent review describes the
synthesis, properties, and uses of many different chitosan amphiphiles (8). However,
high-value applications still account for most nanoparticle uses, improvements in
technology as well as consumer trends are allowing nanoparticle uses to penetrate
commodity areas as well. For example, one recent publication describes amphiphilic
chitosan micelles for the controlled release of rotenone (9). However, that used a
multi-step synthesis and the encapsulation efficiency was low. Another report, from 2003
described controlled release of agrochemicals from chitosan (10), but those were
microparticles.
The objective of this project was to study the beneficial effects of using nanoparticles
in wood preservation. We had previously studied controlled release nanoparticles in solid
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solvent-displacement route (11-13). The nanoparticle-treated wood was tested against
both a brown and white rot fungus, and biological efficacy compared well with the
solution-treated controls. At that time no work was done to test the biocide leaching.
The rationale for employing controlled release nanoparticles to deliver organic
biocides into solid wood was the hypothesis that a controlled biocide release would
maintain an effective protection of the solid wood and might also reduce biocide leaching
into the environment. The significance of reducing biocide leaching from treated wood is
that when biocide leaches from wood it leaves the wood less well-protected from
biological attack, and the leached biocide can have detrimental effects on the
environment into which it is released. If less biocide is lost to the environment, then
potentially the wood could be effectively protected with less biocide, which is beneficial
to both the environment and to the cost of the preserved wood. In this application solid
nanoparticles are favored over liquid micelles, which are more easily delivered into wood
than solid particles, because of the desire to control the biocide release and to avoid the
use of surfactant. The amphiphilic design is preferred because this allows a hydrophobic
core composition to be used to manipulate the release rate while the shell can be
hydrophilic to give a stable suspension in water. The nanometer size, preferably below
150 nm, is required because of the anatomy of solid wood, where the small size is
required to penetrate the pit pores to enter into the wood interior.
Our recent study supported the hypothesis of reduced biocide leach using
gelatin-g-PMMA nanoparticles (1), but ungrafted gelatin complicated analysis of the
data, and the gelatin may have promoted biological decay within the wood. The purpose
of this paper is to prove the hypothesis that decreased biocide leach occurs by use of
controlled-release nanoparticles, to quantify the decrease in biocide leaching, to show
that wood preservation is not decreased, and to confirm nanoparticle penetration into
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wood interior on larger wood specimens than those used in standard soil jar studies. Here
we prepared fungicide-containing chitosan-g-PMMA core-shell nanoparticles using the
grafting approach outlined in Scheme 4.1. Chitosan was selected as the shell material
despite the fact that the NPs could be prepared at only ~2-5 wt% polymer solids in an
aqueous medium containing acetic acid, because it was speculated that chitosan might
enhance wood preservation, while gelatin, which can be used to prepare nanoparticles by
this approach at 10 wt% solids appeared to contribute to biological decay and made
analysis more difficult.

Scheme 4.1. Synthetic route producing self-assembled chitosan-g-PMMA nanoparticles.
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4.2 Experimental Part
4.2.1 Materials
Chitosan (~ 70% deacetylation) from crab shell was donated by Cochin University of
Science and Technology (Cochin, India). Tebuconazole fungicide was donated by
Lanxess Corporation (Pittsburg, PA). Methyl methacrylate (MMA, 99.0%) and
2-hydroxyethylmethacrylate (HEMA, 97%) were from Sigma Aldrich (Milwaukee, USA)
and were distilled prior to use. Ammonium persulfate (APS, 95%) and benzophenone
(99%) were from Mallinckrodt Chemical Works (St. Louis, USA) and Sigma Aldrich, and
were used as received. Fungal tests used Gloeophyllum trabeum (ATCC 11539), a
basidomycete brown rot wood decay fungus. Wood blocks were 19x19x19 mm, unless
otherwise noted, and were cut from southern pine sapwood in the MTU School of Forest
Resources and Environmental Science.
4.2.2 Preparation of Nanoparticles
Nanoparticles were prepared using a modification of the methods reported by Li (14)
and Qian (15). Briefly, chitosan was dissolved in deionized water (DI H2O) containing
acetic acid (0.67 g acetic acid/g chitosan). For example, 0.5 g chitosan was dissolved in
0.43 wt% AcOH to give 75 mL of solution at 50 C. The reaction solution was purged
with nitrogen gas for 0.5 h prior to the addition of MMA (MMA to Chitosan 2:1 w/w).
The total concentration of chitosan and MMA ranged from 1-5 % w/w. Tebuconazole (30
w% based on the combined mass of chitosan and MMA) was dissolved in about 5 mL of
acetone and then added dropwise to the reaction solution under magnetic stirring. After
mixing for 10 min, the reaction temperature was increased to 70 C. APS (0.037% w/v),
dissolved in a small amount of deionized water, was then added to initiate the grafting
reaction. The reaction was kept at 70 C with magnetic stirring at 400 rpm for 24 h. This
procedure was also used to prepare nanoparticles without tebuconazole by skipping the
tebuconazole addition step. The yield of chitosan-g-PMMA NPs without tebuconazole
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ranged from ~ 94-99% with a grafting efficiency of ~ 74-87%.
4.2.3 Nanoparticle Size
The particle size of as-made nanoparticles was determined (in aqueous suspension)
by Dynamic Light Scattering (Coulter NP4 Plus, Beckman Coulter, Fullerton, CA) and by
SEM (Shimadzu QP5050A, Shimadzu Corporation, Germany) using freeze-dried
nanoparticles.

4.2.4 Nanoparticle Composition
Nanoparticle composition (without tebuconazole) was determined by gravimetric
analysis. The as-made nanoparticle suspension was collected, gently heated to evaporate
most solvent, and then vacuum dried at 50 C for 48 hrs. The dried NPs were extracted
with 315 mL of chloroform to separate any PMMA homopolymer, and then 320 mL of
warm deionized water containing 0.67 g acetic acid to separate any ungrafted chitosan.
The extracts were vacuum dried at 50 C for 48 hrs to obtain the mass of PMMA and
ungrafted chitosan. The residual mass was chitosan-g-PMMA.

4.2.5 Tebuconazole Content in Nanoparticles
An aliquot of the tebuconazole-containing nanoparticle suspension was weighed,
gently heated to remove most solvent, and then vacuum dried at 50 C for 48 hrs to get
the initial mass of tebuconazole-containing NPs. The tebuconazole component was
extracted from the dried NPs using 315 mL of ethanol, and the combined extracts were
then vacuum dried at 40 C to get the tebuconazole mass. The solid extracts were
confirmed to be pure tebuconazole by 1H NMR. The calculation of the actual content of
tebuconazole in NP suspension and the needed amount of the as-made NPs suspension to
treat wood blocks by pressure-treatment is shown in equations (1) and (2):
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(1) Tebuconazole% 

Mass(Teb.)
 100%
Mass( suspension)

(2) Mass( suspension) 

Re tention (T arg et )  V ( woodblocks)
Tebuconazole%

4.2.6 Delivery Efficiency into Wood Blocks
Wood blocks were submerged in alcohol for 24 hrs to remove some soluble
extractives and wood sawdust near the surface pores, which would interfere with GC-MS
analysis and gravimetric analysis. Then wood blocks were treated with NP suspensions in
accordance with procedures given as the standard method in Wood Pressure Treatment
(AWPA E11-97) (16). The quantity of as-made nanoparticle suspension needed to deliver
target retentions of 0.2, 0.4 or 0.8 kg tebuconazole/m3 wood, assuming quantitative
delivery, was taken and diluted to 90 mL. The 90 mL volume was required to sufficiently
cover 6 wood blocks having dimensions of 19x19x19 mm when these blocks were placed
in a beaker. The wood blocks were covered with a plastic mesh and aluminum blocks to
keep them submerged throughout the treatment process. The beaker was then transferred
into the pressure cylinder and subjected to a pressure treatment consisting of a partial
vacuum of less than 25 mmHg for 0.5 h, followed by pressurization to 100 psi for 1 h.
Specimens were removed, and the remaining suspension was transferred into a
pre-weighed aluminum dish and heated to dryness to determine the NP mass that was not
absorbed by wood. Because some extractives are absorbed into the suspension during the
wood treatment, a measurable residue also results from treating wood “blanks” with
water. Therefore the measured mass from wood “blanks” is used to adjust the undelivered
mass from the NP-treated wood specimens. Therefore the delivery efficiency percentage
is calculated as:
(3) % Delivery = [(dry NP mass in wood – average mass loss from blanks)/initial dry
NP mass] x 100
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4.2.7 Leaching Tests
The leaching test was performed according to The American Wood Preservers
Association Standard (AWPA E11-97) (16).The leachate was collected in a beaker and
heated at 80 C to remove water, and then acetone was added to the dried leachate. The
beaker was sealed for 3 hrs to completely extract the tebuconazole from the leachate.
Then the acetone solution was transferred to a volumetric flask and a known quantity of
benzophenone was added to the solution for use as an internal standard to allow a
quantitative analysis by GC-MS.
4.2.8 GC-MS Analysis
AGas Chromatograph/Mass Spectrometer (Shimadzu 5050A, Shimadzu Corporation,
Germany) equipped with a programmed-temperaturevaporizer was used to measure the
amount of leached tebuconazole collected as described. MS withelectron-impact (EI)
ionization (electronenergy 70 eV) was performed in selectedion monitoring (SIM) mode.
The injection temperature and volume were 280 C and 1 L, which was 100% delivered
into chromatography column under a flow rate of 1 mL He/min as the carrier gas. The
oven temperature, initially at 50 ˚C, was raised to 100 C and held for 3 min to remove
solvent. Then the MS detector began to identify the analyte while ramping the
temperature at 10 C/min, and finally holding 5 min at 325 C to remove possible
residues in column. The quantitative analysis was based on the peak areas from mass
chromatograph. The internal response factor (IRF) was firstly identified by a standard
solution with a known amount of tebuconazole (TEB) and benzophenone (BEN). The
IRF was calculated according to equation 4:
(4) IRF 

Area ( BEN )  Amount (TEB)
Amount ( BEN )  Area (TEB)

After determining the IRF, the leached tebuconazole amount could be calculated based on
the internal standard method according to equation 5.
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(5) Amount (TEB) 

Area (TEB)  Amount ( BEN )  IRF
 V ( solution )
Area ( BEN )

4.2.9 Soil Jar Decay Test
Treated southern pine wood blocks (19x19x19 mm) were dried at 40 ˚C for 24 h. The
mass was measured to ± 0.005 g. All blocks were exposed to the brown rot fungus,
Gloeophyllum trabeum ATCC 11539 for 12 weeks. Decay testing was done using
American Wood Preservers Association (AWPA) testing method E-10-07, "Standard
Method of Testing Wood Preservatives by Laboratory Soil Block Cultures”.
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4.3 Results and Discussion
4.3.1 Study of Reaction Conditions
NP diameter typically shows a strong dependency on the concentration of the
medium in which they are made regardless of if they are made by reaction,
solvent-displacement or precipitation. To be used as controlled release devices in solid
wood an NP diameter below 150 nm was desired for good penetration into the wood
interior. Consequently, the first study tested the effect of the reaction concentration on NP
diameter (Fig.4.1). Because the NPs will be introduced into the wood in aqueous
medium, the diameter of the water-swollen NPs will affect their ability to penetrate the
wood interior. Figure 4.1 shows the particle size of the water-swollen NPs, measured by
DLS, of chitosan-g-PMMA NPs (designated C2M, indicating that the polymer matrix
was made using a mass ratio of 2 parts of MMA to 1 part chitosan) after 24 h of reaction
at concentrations, based on polymer solids. The polymer solids concentration ranged
from 1.5 up to 5 wt% in acidic H2O (0.43 wt% AcOH). The results show that a
concentration of 2 wt% or less is required to afford nanoparticles with a water-swollen
diameter below 200 nm. The C2M water-swollen diameter was ~167±56 nm and
typically increased by ~20-30 nm when prepared with biocide. Therefore, 2 wt% C2M in
D.I. H2O was used as the maximum acceptable concentration for these studies, although
the diameter was larger than desired.
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Figure 4.1. Particle size (by DLS) of C2M NPs as a function of reaction concentration.
The particle size can be decreased by increasing the protonation of the chitosan
amine groups (by increasing acetic acid from 0.67g to 2.0 g/g chitosan). At either
concentration of acetic acid the diameter of the NPs can be further decreased by
sonication. For example, the final NP diameter of C2M NPs made at 0.67 g of acetic acid
per gram of chitosan resulted in decreasing the diameter from 167±56 nm to 132±48 nm.
Interestingly, the NP diameter was not significantly altered by the ratio of the MMA to
chitosan in the range we studied (1, 2 or 3 parts MMA to 1 part chitosan).

The NPs with

1, 2, and 3 parts of MMA to 1 part of chitosan (CM, C2M, and C3M respectively),
prepared at 2 wt% increased by ~ 22 nm as MMA content increased from 1:1 to 3:1 with
respect to chitosan.
Interestingly, changing the ratio of MMA to chitosan does not significantly affect
particle size, though it does increase the extent of PMMA homopolymer, as shown in
Figure 4.2. The increase in the extent of homopolymerization is coincident to a slight
decrease in the extent of grafting to chitosan. The amount of ungrafted chitosan is
relatively constant. The ungrafted chitosan is probably the major contributor to the
water-swollen diameter of the nanoparticles, which are typically ~50-100 nm larger than
the diameter observed by SEM.
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Figure 4.2. Composition of CM, C2M, and C3M NPs (142±60, 167 ±56 and 166±51 nm,
respectively when prepared at 2 wt% in 75 mL D.I. H2O with 0.43 wt% AcOH).

4.3.2 Characterization of Fungicide-Containing Nanoparticles
In the second study the amount of tebuconazole introduced into the NPs and the
effect of the tebuconazole on NP diameter was determined. In this work we arbitrarily
selected a target tebuconazole quantity to be 30% of the final NP mass. Table 4.1 shows
that the tebuconazole is incorporated at ~93% yield. This high incorporation efficiency of
the water-insoluble biocide supports the conclusion that this polymerization does not
follow an emulsion polymerization route, but proceeds in a micellar route, leading to a
final solid NP. The final suspension, after sonication, affords water-swollen
C2M-tebuconazole NPs of ~150 nm.
One important advantage of using this radical grafting approach to amphiphilic
copolymer NPs is that it is easy to “tune” the core composition from hydrophobic (only
MMA) to increasingly hydrophilic by increasing the HEMA content. Even small changes
in core hydrophilicity can alter the biocide release rate, which is diffusion controlled.
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Here the core composition was changed slightly by replacing 2 wt% of MMA monomer
with HEMA monomer, giving C2MH NPs. The results, shown in Table 4.1, show the
water-swollen C2MH-tebuconazole NPs have a larger diameter than that found for
C2M-tebuconazole NPs (189±74 compared to 149±57 nm). However, SEM found no
significant difference in the average diameter of these NPs. The tebuconazole
incorporation efficiency remained high, but was less than that obtained for C2M NPs,
down from ~93% to ~82%. This indicates that increasing the hydrophilicity of the system
compromises the efficiency of the micelle “capture” of tebuconazole. Again, the high
entrapment efficiency shows that this polymerization proceeds by a micellar route (17)
rather than a typical emulsion route. That is, the biocide was present within a
chitosan-stabilized micelle together with the acrylic monomer(s) at the start of the
polymerization. Possibly the HEMA content allowed more tebuconazole to be retained in
the shell and this was lost during NP isolation.
Table 4.1. NP size and tebuconazole content in C2M and C2MH NPs
Sample

NP size,nm
(DLS/SEM)

NPs
(g)

Tebuconazole
(g)

Tebuconazole,
wt%
(Theo./Actual)

C2M-30% Teb.

149±57/100~150

0.3500

0.0972

30.0 / 27.8

C2MH-30%Teb.

189±74/100~150

0.5100

0.1257

30.0 / 24.6

4.4. Wood Leaching and Wood Preservation
4.4.1 Nanoparticle delivery into wood blocks
Aqueous suspensions of tebuconazole-containing C2M and C2MH NPs (C2M-Teb
and C2MH-Teb) were prepared and used to pressure-treat southern pine sapwood blocks
according to the standard method of wood pressure treatment (AWPA E11-97) (16). The
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delivered NP mass was determined by measuring the undelivered mass, and the retention
of tebuconazole in the wood blocks was calculated from the absorbed NP mass, as
described in the Experimental. The results are shown in Table 4.2.
Table 4.2.Nanoparticle delivery and tebuconazole retention in wood blocks.
Target retention

Delivery

Actual retention Kg

Kg Teb/m3

Efficiency %

/m3

C2M-TEB.

0.20
0.40
0.80

66.1
59.9
54.7

0.13
0.24
0.44

C2MH-TEB.

0.20
0.40
0.80

68.5
55.7
56.6

0.14
0.22
0.45

TEB.Control

0.20
0.40
0.80

100
100
99.4

0.20
0.40
0.795

Sample

Previous studies with nanoparticle-treated southern pine sapwood (1,11-13) showed
good biological efficacy and good penetration, but treatment was limited to 19x19x19
mm blocks. One of the objectives of this work was to further prove good penetration of
wood, using large wooden “field” stakes (1919455 mm). Several stakes were treated
and sectioned to verify penetration of the wood interior is achieved even on larger
wooden parts.
Figure 4.3 a shows an image of a treated field stake. Despite NP aggregates reducing
delivery efficiency, good penetration of the wood stake was achieved as shown by
FESEM images (Fig. 4.3 b and 4.3 c) showing interior sections. Figure 4.3 b shows a
region deep in the interior of the wood stake while Figure 4.3 c shows a section nearer
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the surface.
(a)

(b)

(c)

Figure 4.3. A wooden stake after NP treatment is shown, with a central section indicated
(a, top); after the indicated central section is cut, then specimens suitable for FESEM are
taken from two locations, one deep in the interior (b, bottom left) and from near the
surface (c, bottom right).

4.4.2 Leaching from wood blocks
The primary purpose of this work was to prove the hypothesis that use of
controlled-release biocide-containing NPs will reduce biocide leaching without
compromising wood preservation. Wood blocks were treated to give theoretical
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biocide-retentions of 0.2, 0.4, and 0.8 kg tebuconazole/m3 sapwood. Figure 4.4a-b shows
the measured biocide leach from solution-treated tebuconazole controls with leach from
wood treated with C2M-TEB and C2MH-TEB NPs at theoretical loadings of 0.4 and 0.8
kg/m3 wood respectively. In both cases the solution-treated control leached significantly
more tebuconazole than the nanoparticle-treated wood, and the C2MH-TEB
nanoparticle-treated

wood

leached

more

tebuconazole

than

the

C2M-TEB

nanoparticle-treated wood.
Based on the cumulative leach the C2MH-TEB treated wood typically leached about
two to three times the amount of tebuconazole as the C2M-TEB treated wood. Because
the retentions of the C2MH-TEB and C2M-TEB treated sapwood were similar the
leaching data are comparable with each other, but not with the solution-treated
specimens. Therefore, Figure 4.4 c re-plots the leach data for TEB-solution treated wood
with the nanoparticle-treated wood, where the actual retentions are all close to 0.4 kg/m3.
Figure 4.4c plots the leach from a TEB-solution treated wood with an actual
tebuconazole content of 0.4 kg/m3, on the same axes as the C2MH-TEB and C2M-TEB
nanoparticle-treated wood systems (0.8 kg/m3 target retention) with actual retentions of
0.45 and 0.44 kg/m3 respectively. Despite the nanoparticle-treated wood having higher
tebuconazole retentions than the solution-treated control, it releases ~2300 µg of
tebuconazole compared to ~200 µg for the C2M-TEB treated wood, and yet, which
means that the C2M-TEB treated-wood leached less than 9 % of the amount of biocide
compared to the solution control, and, as the next section shows, did not sacrifice wood
preservation based on results from a soil jar test.
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(a)

(b)
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(c)
Figure 4.4. Cumulative leaching quantity of a.i. from wood blocks treated with TEB
solution control, C2M-TEB and C2MH-TEB NP formulations.

4.4.3 Wood Preservation Efficacy By Soil Jar Decay Test
Soil jar decay tests were performed on already-leached wood blocks treated with
C2M-TEB and C2MH-TEB NPs and a solution treated tebuconazole control, according
to the AWPA standard method. The decay test results are shown in Figure 4.5.
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Figure 4.5. Weight loss of leached southern pine sapwood from soil jar decay tests.
Theoretical retentions were 0.2, 0.4, and 0.8 kg tebuconazole/m3 wood. For 0.2 kg/m3
wood actual tebuconazole retentions were 0.2, 0.13, and 0.14 kg/m3 for TEB, C2M-TEB,
and C2MH-TEB respectively. For 0.4 kg/m3 wood actual tebuconazole retentions were
0.4, 0.24, and 0.22 kg/m3 for TEB, C2M-TEB, and C2MH-TEB respectively. For 0.8
kg/m3 wood actual tebuconazole retentions were 0.795, 0.44, and 0.45 kg/m3 for TEB,
C2M-TEB, and C2MH-TEB respectively.

The weight loss of the C2M controls (wood treated with C2M nanoparticles that
contain no biocide) may be slightly greater than the untreated pine controls when the
nanoparticle “blanks” are introduced at higher levels. If this difference is real than
chitosan, like gelatin, may slightly promotes fungal decay by G. trabeum, but the
standard deviations are high, so the trend is not definitive. The weight loss for the
tebuconazole-containing nanoparticle treated specimens show no significant difference in
the preservation efficacy at any retention with any formulation except the C2MH-TEB
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treated wood at a theoretical retention of 0.2 kg/m3, but with actual retention of 0.14
kg/m3. Therefore, the tebuconazole introduced in controlled-release NPs retain efficacy
against G. trabeum, and does so with substantially less leach than tebuconazole
introduced in solution.

4.5 Conclusion
A simple, efficient, and versatile one-step route was used to prepare self-assembling
and biocide-containing core-shell nanoparticles from chitosan grafted with acrylic
monomers. The method gives high biocide capture efficiency and a high yield of
nanoparticles (~150 nm) that can be delivered into southern pine sapwood. SEM
investigation of nanoparticle-treated field stakes showed nanoparticles penetrated
throughout the wood interior. The biocide-containing nanoparticles, C2M-Teb, captured
93% of the available biocide during their preparation, effectively protected sapwood from
biological attack, and showed only ~9% of the biocide leach as wood blocks treated with
a tebuconazole solution. Using this method the nanoparticles’ core composition can be
manipulated by replacing portions of MMA with other acrylic monomers during the
nanoparticle synthesis. This allows the core composition to be appropriately “tuned” for
other biocides. When just 2% of the MMA was replaced with HEMA the nanoparticles
possessed a more hydrophilic core, resulting in slightly larger nanoparticles. The wood
blocks treated with these nanoparticles leached much more biocide than the C2M
nanoparticle-treated wood, but it was still only ~26% of the biocide leached by the
solution-treated tebuconazole control wood blocks. This shows that very small changes in
the core-composition can effectively tune biocide release and minimize biocide leaching.
The results demonstrate this method can efficiently incorporate the biocide, significantly
reduce biocide leach without compromising wood preservation, and the core-composition
is easily altered to allow the nanoparticles to be “tuned” appropriately for other organic
biocides.
146

Main Findings in This Chapter:
The biocide-loaded chitosan-g-PMMA nanoparticlesfor low leaching wood
preservation were prepared by one-pot synthesis route with biocide capturing efficiency
as high as 93%. The biocide leached from treated wood via nanoparticle was only 9%
leached as much quantity as from solution control. The reduced biocide leaching did not
compromise wood protection efficacy against biological decay. FESEM analysis
confirmed the nanoparticles effectively penetrated throughout wooden stake with
dimension of 19x19x445 mm. High biocide capturing efficiency, controllable release
rate from nanoparticles, simple and one-pot synthesis route, effective protection efficacy,
and cost-effective match the market requirements of using nanotechnology for wood
preservation.
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Abstract
Copper-based nanoparticle wood preservatives typically contain a mixture of
nanoparticle sizes. We wanted to know if nanoparticle size was a significant effect in
quantity of leach and if the leachate contained nanoparticles. To do this we prepared
copper oxide nanoparticles with uniform diameters of 10 nm and 50 nm, and measured
the leachate from southern pine sapwood treated with these nanoparticles. We also
studied the effect of polymer stabilizers on nanoparticle leaching. It was found that
significant numbers of nanoparticles leached from the treated wood. The trends showed
that nanoparticle size was a major factor in leaching. The 50 nm nanoparticles leached
slightly less than a soluble copper salt control, but 10 nm nanoparticles leached
substantially more than the control. Polymer stabilizers increased leaching. The
cumulative leaching, calculated as % loss of initial Cu2+ retention, was 15.6%, 14.3%,
and 12.3% Cu2+ for 10 nm nanoparticles stabilized with a slightly acidic stabilizer, a
slightly basic stabilizer, and unstabilized 10 nm nanoparticles, versus only 6.7% for the
quaternary ammonium control. An effort to determine if 10 nm nanoparticles had greater
efficacy against gloeophyllum trabeum brown rot fungus failed due to unexpectedly low
retention levels. These findings indicate that nanoparticle size is a major factor in
leaching and that nanoparticles themselves can leach from treated wood.

Keywords: biocide, copper oxide, leaching, nanoparticle, wood preservation
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5.1 Introduction
Solid wood intended for exterior use must be protected from biological decay by
treatment with wood preservatives (1). Copper chromated arsenic (CCA) was long the
dominant preservative used to treat wood for home applications, but as CCA was being
phased out for use around the home, alternative forms of copper were developed. These
newer copper-based preservatives, including the so-called “micronized” copper, were
recently reviewed (2).
Soluble forms of copper, such as the ammoniacal copper systems (ACQ, A, B, C, and
D), copper amine systems and copper azole systems, as well as water-borne and oil-borne
copper naphthalene systems, are now typically used. However, “micronized” copper
particle systems are making significant inroads in the wood preservative industry. These
solid copper salts may be delivered in aqueous suspensions that may include other
biocide components, along with unspecified polymeric dispersants (2). The term
“micronized” suggests larger particles, but these commercial systems appear to be much
smaller with many particles less than 100 nm in diameter (3) so they should more
properly be termed “nanocopper” systems. For example, Osmose’s copper carbonate
formulations are thought to be comprised of nanoparticles with an average diameter of
approximately 80, 120, and 250 nm (4). A formulation with an average diameter of
approximately 40 nm for “refractory” wood species also exists (5).
Use of bioactive nanoparticles has been debated both for concerns about the
environmental implications and some disagreement about “threshold levels” (minimal
level required for biological effect) of copper-based nanoparticles. Also, questions remain
about if these nanoparticles are more effective for protection against fungal attack than
soluble systems. Copper-based nanoparticles are often claimed to have higher efficacy
and lower leach than soluble forms of copper wood preservatives. However, the
published literature on “nanocopper” is somewhat limited and not always in agreement.
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Different commercial systems tested against Gloeophyllum trabeum report threshold
values as low as 0.6 kg CuO/m3 wood to as high as 4.2 kg CuO/m3 wood. Some research
has shown that these copper systems have greater efficacy than traditional soluble copper
systems, while other research notes that greater efficacy is not observed against all
species (2). For example, Clausen and co-workers found that copper-based nanoparticles
(from Nanoarc) were more effective in soil jar tests than soluble copper salts against G.
trabeum and T. versicolor, but had only similar or less effect when tested against
Antrodia sp., various species of mold, and termites (Reticulitermes flavipes kollar) (6).
Some reports using Formosan termites showed similar efficacy between nanoparticle and
soluble copper systems (2).

Environmental concerns with nanoparticle copper systems

stem largely from uncertainties about the environmental fate of the nanoparticles (4,7-9)
and awareness of the toxicity of copper oxide nanoparticles to non-target species (10).
Studies that address biocide leaching from wood treated with nanoparticle copper
systems appear to be largely confined to the patent literature (11), although published
studies do address the fate of nanoparticles under various conditions. For example, two
recent studies described the fate of copper oxide nanoparticles in soils (12,13). Those
researchers found that the nanoparticles tended to aggregate, but many factors influenced
their mobility in soils, including dissolved organic matter and ionic strength. Another
recent publication addressed the fundamental issues affecting the aggregation and
deposition of engineered nanomaterial in aquatic environments (14). Benn and
Westerhoff also showed that Ag nanoparticles could leach from socks during washing,
and that significant differences in leaching occurred based on the type of sock tested,
which suggested that the manufacturing process strongly influenced nanoparticle
leaching (15).
As stated above, toxicity of nanoparticles against different species is also in question.
For example, antimicrobial activity of different nanoparticles, including CuO, was found
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against the beneficial soil microbe Pseudomonas putida KT2440. Nano-CuO and
solvated copper ions both had toxicity against this microbe, but the bulk form (micro
meters to macro size) of CuO was non-toxic (16). The authors also cited a report that
claimed that ZnO nanoparticles of 8 nm were more toxic to S. aureus than nanoparticles
of 50-70 nm (17).
Outside of the patent literature and abstracts from professional meetings little research
on leaching of CuO nanoparticles is published. The most detailed information found was
a review by Freeman and McIntyre (2)that referenced professional meetings and
workshops, and more recently by Kartal and co-workers (6). These works described
results from commercial systems with proprietary compositions that were not always
specific about nanoparticle size. It was also unclear if these formulated systems contained
additives that had biological activity or that may have enhanced adhesion to wood, i.e.
“fixation”. If fixation was promoted in these systems the mechanism was likely to be
based on approaches similar to those in conventional copper systems. Those systems
often use amines that promote adhesion through chemical interactions with acid and
phenolic groups of lignin, or use ethanolamine to form a 5-member ring complex with
solubilized copper ions that also preferentially interact with lignin (2,18).We are not
aware of reports of nanoparticles themselves being leached from treated wood, but if this
occurs, it seems that there is a probability of leaching being affected not only by the
treating composition but also wood species and treating conditions.
Answering all these questions is beyond the scope of this paper. Our objective here is
to answer the following basic questions regarding copper-based nanoparticle
preservatives: does nanoparticle-treated wood leach copper as nanoparticles; if
nanoparticles are leached is nanoparticle size a factor; do polymer stabilizers affect the
amount of copper leached; and can extremely small CuO nanoparticles give biological
efficacy against fungal attack at extremely low levels of treatment?
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To answer these questions we treated pine sapwood with CuO nanoparticles,
synthesized using procedures known to give nanoparticles with uniform size (19), and a
soluble copper salt (ACQ) as a control. We collected and measured leachate by
standardized methods and used Transmission Electron Microscopy (TEM) to both verify
the uniformity of nanoparticle size initially, and to check the leachate for the presence of
CuO nanoparticles. The effect of nanoparticle size on leaching was studied using 10 and 50
nm CuO nanoparticles. To study the effects of polymer additives on leaching we stabilized
some CuO nanoparticles with a slightly basic polyvinylpyrrolidone (PVP) and others with
a slightly acidic modified chitosan. To determine if the nanoparticles have biological effect
at low “loading” levels of CuO nanoparticles in the treated pine sap wood at levels below
the typical minimal treatment levels for copper which is often taken as 2 kg Cu2+/m3 of
wood.
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5.2 Experimental Section
5.2.1 Materials
Poly(vinylpyrrolidone) (Mw ~24,000 g/mol), glycidyltrimethylammonium chloride
(GTMAC), sodium hydroxide (pellets, 97+ %), copper (II) acetate monohydrate ( 98+ %)
and acetic acid (99.7+ %) were purchased from Sigma-Aldrich. Chitosan (70%
deacetylation) was donated by Cochin University of Science and Technology (Cochin,
India). Copper standard solution (1 mg Cu2+/mL in 2 % HNO3 aqueous solution), H2SO4
conc.

(98.0 %), and hydrogen peroxide (30% aqueous solution) were purchased from

ACROS ORGANICS, VWR, and Mallinckrodt Chemicals, respectively. All reagents
were used as received. ACQ solution (15 mg Cu2+/mL) and wood blocks cut to
dimensions of 19 mm x 19 mm x 19 mm from southern pine sapwood were donated by
MTU School of Forest Resources and Environmental Science, and was used as received.
Fungal tests used Gloeophyllum trabeum (ATCC 11539), a basidiomycete brown rot
wood decay fungus.

5.2.2 Preparation of Water-Soluble Modified Chitosan (HTCC)
A water-soluble chitosan derivative, [(2-hydroxy-3-trimethylammonium)propyl]
chitosan chloride (HTCC) was synthesized according to the reported procedure (20),
where chitosan (3.0 g, ~70% deacetylated) was dispersed in 30 mL of deionized (D.I.)
water at 85 °C in a round bottom flask equipped with condenser and magnetic stirring
bar. GTMAC (10.7 mL, 55.5 mmol) was then added to the chitosan suspension in 3
portions (3.6 mL x 3) at 2 h intervals. The reaction was maintained for 24 h at 85 °C with
vigorous magnetic stirring. The resulting yellowish solution was diluted with 50 mL of
D.I. water and allowed to stand for 6 h. The product was collected from the upper layer
by precipitating in cold acetone. The product was re-dissolved in D.I. water and
precipitated two additional times to purify it. The solid product was dried under vacuum
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at 50 °C for 12 h to yield 7.57 g of water-soluble chitosan derivative. Scheme 5.1 shows
the chemical reaction.

Scheme 5.1.

Synthesis of [(2-hydroxy-3-trimethylammonium) propyl] chitosan

(HTCC), a water-soluble chitosan derivative.
5.2.3 Preparation of Polymer-Stabilized and Unstabilized CuO Nanoparticles
CuO nanoparticles (~10 nm) were prepared using a modification of reported methods
(19,21,22). Glacial acetic acid (1.0 mL, 17.5 mmol) was added to aqueous copper acetate
(300 mL, 0.02 M) at room temperature. The temperature was increased to 100 C, and
then finely ground sodium hydroxide (1.0 g, 25 mmol) was quickly added with vigorous
magnetic stirring. The reaction was continued for 6 h to yield a dark suspension. The
CuO nanoparticles were collected by centrifugation at 4000 rpm, washed with D.I. water
(3 x 10 mL) to remove the unreacted chemicals, and re-dispersed in D.I. water by
sonication. CuO nanoparticles with ~10 nm diameter were produced as long as the
concentration of the copper acetate solution was 0.02–0.12 and the temperature and molar
ratio of copper acetate : acetic acid : sodium hydroxide were constant. The purified CuO
nanoparticle suspension was diluted with D.I. water to 100 µg/mL for TEM analysis
(JEOL JEM-4000FX, Tokyo, Japan) and showed a uniform size of ~10 nm. CuO
nanorods with ~50 nm diameter were prepared by changing the feedstock ratio and
temperature. At 50 C, 2.5 g (62.5 mmol) of sodium hydroxide was added to 300 mL of
0.1M aqueous solution (30 mmol) of copper acetate mixed with 2.5 mL (40 mmol) of
glacial acetic acid. The reaction mixture was maintained at 50 C for 30 min and then
increased to ~120 C for 5 h. The as-made suspension was cooled down to room
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temperature, and the CuO nanoparticles were collected by centrifugation, washed with
D.I. water (3 x 10 mL) and centrifuged at 4000 rpm to remove unreacted chemical and
isolate small size nanoparticles, and re-dispersed in D.I. water. The purified CuO nanorod
suspension was similarly diluted to 100 µg/mL for TEM analysis, and showed nanorods
with ~50 nm length and ~10 nm diameter.
Polymer-stabilized CuO-10 nanoparticles were prepared the same way as the
unstabilized nanoparticles above except in the presence of HTCC or PVP as a stabilizer.
For example, HTCC (0.96 g, theoretical wt. ratio of 1:1 HTCC:CuO) was dissolved in a
0.04 M aqueous solution of copper acetate (12 mmol in 300 mL D.I. water) mixed with
glacial acetic acid (2.0 mL, 35 mmol) in a 500 mL round bottom flask. The mixture was
vigorously stirred for 1 h at 100 °C to give a clear blue solution. Then finely ground
NaOH pellets (2.0 g, 50 mmol) were quickly added and the reaction was kept for 6 h at
100°C with vigorous magnetic stirring. After cooling down to room temperature the
HTCC-stabilized CuO nanoparticles were similarly collected by centrifugation, washed
with D.I. water (3x10 mL), and then re-dispersed in D.I. water by sonication to form a
stable HTCC-stabilized CuO nanoparticle suspension. TEM micrographs showed a
uniform particle size of ~10 nm.
HTCC-stabilized CuO-50 nanoparticles were prepared in the same way as CuO-50
except in the presence of HTCC. Particle size by TEM was ~50 nm.
The nanoparticles are designated as follows: CuO nanoparticles without polymer
stabilizing are designated CuO-10 and CuO-50 for the 10 nm and 50 nm nanoparticles
respectively, while CuO nanoparticles with a PVP polymer stabilizer are PVP-CuO-10,
and HTCC stabilized nanoparticles are HTTC-CuO-10 or HTTC-CuO-50, depending on
the nanoparticle size. The synthesis is illustrated in Scheme 5.2.
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Scheme 5.2. Synthesis of polymer-stabilized CuO nanoparticles by aqueous thermal
hydrolysis using D.I. water as the solvent and heating at reflux.

5.2.4 Preparation of ACQ
ACQ was prepared for us in the Department of Forest Resources and Environmental
Science using the following standard procedure. Copper carbonate (equivalent to 68.75%
CuO, 931.4 g), didecyldimethylammonium chloride (DDAC, 80% solution, 399.6 g), and
ethanolamine (100%, 1760 g) were added to water (908.1 g) and stirred to give a solution
that is 24% in the active ingredient. The prepared ACQ solution was then diluted with
D.I. water to a solution with a concentration of 15 mg Cu2+/mL.
5.2.5 Measurement of Cu2+ Concentration
The Cu2+concentration in the suspensions and ACQ solution was measured by
atomic absorption spectrophotometry (BUCK Scientific Model 200A, BUCK Scientific
Inc, USA). Briefly, 2.0 mL of as-made nanoparticle suspensions or ACQ solution was
transferred to a beaker and heated to dryness, followed by adding concentrated H2SO4 (3
mL) and H2O2 (2 mL, 30 % solution) to digest under gentle boiling until a clear light blue
solution was obtained. The digested sample was transferred to a 250 mL volumetric flask
and D.I. water was added to scale. A series of copper standard solutions was prepared to
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give the calibration curve shown in Figure 5.1. The concentration of Cu2+was calculated
using Beer’s law and found to be 4.6 mg Cu2+/mL (CuO-10 control), 4.8 mg Cu2+/mL
(PVP-CuO-10), 3.8 mg Cu2+/mL (HTTC-CuO-10), 5.6 mg Cu2+/mL (CuO-50 control),
6.8 mg Cu2+/mL (HTCC-CuO-50) and 15 mg Cu2+/mL (ACQ solution).
5.2.6 Treatment of Wood Blocks
Wood blocks (19x19x19 mm) were extracted in warm alcohol for 24 h to remove
soluble extractives and wood sawdust near the surface pores and then dried at 40 ºC for
48 h in order to achieve maximum delivery of CuO nanoparticles. The pre-treated wood
blocks were then treated with a nanoparticle suspension or ACQ solution according to the
standard method of Wood Pressure Treatment (AWPA E11-97). The quantity of
nanoparticle suspension needed to deliver target retentions of 0.64, 2.0, and 4.0 kg Cu2+/
m3 wood was measured and the suspension was then diluted to 90 mL by D.I. water. The
volume of 90 mL was required to sufficiently cover 6 wood blocks having dimensions of
19 mm x 19 mm x 19 mm when these blocks were placed in a beaker. The wood blocks
were covered with a plastic mesh and aluminum blocks to keep them submerged
throughout the pressure-treatment process. The beaker was transferred into the pressure
cylinder and subjected to a pressure treatment consisting of a partial vacuum of less than
25 mm Hg for 30 min, followed by pressurization to 100 psi for 1 h. The specimens were
removed from cylinder, and dried at 40 ºC for 48 h and then dried at air atmosphere under
room temperature for 24 h. The mass of each dry block was weighed, and the density of
each treated dry block was calculated according to equation (1):

 Block 

M Block
VBlock

(1)

Where the volume for each block was: VBlock  19 19 19(mm )  6859(mm ) .
3

3

Wood blocks treated for desired target retentions were digested to determine the
actual copper retention. The wood blocks were first ground into powder, and a known
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quantity of that powder was weighed out and identified as MSample. Each sample was
digested by adding the appropriate amount of H2SO4(conc.) and hydrogen peroxide (30 %
aqueous solution). Then the samples were heated until all solids were digested to form a
clear solution, then transferred into a volumetric flask, and diluted to scale using D.I.
water. Previously prepared standard copper solutions were analyzed by atomic absorption
spectrophotometer to give a calibration curve. Then sample solutions were analyzed to
measure the concentration of copper ion (CCu2+) and the actual concentration of copper
was calculated according to the calibration curve and Beer’s law. The actual retention of
Cu2+ in each block was calculated by equation (2):

Actual

Re tention 

CCu2  VCu2   B l o c k
MS a m p l e

(2)

A wooden stake with dimensions of 19 mm x 19 mm x 455 mm was also treated with
PVP-stabilized CuO nanoparticles. A central section was cut out and FESEM analysis
(Hitachi S-4700, Hitachi High Technologies America, Inc.) was performed to confirm
effective penetration of nanoparticles throughout the interior of the treated stakes.

5.2.7 Leaching Tests
Leaching tests were performed according to The American Wood Preservers
Association Standards (AWPA E11-97) (23). Leachate was collected in a beaker and
heated at 80ºC to remove water. H2SO4(conc.) (~4mL) and H2O2 (2-4 mL, 30 % solution)
were added to digest the solids (the digestion reagent quantities were determined
according to the amount of leachate). The beaker was covered with a watch glass and
heated to boiling until the digestion was completed and a clear solution formed. The
digestion dissolves solid nanoparticles so Cu2+ ions can be detected. Due to the small
quantity and small size of the nanoparticles we did not attempt to separate CuO
nanoparticles to quantify the relative numbers of nanoparticles versus Cu2+ ions in the
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leachate because the relative error would be too high.
The digested solution was transferred into a volumetric flask (250.00 mL volumetric
flask for high concentration leachate, 50.00 mL or 25.00 mL volumetric flask for low
concentration leachate), and D.I. water was added to the scale. A series of Cu2+ standard
solutions was prepared for calibration curves by atomic absorption analysis (Figure 5.1).
By this method, leachate was collected at regular leaching intervals, and the concentration
(X value) of Cu2+ in the leachate was measured by its absorbance (Y value) on the
calibration curve regression equation, so the quantity of the Cu2+of each leachate was
obtained by equation (3).

AmountCu2  X VSample

solution

(3)

Figure 5.1. A standard curve for analysis of copper in nanoparticle suspensions or
leachate by atomic absorption spectrophotometry.
5.2.8 Soil Jar Decay Test
Treated wood blocks (southern pine sapwood, 19mm x 19mm x 19mm) were dried at
40 C for 24 h. Another batch of wood blocks were leached in water for three weeks, and
then dried at 40 C for 24 h. The mass of the dried wood blocks was measured to ±0.0005 g.
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These two batches were designated as “unleached” and “leached” specimens. All blocks
were exposed to the brown rot fungus, Gloeophyllum trabeum ATCC 11539 for 12 weeks
using American Wood Preservers Association (AWPA) testing method E-10-07, “Standard
Method of Testing Wood Preservatives by Laboratory Soil Block Cultures”.
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5.3 Results and Discussion
5.3.1 Preparation and Characterization of Polymer-Stabilized CuO Nanoparticles
Both alco-thermal (21) and aqueous-thermal (19) methods were initially tested as
routes to give CuO nanoparticles. The aqueous-thermal method was selected to use here
because it gave nanoparticles with a uniform size that were relatively stable even without
a polymer stabilizer.

CuO nanoparticles of ~10 nm are designated as CuO-10, and when

prepared in the presence of either PVP or HTCC polymer-stabilized nanoparticles are
obtained that are designated as PVP-CuO-10 and HTTC-CuO-10, respectively (Scheme
5.2).
The aqueous-thermal method is reported to give 10 nm nanoparticles when the
copper acetate concentration was 0.02 M. We obtained spherical 10 nm diameter
nanoparticles as long as the copper acetate concentration in the aqueous solution was kept
between 0.02–0.12 M, and the ratio of copper acetate : acetic acid : sodium hydroxide
was kept constant. When polymer stabilizer was used the ratio of PVP or HTCC to CuO
was maintained at 1:1 w/w. The size and shape of the nanoparticles prepared under these
conditions was verified by TEM (Fig.5.2a, b).Suspensions of PVP-stabilized and
HTCC-stabilized CuO nanoparticles appeared to be stable for several months at a
concentration of 3.8 – 4.8 g CuO/L.

(a)

(b)

Figure 5.2. Representative TEM images of (a) unstabilized CuO-10 nanoparticles and (b)
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PVP-stabilized CuO-10 nanoparticles, prepared by aqueous-thermal hydrolysis.
Based on these studies the only variable that had a significant effect on the final size
of the CuO nanoparticles was the concentration of the initial copper salt and the reaction
temperature. CuO nano-rods with a length of ~50 nm and a diameter of ~10 nm were
made by adding sodium hydroxide at 50 C and heating at 120 C using copper acetate
concentration at 0.1 M. In the presence of HTCC or PVP a stable polymer-stabilized CuO
nano-rod was prepared. TEM images of CuO-50 and HTCC-CuO-50 nano-rods are
shown in Figure 5.3 a,b respectively.

(a)
(b)
Figure 5.3.TEM images of (a) CuO-50 nano-rods and (b) HTCC-CuO-50 nano-rods.
5.3.2 Nanoparticle and ACQ Retention in Wood Blocks
PVP-stabilized CuO nanoparticles, HTCC-stabilized CuO nanoparticles, and
unstabilized CuO nanoparticle suspensions were prepared and used to pressure-treat
southern pine sap wood blocks (19 mm × 19 mm × 19 mm) according to the standard
method of wood pressure treatment (AWPA E11-97). Target retentions ranged from 2.0
to 4.0 kg Cu2+/m3 wood. Similarly, an ACQ solution control (15 mg Cu2+/mL) was used
to give the same target retention in southern pine sapwood blocks. The various
nanoparticle suspensions appeared stable the actual delivery efficiency in the wood was
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usually ~30-45% and only 48.1% for the ACQ control. The data do not suggest a
significant impact of the polymer on the retention of the treated wood. The low retention
is attributed to the high dilution of the suspensions needed to cover the wood blocks with
fluid during the pressure-treatment process. The results are summarized in Table 5.1,
showing retentions as both kg of Cu2+ per m3 wood and CuO per m3 wood. It should be
noted that as a “legacy” of traditional wood treatment formulations in some circles
copper content is often reported as if it exists as CuO even if it is added as CuCO3 or as a
soluble copper salt. That is why in Table 5.1 we show ACQ as Cu2+ and as if it were
CuO even though it is a soluble salt, and for comparison with our actual CuO
nanoparticle retentions.
Table 5.1. Delivery efficiency and Cu2+/CuO retention in wood blocks.
Target retention
Delivery
Actual retention
Sample
Kg/m3
Efficiency
Kg/m3
Cu2+/CuO
%
Cu2+ /CuO
PVP-CuO-10
2.0/2.5
44.8
0.896/1.12
10 nm Nanoparticles
HTCC-CuO-10
2.0/2.5
44.0
0.880/1.10
10 nm Nanoparticles
CuO-10
2.0/2.5
40.1
0.802/1.00
10 nm Nanoparticles
CuO-50
2.0/2.5
33.2
0.660/0.825
50 nm Nanoparticles
4.0/5.0
30.3
1.21/1.513
HTCC-CuO-50
2.0/2.5
38.1
0.760/0.950
50 nm Nanoparticles
ACQ Control

2.0/2.5

48.1

0.962/1.203

Despite the lower than expected delivery efficiency, nanoparticle penetration
throughout the wood was verified by FESEM. PVP-CuO-10 nanoparticles were used to
treat southern pine field stakes (19 mm × 19 mm × 455 mm) and a central section of the
stake was sectioned out and visualized by FESEM to confirm effective penetration
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throughout the wood. Figure 5.4a shows PVP-CuO-10 nanoparticles absorbed onto the
pit pairs from a region nearer the wood surface. Figure 5.4b is an image from deep in the
interior of the wooden stake.

Figure 5.4. FESEM micrographs of wood sectioned from the center portion of a 19 mm x
19 mm by 455 mm southern pine field stake showing PVP-CuO-10 nanoparticles (a) near
the surface (scale bar 300 nm) and (b) deep in the interior (scale bar 400 nm).
5.3.3 Leaching Tests
The results of the AWPA standard leaching tests are shown in Figure 5.5 and
reported as a percentage of Cu2+ based onthe original retention, regardless of if the copper
was introduced as CuO or as ACQ. Several significant findings can be seen from these
data.
First, based on our results, the size of the CuO nanoparticles is the most significant
factor affecting leaching. Wood specimens treated with 10 nm nanoparticles (solid
symbols in Figure 5.5), all leached significantly more copper than was released from the
wood treated with 50 nm CuO nanoparticles. Second, the polymer stabilizers used here
(the weakly acidic HTCC and the weakly basic PVP) enhanced leaching compared to the
unstabilized CuO nanoparticles, with unstabilized CuO-10 nanoparticles leaching 12.3%
of its original retention, compared 15.6 % of the original retention of the weakly acidic
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HTCC-CuO-10 nanoparticles and 14.3% of the weakly basic PVP-stabilized CuO-10
nanoparticles. The HTCC-capping also promoted leaching in the CuO-50 nanoparticles
(hollow triangle symbols in Figure 5.5) when compared to the ACQ salt (hollow black
diamonds) The unstabilized CuO-50 nm nanoparticles leached only approximately 5 % of
the copper compared to 6.7% for the ACQ control and approximately 7% for the
HTCC-stabilized CuO-50 nanoparticles.
We are aware of only one other publication, by Kartal and co-researchers, that
addresses leaching of copper oxide nanoparticles (6) and those authors found favorable
leach resistance of copper and zinc oxide nanoparticles compared to their more soluble
equivalents. They used commercial nanoparticle formulations so the exact composition,
nanoparticle size, and uniformity of size were not provided. However, given that
commercial formulations all appear to use nanoparticles that are larger than CuO-10, our
results are consistent with those reported findings, which are that nanoparticles leach
slightly less than soluble salts, and polymer stabilizers (here HTCC and PVP) facilitate
leaching. However, the results with CuO-10 nanoparticles indicate that nanoparticle size
is a factor to be considered in leaching. We can only speculate that the reason the CuO-10
nanoparticles leach so much more than the CuO-50 nanoparticles is simply that their
small size makes them more mobile than CuO-50 and so the solid phase nanoparticles
leach out of the wood more readily than solubilized Cu2+ ions or 50 nm nanoparticles. It
is also likely that CuO-10 and CuO-50 nanoparticles were retained on the surface and
these are contributors to leachate residues. Whatever the reason may be, the final result
from this small study remains the same: CuO-10 nm nanoparticles leach significantly
more than CuO-50 nm nanoparticles.
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Figure 5.5. Cumulative leaching of Cu2+ from wood blocks (plotted as a percent of
original retention).
We also wanted to know if the nanoparticles themselves were leaching, TEM
micrographs (Fig.5.6a) the presence of significant numbers of nanoparticles in the
leachate and EDS analysis (Fig.5.6b) confirmed that these were copper. We suspect that
the polymer stabilizers increased the leaching of nanoparticles, perhaps simply by
preventing aggregation of nanoparticles within the wood, making them more mobile, but
we were not able to prove this. A similar trend was observed for HTCC-CuO-10
nanoparticles with the confirming TEM and EDS given in Figure 5.6c and 5.6d,
respectively.
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(a)

(b)

(c)

(d)

Figure 5.6. TEM images of CuO nanoparticles found in leachate from polymer-stabilized
CuO-10 nanoparticle and unstabilized CuO-10 nanoparticle treated wood blocks and
verified by EDS to be CuO.(a) CuO-10 nanoparticles in leachate burst released after the
first 24 h; (b) its EDS spectrum; (c) HTCC-CuO-10 nanoparticles in leachate collected
between 24 h and 48 h; (d) its EDS spectrum.

The significance of these results lies in the perception that smaller nanoparticles are
desirable as a means to enhance biological effect, and that less soluble forms of wood
preservatives are thought of as a means to reduce biocide leaching. However, this study
shows that smaller (10 nm) nanoparticles are more prone to leaching than a soluble
copper salt. Besides the still unresolved concerns of nanoparticles released into the
environment, increased leaching is also undesirable because loss of the preservative
reduces the longevity of the preserved wood. Another significant result was that 50 nm
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nanoparticles were less susceptible to leaching than the 10 nm nanoparticles, indicating
that if enhanced efficacy is achieved with smaller nanoparticle size then there will be an
optimal size that achieves the best efficacy without increased susceptibility to leaching.
Finally, this work showed that both a weakly acidic (HTCC) and a weakly basic (PVP)
polymer stabilizer enhanced the leaching of the 10 nm nanoparticles, and HTCC also
slightly enhanced the leaching of the 50 nm nanoparticles. PVP was not evaluated with
the larger nanoparticles, though the fact that wood is slightly acidic suggests PVP, or an
even more basic stabilizer, might give better results than we observed. Therefore,
nanoparticle stabilizers and/or post-conditioning protocols should be tested with different
sizes of nanoparticles, to determine if they are as effective with smaller nanoparticles as
they are with larger ones, to determine if they reduce leaching or perhaps even promote
leaching of the nanoparticles.

5.3.4 Biological Efficacy against G. trabeum in Soil Jar Decay Tests
The final objective of this work was to determine if 10 nm nanoparticles, due to their
very high surface area, might afford protection against fungal attack at very low treating
levels. Wood specimens were treated with PVP-CuO-10 and ACQ as a control. The
retention efficiency was lower than expected so the actual biocide content was lower than
intended, at 0.127 kg Cu2+/m3 wood for the PVP-CuO-10 and 0.188 kg Cu2+/m3 wood for
the ACQ when the target retention was 0.32 kg/m3. No significant biological effect was
evident at this level, nor was any significant difference detected on comparing the ACQ
and PVP-CuO-10 nanoparticles (Fig. 5.7). Higher retentions were not attempted because
of the significant leaching of the polymer-stabilized and unstabilized CuO-10
nanoparticles.
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(a)

(b)
Figure 5.7. Weight loss of southern pine sapwood treated with PVP-CuO-10
nanoparticles and ACQ measured using soil jar decay tests of (a) leached wood blocks,
and (b) unleached wood blocks. The target retentions shown are based on Cu 2+.
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5.4 Conclusion
This research produced three major findings concerning leaching of copper from
nanoparticle-treated wood, though it must be noted that we used small sample sizes.
These are: nanoparticles are leached in significant numbers from pine sapwood treated
with 10 nm or 50 nm copper oxide nanoparticles, that nanoparticle size is a significant
factor in the relative abundance of leaching, and that polymer stabilizers enhance
nanoparticle leaching. Due to the high potential error inherent in trying to separate
nanoparticles of this size, we did not determine if all the released copper was in the form
of nanoparticles, but both the total leaching and the abundance of nanoparticle leaching
was significantly higher for CuO-10 nanoparticles than for CuO-50 nanoparticles. We
found that both weakly acidic (HTCC) and weakly basic (PVP) polymer stabilizers
increased nanoparticle leaching compared to the un-stabilized nanoparticles of the same
size. An attempt was made to determine if the CuO-10 nanoparticles had greater
biological effect than the larger CuO-50 nanoparticles. However, our nanoparticle
retention levels were below the minimum required for any significant effect to be
determined, so we did not answer that question. Although neither the environmental fate
nor negative environmental impact of different “nano copper” based wood preservatives
are yet known, the major implications from this work are that larger “nano copper”
nanoparticles would be more advantageous than otherwise similar treatments using
smaller “nano copper” because the greater leaching will likely leave the wood less
well-protected.

175

Main Findings in This Chapter:
Copper oxide nanoparticles with uniform size distribution of ~10 nm and ~50 nm
were prepared by thermal hydrolysis with or without presence of polymer stabilizers.
Leaching test of copper oxide nanoparticle-treated wood showed that copper leached
more quantity from ~10 nm treated wood than soluble copper salt (ACQ) control, but ~50
nm nanoparticle treated one leached slightly less copper than ACQ control. The higher
quantity of copper leaching from nanopartcile-treated wood was confirmed by TEM and
EDS analysis that the nanoparticles themselves were leached from treated wood. It was
found that both weakly acidic (HTCC) and weakly basic (PVP) polymer stabilizers
increased nanoparticle leaching compared to the un-stabilized nanoparticles of the same
size. Biological activity of ~10 nm copper oxide nanoparticle was compared with
ACQ-solution treated wood, but nanoparticle retention levels were below the minimum
required for any significant effect to be determined. The major implications from this
work are that reasonably larger copper oxide nanoparticles would be more advantageous
than otherwise similar treatments using smaller nanoparticles because the greater
leaching from smaller nanoparticle treatment would sacrifice wood protection period.
Our research shows the trends that nanoparticle size is main factor to affect copper
leaching.
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Chapter 6
Future Work
In chapter 2 and 3, the self-assembly study of peptide-functionalized amphiphilic
copolymer confirmed the hypothesis that ionic complementary peptides could direct
peptide-functionalized polymeric nanoparticles to self-assemble into nanoparticle fibers
and 3D scaffolds by ionic complementary self-assembly between two oppositely charged
-sheet peptides. The 1D nanoparticle fiber has a length range from tens to hundreds
micrometer. Smaller nanoparticle self-assemble into more compact and stable 3D scaffolds
than bigger nanoparticles, but with less porosity.
The self-assembly of the designed peptides (P1: H2N-TTTT-AEAEAEAE-amide and
P2: H2N-TTTT-AKAKAKAK-amide) in aqueous solution (PBS and neutral deionized
water) were also studied. Results showed that reasonable salt (NaCl) concentration
facilitated the peptide self-assembly to form a stable membrane with a distinct
morphology, but no nanofiber structure was observed. And if the self-assembled peptide
membrane was washed with deionized water to remove salt, the morphology was altered
and gavean amorphous aggregate, which is attributed to high water solubility of the
designed peptides (P1 and P2).
Based on the analysis of the data from these studies, in future work, several aspects can
be further conducted to improve the self-assembly system for practical application.
1. Reduce the spacer parts of both P1 and P2 from four units to two units, and
increase self-assembly units from 8 to 12, so the peptide structure for P1 and P2 are shown
as:

P1

(H2N-TT-AEAEAEAEAEAE-amide)

and

P2

(H2N-TT-AKAKAKAKAKAK-amide). Reduce threonine (T) and increase self-assembly
units, alanine (A), glutamic acid (E) and lysine (K) can increase the stability of the
self-assembled -sheets structure, and also can perform self-assembly in a lower peptide
concentration. Or we can substitute valine (V) or leucine (L) for alanine (A) to increase the
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hydrophobicity of P1 and P2, but still keep same self-assembly unit numbers to form P1:
H2N-TTTT-VEVEVEVE-amide

and

P2:

H2N-TTTT-VKVKVKVK-amide.

So

self-assembly of P1 and P2 with new sequence can also form more stable -sheets structure
at lower peptide concentration.
2. Synthesize P2 using another type of resin to keep the amine protection group after
P2 is cleaved from resin, so that when P2 is used to couple with copolymer, only the
peptide amine terminal is reacted with the carboxylic acid group of copolymer terminal.
Because lysine also has an amine group on the side chain, without a protection group, some
coupling will occur at thelysine amine to form a branched structure (Figure 6.1). Such a
branch structure detrimental to the subsequent assembly between P1 and P2.

Figure 6.1. Branch structure if copolymer is coupled with lysine amine groups but not the
peptide amine terminal.

3.

Cytotoxicity tests showed that NIH3T3 cells did not effectively adhere to the

self-assembled 2D nanoparticle membrane surface. In order to increase cell adhesion to
scaffolds, both 2D and 3D, the nanoparticle surface probably needs modification with
some types of cell adhesion peptides or other type of receptor to increase cell adhesion. The
surface modification can be done by functionalizing cell receptors (i.e. cell adhesion
peptides) with vinyl groups and then copolymerizing them with hydrophilic monomer to
build up a hydrophilic block,so the cell receptors are formed on the hydrophilic shell of the
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nanoparticle surface. The nanoparticle surface functionalization with receptors is shown in
Figure 6.2.

Figure 6.2. Cartoon shows covalently incorporate cell receptors in hydrophilic block to
self-assemble into core-shell nanoparticle with cell receptors on nanoparticle surface.
Such surface functionalized nanoparticles can interact with cell surfaces to increase
cell adhesion. If the self-assembled nanoparticle scaffold is mixed with a specific cell type,
it is possible that the cells themselves will also interact with nanoparticles to form in-situ
self-assembled 3D scaffolds. Then the incorporated drugs released from the nanoparticles
can stimulate cell proliferation and migration to guide cells to develop into the desired
mature cell type for specific tissue regeneration applications.

4.

Techniques for determining bioactivity are needed if bioactive drugs are

incorporated and released from the designed solid nanoparticles.

Also, specific

quantitative analysis techniquesare needed to determine the release rate of bioactive drugs
from nanoparticle. These two steps are important if this self-assembled nanoparticle
scaffold is used to load growth factors for tissue regeneration because most growth factors
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are required to remain bioactive so its functionality will stimulate cell activities to work
normally. If multiple growth factors are simultaneously loaded, maybe a more advanced
technique is required to determine release rate and bioactivities of each growth factor.

5.

In vitro cell tests with self-assembled scaffolds with or without loading of drugs

also must be done. This is important to know the cell growth behavior inside the scaffolds,
and also monitor the stability of the scaffolds when culturing in cell media.

6. Possible toxicity of decomposed components from scaffolds must be tested before
the scaffolds are tested in vivo.
The above work was not done by the author because offinancial and time limitations,
but the work described above is expected to improve the design and efficacy of the
scaffolds and achieve better control of the self-assembled structure.
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Appendix A
Supplementary Data for Chapter 2
Studies of Novel Self-Assembly Structures from Peptide-Functionalized
Polymeric Micro- and Nanoparticles for Tissue Engineering
Xiaochu Ding, Jagadeesh Janjanam, Ashutosh Tiwari, Marty Thompson, Patricia A.
Heiden*,
Department of Chemistry, Michigan Technological University, Houghton, MI 49931,
USA
*Corresponding author: +1 906 487 3452; Fax: +1 906 487 2061.
Email address: paheiden@mtu.edu (P.A. Heiden).

1. MALDI-DOF MS analysis of the designed peptides (a) P1 and (b) P2.

(a)
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(b)
Figure 2.1S. MALDI-TOF MS analysis of the designed peptides.(a) P1
(H2N-TTTT-AEAEAEAE-amide) and (b) P2 (H2N-TTTT-AKAKAKAK-amide).P1 and
P2 have theoretical molecular weight of 1223.25 and 1219.45 Da. MALDI-TOF MS
analysis shows strong MS peak at 1246.42[M(P1)+Na+] and 1220.01[M(P2)+H+] Da.
The Figure 2.1S shows the spectra of molecular weight of the designer peptides, P1
(H2N-TTTT-AEAEAEAE-amide) and P2 (H2N-TTTT-AKAKAKAK-amide), by
MALDI-TOF MS analysis.
2. Synthesis of S,S-bis(,-dimethylacetic acid) trithiocarbonate (BDAT)
The RAFT chain transfer agent, BDAT, was synthesized by adding carbon disulfide
(2.74 g, 0.036 mol), chloroform (10.75 g, 0.09 mol), acetone (5.23 g, 0.09 mol) and
tetrabutylammonium hydrogen sulfate (0.241 g, 0.71 mmol) into room temperature
ligroin (12 mL) in a 250 mL round bottom flask. The flask was equipped with an efficient
condenser and a magnetic stir bar and maintained under a nitrogen atmosphere. Then
NaOH (50 wt.% in H2O) (20.16 g, 0.252 mol) was added drop-by-drop to the reaction
mixture over 1.5 h at a rate sufficient to keep the reaction temperature below 25 C. After
the addition was completed the reaction was continued overnight at 22-25 C. Then
deionized H2O (90 mL) was added to dissolve the yellow solids. This was followed by
addition of HClconc.(12 mL, via syringe) to acidify the aqueous solution and produce
yellow crystalline solids. The crude product was collected by vacuum filtration and
washed several times with deionized H2O. After drying under reduced pressure at room
temperature for 12 h, 3.26 g of crude BDAT product was obtained. The product was
purified by recrystallization in toluene/acetone (3:1 v/v) to afford a yellow crystalline
product.
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3.

1H-NMR

analysis

of

PHEMA-b-12PMMA-b-PHEMA,

PHEA-b-12PMMA-b-PHEA and their block ratio calculation equation

(a)

(b)
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Figure 2.2S. 1H-NMR spectra (in DMSO-d6) of (a) the synthesized hydrophilic polymer
of PHEMA and (b) tri-block copolymer of PHEMA-b-12PMMA-b-PHEMA by RAFT
polymerization.
Proton peak assignments of hydrophilic block (PHEMA) and amphiphilic block
copolymer (PHEMA-b-12PMMA-b-PHEMA). PHEMA Block (in DMSO-d6,):
0.79-1.10 (-CH3), 1.80 (-CH2-), 3.59 (-CH2-OH), 3.91 (-CH2-O-C=O), 4.80 (-OH).
PHEMA-b-PMMA-b-PHEMA(in DMSO-d6,):0.72-1.13 (-CH3), 1.42-1.77
(-CH2-), 3.53 (-OCH3, from PMMA block, also contains –CH2-OH from the PHEMA
block), 3.87 (-CH2-O-C=O).
The integrated peak area of : 3.91 (-CH2-O-C=O from PHEMA block) and : 3.53
(-OCH3, from PMMA block, also contains –CH2-OH from the PHEMA block) are used to
determine actual block ratio of PHEMA to PMMA (XN:XM) to be 1:11 based on below
equation.

Area CH 2 O C O
2X N
2.22


3 X M  2 X N Area OCH 3  CH 2 OH 40.22

(a)
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(b)
Figure 2.3S.1H-NMR spectra (in DMSO-d6) of (a) the synthesized hydrophilic PHEA
and (b) tri-block copolymer of PHEA-b-12PMMA-b-PHEA by RAFT polymerization.
Proton peak assignments of hydrophilic block (PHEA) and amphiphilic block copolymer
(PHEA-b-12PMMA-b-PHEA).
PHEA Block (in D2O, ): 1.54-1.86 (-CH2- from backbone), 2.32 (-CH- from
backbone), 3.53 (-OH), 3.68 (-CH2-OH), 4.08 (-CH2-O-C=O).
PHEA-b-12PMMA-b-PHEA(in DMSO-d6,):0.74-0.92 (-CH3), 1.80 (-CH2-), 2.38
(-CH-), 3.44-3.54 (-OCH3, from PMMA block, also contains–CH2-OH from the PHEA
block), 3.98 (-CH2-O-C=O).
The integrated peak area of : 3.98 (-CH2-O-C=O from PHEA block) and :
3.44-3.54 (-OCH3, from PMMA block, also contains –CH2-OH from the PHEA block)
are used to determine actual block ratio of PHEA to PMMA (XN:XM) to be 1:8.7 based on
below equation.

AreaCH 2 O C O
2X N
2.53


3 X M  2 X N AreaOCH3  CH 2 OH 35.62
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4. Coupling peptides to copolymers by FTIR analysis

(a)

(b)

Figure 2.4S. Comparison of FT-IR spectra of the synthesized copolymer, P1(Peptide1),
P2(Peptide2), and Peptide-copolymer conjugates. (a) Comparison of IR spectra of
P1(Peptide1), P2(Peptide2) and Peptide- PHEMA-b-12PMMA-b-PHEMA conjugates. (b)
Comparison of IR spectra of P1(Peptide1), P2(Peptide2), and PeptidePHEA-b-12PMMA-b-PHEA conjugates.
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Appendix B
Supplementary Data for Chapter 3
Smart Self-Assembly of Peptide-Functionalized Amphiphilic Copolymer
Nanoparticles: Novel Fibers and 3D Scaffolds with Ability for Multiple
Drug Loading and Independent Controlled Release
XiaochuDinga, Trevor Moserb, Qi Gaob, TolouShokuhfarb, Patricia A. Heidena*,
a

Department of Chemistry, Michigan Technological University, Houghton, MI 49931,

USA
b

Department of Mechanical Engineering and Engineering Mechanics, Michigan

Technological University, Houghton, MI 49931, USA
*Corresponding author: +1 906 487 3452; fax: +1 906 487 2061.
Email address:paheiden@mtu.edu (P.A. Heiden).
1. Calibration curve for quantitative analysis of controlled release using different
model drugs

Figure 3.1S. Calibration curve of DBF used for quantitative determination of uncaptured
DBF and controlled released DBF sample solutions.
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(a)

(b)
Figure 3.2S. Calibration curves of (a) nitrofurazone and (b) amoxicillin used for
quantitative determination of uncaptured model drugs and simultaneously released model
drugs(nitrofurazone and amoxicillin) from same scaffold.
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Appendix C
Peptide Synthesis Program
Peptide 1: TTTT-AEAEAEAE
T= Threonine, A= Alanine, E= Glutamic Acid (negative charge between pH 4.4-10)
Use Endeavor 90 peptide synthesizer (AAPPTec LLC) to synthesize peptide 1. It is
conducted on a 0.65 mmol/g Rink Fmoc-amide resin (0.65 mmol amide groups).
Aminno acid is made in 4× excess to Rink Fmoc-amide resin (4×0.65 mmol amino acid
in 5.2 mL of 0.9 M DIPEA/DMF solution for coupling each amino acid).
Synthesizing Program:
1. ** swelling & deprotection**
2. Wash RV1 with 10.00 mL from DMF 2 times.
3. Fill RV1 with 25.00 mL from DMF.
4. Blank.
5. Mix RV1 via Mechanical Mix for 45 minutes.
6. Empty RV1.
7. Fill RV1 with 15.00 mL from PIP.
8. Mix RV1 via Mech/N2 Mix for 5.00 minutes.
9. Empty RV1.
10. Blank.
11. Fill RV1 with 15.00 mL from PIP.
12. Mix RV1 via Mech/N2 Mix for 20 minutes.
13. Empty RV1.
14. Blank.
15. ** clean PIP from the fluid lines**
16. Clean lines with 50.00 mL from DMF.
17. Blank.
18. ** wash Rink resin**
19. Wash RV1 with 10 mL from DMF 4 Times.
20. Fill RV1 with 10 mL from DMF.
21. Delay 5.00 minutes.
22. Empty RV1.
23. Blank.
24. Blank.
25. ** Fmoc-Glutamic Acid 1**
26. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes.
27. Fill RV1 with 5.20 mL from AA1.
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28. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
29. Empty RV1.
30. Fill RV1 with 10.00 mL from DMF.
31. Wash RV1 with 10.00 mL from DMF 4 Times.
32. Fill RV1 with 10 mL from DMF.
33. Delay 5.00 minutes.
34. Empty RV1.
35. Fill RV1 with 15.00 mL from PIP.
36. Mix RV1 via Mech/N2 Mix for 5 minutes.
37. Empty RV1.
38. Fill RV1 with 15.00 mL from PIP.
39. Mix RV1 via Mech/N2 Mix for 20 minutes.
40. Empty RV1.
41. Blank.
42. Fill RV1 with 10.00 mL from DMF.
43. Wash RV1 with 10.00 mL from DMF 4 Times.
44. Fill RV1 with 10 mL from DMF.
45. Delay 5.00 minutes.
46. Empty RV1.
47. Blank.
48. Blank.
49. ** Fmoc-Alanine 2**
50. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes.
51. Fill RV1 with 5.20 mL from AA2.
52. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
53. Empty RV1.
54. Fill RV1 with 10.00 mL from DMF.
55. Wash RV1 with 10.00 mL from DMF 4 Times.
56. Fill RV1 with 10 mL from DMF.
57. Delay 5.00 minutes.
58. Empty RV1.
59. Fill RV1 with 15.00 mL from PIP.
60. Mix RV1 via Mech/N2 Mix for 5 minutes.
61. Empty RV1.
62. Fill RV1 with 15.00 mL from PIP.
63. Mix RV1 via Mech/N2 Mix for 20 minutes.
64. Empty RV1.
65. Blank.
66. Fill RV1 with 10.00 mL from DMF.
67. Wash RV1 with 10.00 mL from DMF 4 Times.
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68. Fill RV1 with 10 mL from DMF.
69. Delay 5.00 minutes.
70. Empty RV1.
71. Blank.
72. Blank.
73.** Fmoc-Glutamic acid 3**
74. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes.
75. Fill RV1 with 5.20 mL from AA3.
76. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
77. Empty RV1.
78. Fill RV1 with 10.00 mL from DMF.
79. Wash RV1 with 10.00 mL from DMF 4 Times.
80. Fill RV1 with 10 mL from DMF.
81. Delay 5.00 minutes.
82. Empty RV1.
83. Fill RV1 with 15.00 mL from PIP.
84. Mix RV1 via Mech/N2 Mix for 5 minutes.
85. Empty RV1.
86. Fill RV1 with 15.00 mL from PIP.
87. Mix RV1 via Mech/N2 Mix for 20 minutes.
88. Empty RV1.
89. Blank.
90. Fill RV1 with 10.00 mL from DMF.
91. Wash RV1 with 10.00 mL from DMF 4 Times.
92. Fill RV1 with 10 mL from DMF.
93. Delay 5.00 minutes.
94. Empty RV1.
95. Blank.
96. Blank.
97.** Fmoc-Alanine 4**
98. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes.
99. Fill RV1 with 5.20 mL from AA4.
100. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
101. Empty RV1.
102. Fill RV1 with 10.00 mL from DMF.
103. Wash RV1 with 10.00 mL from DMF 4 Times.
104. Fill RV1 with 10 mL from DMF.
105. Delay 5.00 minutes.
106. Empty RV1.
107. Fill RV1 with 15.00 mL from PIP.
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108. Mix RV1 via Mech/N2 Mix for 5 minutes.
109. Empty RV1.
110. Fill RV1 with 15.00 mL from PIP.
111. Mix RV1 via Mech/N2 Mix for 20 minutes.
112. Empty RV1.
113. Blank.
114. Fill RV1 with 10.00 mL from DMF.
115. Wash RV1 with 10.00 mL from DMF 4 Times.
116. Fill RV1 with 10 mL from DMF.
117. Delay 5.00 minutes.
118. Empty RV1.
119. Blank.
120. Pause.
121. ** Fmoc-Glutamic Acid 5**
122. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes.
123. Fill RV1 with 5.20 mL from AA1.
124. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
125. Empty RV1.
126. Fill RV1 with 10.00 mL from DMF.
127. Wash RV1 with 10.00 mL from DMF 4 Times.
128. Fill RV1 with 10 mL from DMF.
129. Delay 5.00 minutes.
130. Empty RV1.
131. Fill RV1 with 15.00 mL from PIP.
132. Mix RV1 via Mech/N2 Mix for 5 minutes.
133. Empty RV1.
134. Fill RV1 with 15.00 mL from PIP.
135. Mix RV1 via Mech/N2 Mix for 20 minutes.
136. Empty RV1.
137. Blank.
138. Fill RV1 with 10.00 mL from DMF.
139. Wash RV1 with 10.00 mL from DMF 4 Times.
140. Fill RV1 with 10 mL from DMF.
141. Delay 5.00 minutes.
142. Empty RV1.
143. Blank.
144. Blank.
145. ** Fmoc-Alanine 6**
146. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes.
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147. Fill RV1 with 5.20 mL from AA2.
148. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
149. Empty RV1.
150. Fill RV1 with 10.00 mL from DMF.
151. Wash RV1 with 10.00 mL from DMF 4 Times.
152. Fill RV1 with 10 mL from DMF.
153. Delay 5.00 minutes.
154. Empty RV1.
155. Fill RV1 with 15.00 mL from PIP.
156. Mix RV1 via Mech/N2 Mix for 5 minutes.
157. Empty RV1.
158. Fill RV1 with 15.00 mL from PIP.
159. Mix RV1 via Mech/N2 Mix for 20 minutes.
160. Empty RV1.
161. Blank.
162. Fill RV1 with 10.00 mL from DMF.
163. Wash RV1 with 10.00 mL from DMF 4 Times.
164. Fill RV1 with 10 mL from DMF.
165. Delay 5.00 minutes.
166. Empty RV1.
167. Blank.
168. Blank.
169.** Fmoc-Glutamic acid 7**
170. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes.
171. Fill RV1 with 5.20 mL from AA3.
172. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
173. Empty RV1.
174. Fill RV1 with 10.00 mL from DMF.
175. Wash RV1 with 10.00 mL from DMF 4 Times.
176. Fill RV1 with 10 mL from DMF.
177. Delay 5.00 minutes.
178. Empty RV1.
179. Fill RV1 with 15.00 mL from PIP.
180. Mix RV1 via Mech/N2 Mix for 5 minutes.
181. Empty RV1.
182. Fill RV1 with 15.00 mL from PIP.
183. Mix RV1 via Mech/N2 Mix for 20 minutes.
184. Empty RV1.
185. Blank.
186. Fill RV1 with 10.00 mL from DMF.
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187. Wash RV1 with 10.00 mL from DMF 4 Times.
188. Fill RV1 with 10 mL from DMF.
189. Delay 5.00 minutes.
190. Empty RV1.
191. Blank.
192. Blank.
193.** Fmoc-Alanine 8**
194. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes.
195. Fill RV1 with 5.20 mL from AA4.
196. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
197. Empty RV1.
198. Fill RV1 with 10.00 mL from DMF.
199. Wash RV1 with 10.00 mL from DMF 4 Times.
200. Fill RV1 with 10 mL from DMF.
201. Delay 5.00 minutes.
202. Empty RV1.
203. Fill RV1 with 15.00 mL from PIP.
204. Mix RV1 via Mech/N2 Mix for 5 minutes.
205. Empty RV1.
206. Fill RV1 with 15.00 mL from PIP.
207. Mix RV1 via Mech/N2 Mix for 20 minutes.
208. Empty RV1.
209. Blank.
210. Fill RV1 with 10.00 mL from DMF.
211. Wash RV1 with 10.00 mL from DMF 4 Times.
212. Fill RV1 with 10 mL from DMF.
213. Delay 5.00 minutes.
214. Empty RV1.
215. Blank.
216. Pause.
217** Fmoc-Threonine 9**
218. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes.
219. Fill RV1 with 5.20 mL from AA1.
220. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
221. Empty RV1.
222. Fill RV1 with 10.00 mL from DMF.
223. Wash RV1 with 10.00 mL from DMF 4 Times.
224. Fill RV1 with 10 mL from DMF.
225. Delay 5.00 minutes.
226. Empty RV1.
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227. Fill RV1 with 15.00 mL from PIP.
228. Mix RV1 via Mech/N2 Mix for 5 minutes.
229. Empty RV1.
230. Fill RV1 with 15.00 mL from PIP.
231. Mix RV1 via Mech/N2 Mix for 20 minutes.
232. Empty RV1.
233. Blank.
234. Fill RV1 with 10.00 mL from DMF.
235. Wash RV1 with 10.00 mL from DMF 4 Times.
236. Fill RV1 with 10 mL from DMF.
237. Delay 5.00 minutes.
238. Empty RV1.
239. Blank.
240. Blank.
241. ** Fmoc-Threonine 10**
242. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes.
243. Fill RV1 with 5.20 mL from AA2.
244. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
245. Empty RV1.
246. Fill RV1 with 10.00 mL from DMF.
247. Wash RV1 with 10.00 mL from DMF 4 Times.
248. Fill RV1 with 10 mL from DMF.
249. Delay 5.00 minutes.
250. Empty RV1.
251. Fill RV1 with 15.00 mL from PIP.
252. Mix RV1 via Mech/N2 Mix for 5 minutes.
253. Empty RV1.
254. Fill RV1 with 15.00 mL from PIP.
255. Mix RV1 via Mech/N2 Mix for 20 minutes.
256. Empty RV1.
257. Blank.
258. Fill RV1 with 10.00 mL from DMF.
259. Wash RV1 with 10.00 mL from DMF 4 Times.
260. Fill RV1 with 10 mL from DMF.
261. Delay 5.00 minutes.
262. Empty RV1.
263. Blank.
264. Blank.
265.** Fmoc-Threonine 11**
266. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes.
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267. Fill RV1 with 5.20 mL from AA3.
268. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
269. Empty RV1.
270. Fill RV1 with 10.00 mL from DMF.
270. Wash RV1 with 10.00 mL from DMF 4 Times.
272. Fill RV1 with 10 mL from DMF.
273. Delay 5.00 minutes.
274. Empty RV1.
275. Fill RV1 with 15.00 mL from PIP.
276. Mix RV1 via Mech/N2 Mix for 5 minutes.
277. Empty RV1.
278. Fill RV1 with 15.00 mL from PIP.
279. Mix RV1 via Mech/N2 Mix for 20 minutes.
280. Empty RV1.
281. Blank.
282. Fill RV1 with 10.00 mL from DMF.
283. Wash RV1 with 10.00 mL from DMF 4 Times.
284. Fill RV1 with 10 mL from DMF.
285. Delay 5.00 minutes.
286. Empty RV1.
287. Blank.
288. Blank.
289.** Fmoc-Threonine 12**
290. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes.
291. Fill RV1 with 5.20 mL from AA4.
292. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
293. Empty RV1.
294. Fill RV1 with 10.00 mL from DMF.
295. Wash RV1 with 10.00 mL from DMF 4 Times.
296. Fill RV1 with 10 mL from DMF.
297. Delay 5.00 minutes.
298. Empty RV1.
299. Fill RV1 with 15.00 mL from PIP.
300. Mix RV1 via Mech/N2 Mix for 5 minutes.
301. Empty RV1.
302. Fill RV1 with 15.00 mL from PIP.
303. Mix RV1 via Mech/N2 Mix for 20 minutes.
304. Empty RV1.
305. Blank.
306. Fill RV1 with 10.00 mL from DMF.
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307. Wash RV1 with 10.00 mL from DMF 4 Times.
308. Fill RV1 with 10 mL from DMF.
309. Delay 5.00 minutes.
310. Empty RV1.
311. Blank.
312. Blank.
313.** Solvent switch & Storage**
314. Fill RV1 with 10.00 mL from DCM.
315. Wash RV1 with 10.00 mL from DCM 4 Times.
316. Fill RV1 with 10.00 mL from DCM.
317. Delay for 5.00 minutes.
318. Empty RV1.
319. Blank.
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Peptide 2: TTTT-AKAKAKAK
T= Threonine, A= Alanine, K=Lysine (Positive charge between pH 4.4~10)
Use Endeavor 90 peptide synthesizer (AAPPTec LLC) to synthesize peptide 2. It is
conducted on a 0.65 mmol/g Rink Fmoc-amide resin (0.65 mmol amide groups).
Aminno acid is made in 4× excess to Rink Fmoc-amide resin (4×0.65 mmol amino acid
in 5.2 mL of 0.9 M DIPEA/DMF solution for coupling each amino acid).
Synthesizing Program:
1. ** swelling & deprotection**
2. Wash RV1 with 10.00 mL from DMF 2 times.
3. Fill RV1 with 25.00 mL from DMF.
4. Blank.
5. Mix RV1 via Mechanical Mix for 45 minutes.
6. Empty RV1.
7. Fill RV1 with 15.00 mL from PIP.
8. Mix RV1 via Mech/N2 Mix for 5.00 minutes.
9. Empty RV1.
10. Blank.
11. Fill RV1 with 15.00 mL from PIP.
12. Mix RV1 via Mech/N2 Mix for 20 minutes.
13. Empty RV1.
14. Blank.
15. ** clean PIP from the fluid lines**
16. Clean lines with 50.00 mL from DMF.
17. Blank.
18. ** wash Rink resin**
19. Wash RV1 with 10 mL from DMF 4 Times.
20. Fill RV1 with 10 mL from DMF.
21. Delay 5.00 minutes.
22. Empty RV1.
23. Blank.
24. Blank.
25. ** Fmoc-Lysine 1**
26. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes.
27. Fill RV1 with 5.20 mL from AA1.
28. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
29. Empty RV1.
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30. Fill RV1 with 10.00 mL from DMF.
31. Wash RV1 with 10.00 mL from DMF 4 Times.
32. Fill RV1 with 10 mL from DMF.
33. Delay 5.00 minutes.
34. Empty RV1.
35. Fill RV1 with 15.00 mL from PIP.
36. Mix RV1 via Mech/N2 Mix for 5 minutes.
37. Empty RV1.
38. Fill RV1 with 15.00 mL from PIP.
39. Mix RV1 via Mech/N2 Mix for 20 minutes.
40. Empty RV1.
41. Blank.
42. Fill RV1 with 10.00 mL from DMF.
43. Wash RV1 with 10.00 mL from DMF 4 Times.
44. Fill RV1 with 10 mL from DMF.
45. Delay 5.00 minutes.
46. Empty RV1.
47. Blank.
48. Blank.
49. ** Fmoc-Alanine 2**
50. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes.
51. Fill RV1 with 5.20 mL from AA2.
52. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
53. Empty RV1.
54. Fill RV1 with 10.00 mL from DMF.
55. Wash RV1 with 10.00 mL from DMF 4 Times.
56. Fill RV1 with 10 mL from DMF.
57. Delay 5.00 minutes.
58. Empty RV1.
59. Fill RV1 with 15.00 mL from PIP.
60. Mix RV1 via Mech/N2 Mix for 5 minutes.
61. Empty RV1.
62. Fill RV1 with 15.00 mL from PIP.
63. Mix RV1 via Mech/N2 Mix for 20 minutes.
64. Empty RV1.
65. Blank.
66. Fill RV1 with 10.00 mL from DMF.
67. Wash RV1 with 10.00 mL from DMF 4 Times.
68. Fill RV1 with 10 mL from DMF.
69. Delay 5.00 minutes.
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70. Empty RV1.
71. Blank.
72. Blank.
73.** Fmoc-Lysine 3**
74. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes.
75. Fill RV1 with 5.20 mL from AA3.
76. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
77. Empty RV1.
78. Fill RV1 with 10.00 mL from DMF.
79. Wash RV1 with 10.00 mL from DMF 4 Times.
80. Fill RV1 with 10 mL from DMF.
81. Delay 5.00 minutes.
82. Empty RV1.
83. Fill RV1 with 15.00 mL from PIP.
84. Mix RV1 via Mech/N2 Mix for 5 minutes.
85. Empty RV1.
86. Fill RV1 with 15.00 mL from PIP.
87. Mix RV1 via Mech/N2 Mix for 20 minutes.
88. Empty RV1.
89. Blank.
90. Fill RV1 with 10.00 mL from DMF.
91. Wash RV1 with 10.00 mL from DMF 4 Times.
92. Fill RV1 with 10 mL from DMF.
93. Delay 5.00 minutes.
94. Empty RV1.
95. Blank.
96. Blank.
97.** Fmoc-Alanine 4**
98. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes.
99. Fill RV1 with 5.20 mL from AA4.
100. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
101. Empty RV1.
102. Fill RV1 with 10.00 mL from DMF.
103. Wash RV1 with 10.00 mL from DMF 4 Times.
104. Fill RV1 with 10 mL from DMF.
105. Delay 5.00 minutes.
106. Empty RV1.
107. Fill RV1 with 15.00 mL from PIP.
108. Mix RV1 via Mech/N2 Mix for 5 minutes.
109. Empty RV1.
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110. Fill RV1 with 15.00 mL from PIP.
111. Mix RV1 via Mech/N2 Mix for 20 minutes.
112. Empty RV1.
113. Blank.
114. Fill RV1 with 10.00 mL from DMF.
115. Wash RV1 with 10.00 mL from DMF 4 Times.
116. Fill RV1 with 10 mL from DMF.
117. Delay 5.00 minutes.
118. Empty RV1.
119. Blank.
120. Pause.
121. ** Fmoc-Lysine 5**
122. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes.
123. Fill RV1 with 5.20 mL from AA1.
124. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
125. Empty RV1.
126. Fill RV1 with 10.00 mL from DMF.
127. Wash RV1 with 10.00 mL from DMF 4 Times.
128. Fill RV1 with 10 mL from DMF.
129. Delay 5.00 minutes.
130. Empty RV1.
131. Fill RV1 with 15.00 mL from PIP.
132. Mix RV1 via Mech/N2 Mix for 5 minutes.
133. Empty RV1.
134. Fill RV1 with 15.00 mL from PIP.
135. Mix RV1 via Mech/N2 Mix for 20 minutes.
136. Empty RV1.
137. Blank.
138. Fill RV1 with 10.00 mL from DMF.
139. Wash RV1 with 10.00 mL from DMF 4 Times.
140. Fill RV1 with 10 mL from DMF.
141. Delay 5.00 minutes.
142. Empty RV1.
143. Blank.
144. Blank.
145. ** Fmoc-Alanine 6**
146. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes.
147. Fill RV1 with 5.20 mL from AA2.
148. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
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149. Empty RV1.
150. Fill RV1 with 10.00 mL from DMF.
151. Wash RV1 with 10.00 mL from DMF 4 Times.
152. Fill RV1 with 10 mL from DMF.
153. Delay 5.00 minutes.
154. Empty RV1.
155. Fill RV1 with 15.00 mL from PIP.
156. Mix RV1 via Mech/N2 Mix for 5 minutes.
157. Empty RV1.
158. Fill RV1 with 15.00 mL from PIP.
159. Mix RV1 via Mech/N2 Mix for 20 minutes.
160. Empty RV1.
161. Blank.
162. Fill RV1 with 10.00 mL from DMF.
163. Wash RV1 with 10.00 mL from DMF 4 Times.
164. Fill RV1 with 10 mL from DMF.
165. Delay 5.00 minutes.
166. Empty RV1.
167. Blank.
168. Blank.
169.** Fmoc-Lysine 7**
170. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes.
171. Fill RV1 with 5.20 mL from AA3.
172. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
173. Empty RV1.
174. Fill RV1 with 10.00 mL from DMF.
175. Wash RV1 with 10.00 mL from DMF 4 Times.
176. Fill RV1 with 10 mL from DMF.
177. Delay 5.00 minutes.
178. Empty RV1.
179. Fill RV1 with 15.00 mL from PIP.
180. Mix RV1 via Mech/N2 Mix for 5 minutes.
181. Empty RV1.
182. Fill RV1 with 15.00 mL from PIP.
183. Mix RV1 via Mech/N2 Mix for 20 minutes.
184. Empty RV1.
185. Blank.
186. Fill RV1 with 10.00 mL from DMF.
187. Wash RV1 with 10.00 mL from DMF 4 Times.
188. Fill RV1 with 10 mL from DMF.
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189. Delay 5.00 minutes.
190. Empty RV1.
191. Blank.
192. Blank.
193.** Fmoc-Alanine 8**
194. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes.
195. Fill RV1 with 5.20 mL from AA4.
196. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
197. Empty RV1.
198. Fill RV1 with 10.00 mL from DMF.
199. Wash RV1 with 10.00 mL from DMF 4 Times.
200. Fill RV1 with 10 mL from DMF.
201. Delay 5.00 minutes.
202. Empty RV1.
203. Fill RV1 with 15.00 mL from PIP.
204. Mix RV1 via Mech/N2 Mix for 5 minutes.
205. Empty RV1.
206. Fill RV1 with 15.00 mL from PIP.
207. Mix RV1 via Mech/N2 Mix for 20 minutes.
208. Empty RV1.
209. Blank.
210. Fill RV1 with 10.00 mL from DMF.
211. Wash RV1 with 10.00 mL from DMF 4 Times.
212. Fill RV1 with 10 mL from DMF.
213. Delay 5.00 minutes.
214. Empty RV1.
215. Blank.
216. Pause.
217** Fmoc-Threonine 9**
218. Dissolve AA1 with 5.20 mL from DIPEA for 5.00 minutes.
219. Fill RV1 with 5.20 mL from AA1.
220. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
221. Empty RV1.
222. Fill RV1 with 10.00 mL from DMF.
223. Wash RV1 with 10.00 mL from DMF 4 Times.
224. Fill RV1 with 10 mL from DMF.
225. Delay 5.00 minutes.
226. Empty RV1.
227. Fill RV1 with 15.00 mL from PIP.
228. Mix RV1 via Mech/N2 Mix for 5 minutes.
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229. Empty RV1.
230. Fill RV1 with 15.00 mL from PIP.
231. Mix RV1 via Mech/N2 Mix for 20 minutes.
232. Empty RV1.
233. Blank.
234. Fill RV1 with 10.00 mL from DMF.
235. Wash RV1 with 10.00 mL from DMF 4 Times.
236. Fill RV1 with 10 mL from DMF.
237. Delay 5.00 minutes.
238. Empty RV1.
239. Blank.
240. Blank.
241. ** Fmoc-Threonine 10**
242. Dissolve AA2 with 5.20 mL from DIPEA for 5.00 minutes.
243. Fill RV1 with 5.20 mL from AA2.
244. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
245. Empty RV1.
246. Fill RV1 with 10.00 mL from DMF.
247. Wash RV1 with 10.00 mL from DMF 4 Times.
248. Fill RV1 with 10 mL from DMF.
249. Delay 5.00 minutes.
250. Empty RV1.
251. Fill RV1 with 15.00 mL from PIP.
252. Mix RV1 via Mech/N2 Mix for 5 minutes.
253. Empty RV1.
254. Fill RV1 with 15.00 mL from PIP.
255. Mix RV1 via Mech/N2 Mix for 20 minutes.
256. Empty RV1.
257. Blank.
258. Fill RV1 with 10.00 mL from DMF.
259. Wash RV1 with 10.00 mL from DMF 4 Times.
260. Fill RV1 with 10 mL from DMF.
261. Delay 5.00 minutes.
262. Empty RV1.
263. Blank.
264. Blank.
265.** Fmoc-Threonine 11**
266. Dissolve AA3 with 5.20 mL from DIPEA for 5.00 minutes.
267. Fill RV1 with 5.20 mL from AA3.
268. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
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269. Empty RV1.
270. Fill RV1 with 10.00 mL from DMF.
270. Wash RV1 with 10.00 mL from DMF 4 Times.
272. Fill RV1 with 10 mL from DMF.
273. Delay 5.00 minutes.
274. Empty RV1.
275. Fill RV1 with 15.00 mL from PIP.
276. Mix RV1 via Mech/N2 Mix for 5 minutes.
277. Empty RV1.
278. Fill RV1 with 15.00 mL from PIP.
279. Mix RV1 via Mech/N2 Mix for 20 minutes.
280. Empty RV1.
281. Blank.
282. Fill RV1 with 10.00 mL from DMF.
283. Wash RV1 with 10.00 mL from DMF 4 Times.
284. Fill RV1 with 10 mL from DMF.
285. Delay 5.00 minutes.
286. Empty RV1.
287. Blank.
288. Blank.
289.** Fmoc-Threonine 12**
290. Dissolve AA4 with 5.20 mL from DIPEA for 5.00 minutes.
291. Fill RV1 with 5.20 mL from AA4.
292. Mix RV1 via Mech/N2 Mix for 30.00 minutes.
293. Empty RV1.
294. Fill RV1 with 10.00 mL from DMF.
295. Wash RV1 with 10.00 mL from DMF 4 Times.
296. Fill RV1 with 10 mL from DMF.
297. Delay 5.00 minutes.
298. Empty RV1.
299. Fill RV1 with 15.00 mL from PIP.
300. Mix RV1 via Mech/N2 Mix for 5 minutes.
301. Empty RV1.
302. Fill RV1 with 15.00 mL from PIP.
303. Mix RV1 via Mech/N2 Mix for 20 minutes.
304. Empty RV1.
305. Blank.
306. Fill RV1 with 10.00 mL from DMF.
307. Wash RV1 with 10.00 mL from DMF 4 Times.
308. Fill RV1 with 10 mL from DMF.
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309. Delay 5.00 minutes.
310. Empty RV1.
311. Blank.
312. Blank.
313.** Solvent switch & Storage**
314. Fill RV1 with 10.00 mL from DCM.
315. Wash RV1 with 10.00 mL from DCM 4 Times.
316. Fill RV1 with 10.00 mL from DCM.
317. Delay for 5.00 minutes.
318. Empty RV1.
319. Blank.
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Appendix D
Permission License Number for Chapter 4
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Appendix E
Permission License Number for Chapter 5
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